The association between sleep and obesity and its impact on health and wellbeing by Hosseini Araghi, Marzieh
THE ASSOCIATION BETWEEN 
SLEEP AND OBESITY AND ITS 
IMPACT ON HEALTH AND 
WELLBEING  
 
 
 
 
 
 
MARZIEH HOSSEINI ARAGHI BSc MPH 
 
A thesis submitted to 
The University of Birmingham 
For the degree of 
DOCTOR OF PHILOSOPHY 
 
 
 
 
 
 
 
 
 
 
 
 
College of Medical and Dental Sciences  
Clinical & Experimental Medicine  
The University of Birmingham  
November 2013 
 
 
 
 
 
 
 
 
 
 
 
University of Birmingham Research Archive 
 
e-theses repository 
 
 
This unpublished thesis/dissertation is copyright of the author and/or third 
parties. The intellectual property rights of the author or third parties in respect 
of this work are as defined by The Copyright Designs and Patents Act 1988 or 
as modified by any successor legislation.   
 
Any use made of information contained in this thesis/dissertation must be in 
accordance with that legislation and must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the permission 
of the copyright holder.  
 
 
 
1 
 
Abstract:  
The focus of this thesis was to investigate, especially in the context of obesity, the 
interactions among sleep duration and quality, and adverse health outcomes.Three 
comprehensive studies are described in the thesis: 1. A cross-sectional epidemiological 
study examined factors that are associated with both short and long sleep duration 
among an older Chinese population, and also assessed whether there was a link 
between sleep duration and chronic conditions such as obesity, hypertension, and 
diabetes. This study showed that long sleep duration was associated with increased 
risk for obesity among women. Additionally, demographic, socio-economic, and 
medical conditions were associated with sleep duration. Identifying potential factors 
that affect sleep will inform future interventions for improving sleep with potential 
downstream effect on obesity and other chronic disorders. 2. A cross-sectional study 
of patients with extreme obesity indicated that the prevalence of sleep disturbance is 
high in this patient population.  There was a positive association between sleep 
disturbance factors and depressive symptoms and quality of life among these 
individuals. The findings emphasise the importance of adequate assessment and 
treatment of sleep problems in this patient population. 3. A systematic review and 
meta-analysis assessed the effectiveness of lifestyle modification interventions on the 
treatment of obstructive sleep apnoea (OSA). Lifestyle interventions such as dietary 
and physical activity improved OSA parameters, but were insufficient to normalise 
them. The findings will inform the development of future interventions for OSA, and 
are likely to contribute to clinical guidelines for OSA management. 
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1 INTRODUCTION 
1.1 Overview of sleep and its importance to health  
It is generally believed that sleep is an important aspect of a healthy lifestyle. An adult 
spends approximately a third of his/her adult life sleeping.  However, the duration and 
need for sleep changes across the lifespan.1 Evidence from animal studies suggests that 
prolonged total sleep deprivation may lead to death; it takes about 2 to 3 weeks for 
totally sleep deprived rats to die.2 The experimental evidence points towards a greater 
impact of short sleep duration on health and well-being as opposed to long sleep 
duration. As experimental studies on the effects of prolonged sleep deprivation cannot 
be conducted in humans, our understanding must rely on evidence from cumulative 
epidemiological studies and short-term experimental studies. Epidemiological 
evidence has, however, been conflicting. Several studies have suggested that both short 
and long sleep duration are associated with an increased risk for mortality.3 The 
experimental evidence points towards a greater impact of short as opposed to long 
sleep. There are several interrelated aspects of sleep including sleep duration and 
quality. Increasing evidence is highlighting the importance of sleep quality as well as 
quantity for optimal health.4 It is believed that the potential adverse physiological 
outcomes of shorter and or poor quality sleep such as obesity, diabetes, and 
cardiovascular may mediate the pathways between sleep and mortality.4 
1.1.1 Sleep architecture 
Electroencephalography (EEG) is commonly used to record the brain activity during 
sleep as part of polysomnography.5 Polysomnographically, sleep is divided in two 
main types; non-rapid eye movement (NREM) and rapid eye movement (REM). Based 
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on recent criteria, NREM sleep is also divided into 3 stages; N1, N2, N3. In general, 
sleep commences with NREM sleep and proceeds from stage N1 to stage N3, followed 
by a stepwise return to N1, which is then followed by REM sleep (Stage R).6 The 
stages are then repeated with every cycle occurring 5-7 times per night. The first 
NREM-REM sleep cycle is shorter than second and later cycles.7 On average, 80% of 
total night-time sleep is NREM and 20% REM. N1 is a transitional phase between 
sleep and wakefulness. It is more likely for N1 sleep to be disrupted by external stimuli. 
The length of this stage is normally between 1 to 7 minutes, which contributes to 
approximately about 4% of total nocturnal sleep.7 Responsiveness to external stimuli 
considerably decreases in N2 stage of sleep and this stage constitutes approximately 
45% of sleep. N3 is commonly known as slow-wave sleep (SWS), which typically 
occurs in the earlier part of the night. The length of N3 sleep normally only contributes 
to a small percentage of total sleep time, and constitutes about 10% of sleep.8 REM 
sleep is normally classified as two subdivided stages; “phasic” REM and “tonic” REM. 
The phasic REM consists of rapid eye movements, muscle twitches, and respiratory 
alterations. REM sleep is dominated by increased sympathetic nervous system activity. 
On the other hand, the tonic REM is dominated by parasympathetic nervous system 
activity. In general, it is believed that most of dreaming occurs during REM sleep. 
Memory processes are also more likely to be promoted in this stage.7  
1.1.2 The mechanisms regulating sleep 
The alternation between sleep and wakefulness is mainly governed by two interacting 
drives: circadian rhythm and homeostatic sleep drives (Figure 1-1).9  
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1.1.2.1 Circadian drive (Process C) 
Circadian comes from the Latin phrase of “circa diem” which means “about a 
day”.  The hypothalamic suprachiasmatic nucleus (SCN), which is also known as 
biological clock regulates various intrinsic body rhythms.10 The SCN synchronises 
daily behavioural and physiological rhythms. The regulation of body core temperature 
is also controlled by the SCN. A decrease in body temperature in the evening can 
potentially promote sleep and conversely, an increase in body temperature is 
associated with wakefulness in the early morning. There are several conditions such 
as seasonal affective disorder (SAD), advanced sleep phase syndrome (ASPS), 
delayed sleep phase syndrome (DSPS), and jet lag, which are related to alterations in 
circadian regulation.11 Melatonin, produced by the pineal gland is a hormone that has 
an important role in the regulation of the human sleep-wake cycle. It has been found 
that melatonin secretion marks the diminution of the circadian drive for wakefulness 
allowing sleep to occur.11 
1.1.2.2 Homeostatic sleep drive (Process S) 
The task of the homeostatic sleep drive is often anecdotally interpreted to be similar to 
what happens in a bank. During wakefulness, a sleep debt accumulates, this needs to 
be repaid through sleeping. Thus, the homeostatic drive becomes stronger as the day 
progresses and when the circadian drive diminishes, sleep can proceed.10 Prior sleep 
and wakefulness may influence the homeostatic drive and determine sleep need or 
sleep pressure. In normal conditions, sleep pressure increases during wakefulness and 
diminishes during sleep. However, with sleep deprivation, it increases continuously 
until sleep occurs. The circadian pacemaker maintains the periods of wakefulness and 
sleep. Daily EEG activities may also be influenced by circadian pacemaker.8  
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Figure 1-1. A model for the regulation sleep-wake under the influence of circadian 
and homeostatic drives.9 
Printed with the permission of Dr Borbely.  
1.1.3 Sleep patterns across the life span 
It is known that sleep patterns change with age. In general, the mechanisms underlying 
onset and prolongation of sleep differ from infancy to later stages of adulthood. It is 
believed that there is an inverse link between sleep efficiency (a common measure for 
sleep quality, calculated as total sleep duration divided by time spent in bed) and age 
advancement. The impact of age on sleep patterns is complex and is not fully 
understood. Investigation of sleep characteristics across the life span may potentially 
help us to understand the function of sleep and develop strategies for improvement of 
sleep efficiency.  
1.1.3.1  Newborns 
Total sleep duration is markedly longer at birth. On average, the sleep duration of a 
newborn is between 16 to 18 hours.12 The circadian system is not fully developed 
among newborns, therefore infants have three distinctive sleep types; quiet sleep 
(equivalent to NREM), active sleep (similar to REM) and intermediate sleep.12 Sleep 
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commencement normally occurs in REM, as there is no distinct NREM. Sleep 
consolidation shows greater establishment at 2 to 3 months of age, when circadian 
rhythms mature. Control of 24-hour core body temperature, nocturnal sleep adjustment 
and regulation of melatonin and cortisol hormones occurs within the first three months 
since birth, as a result of circadian rhythm development.13  
Sleep-wake cycles become more regular by 3 months of age. Sleep onset begins with 
NREM sleep with the duration of NREM-REM cycle being approximately 50 minutes. 
Total sleep duration significantly decreases between 6 and 12 months of age and the 
majority of sleep occurs in the evenings with one or two napping episode during the 
day.12 
1.1.3.2 Young children and adolescents  
It is believed that sleep duration decreases, as a child gets older. By 5 years of age, the 
total amount of sleep decreases by 2 hours.14 Environmental changes as well 
physiological changes have a significant impact on sleep characteristics among young 
children. A reduction in the frequency of daytime napping among children aged 
between 3 to 5 years old could be a potential factor that contributes to reduction in 
sleep time. School time routines may also correlate with a decrease in time asleep.13 
Circadian sleep phase preferences appear to be consolidated by the time children enter 
school.13 It has been previously found that compared to adolescents, younger children 
tend to have prolonged REM sleep and their sleep time in N3 sleep is relatively 
higher.15  
Total sleep duration between 9 to 10 hours per night has been recommended for 
adolescents to have favourable performance.15 However, the majority of individuals 
who are in their second decade of life sleep less than recommended amount. The 
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results of a large population-based study in the US demonstrated that the average sleep 
time of a group of students who are in secondary school is about 7.9 hours per night.16 
Sleep deprivation and excessive technology use has been reported to be significantly 
associated with a greater risk of obesity among UK adolescents.17 Alteration in the 
regulation of hormones and initiation of puberty has been found to be associated with 
a reduction in SWS and a rise in N2 sleep. It has also been found that compared to 
earlier stages of puberty, the later stages are associated with excessive daytime 
sleepiness.15 
1.1.3.3 Adults and older people 
A decline in sleep consolidation and earlier arousal from sleep in the morning are 
considered to be two consistent sleep changes that occur at later stages of adulthood.18 
Older individuals are more likely to go to bed earlier in the evenings and also wake up 
at an earlier time in the mornings compared to younger individuals i.e. their sleep phase 
is advanced. Common causal factors for poor sleep quality in older individuals is 
summarised in Table 1-1. Although, the underlying reasons for early morning 
awakening of older adults is not known, one explanation is a positive association with 
light sensitivity and ageing.18 Age-related alterations in the circadian pacemaker could 
also be a potential mechanism explaining why older individuals experience early 
awakenings.19 Delay in the morning body temperature rise and modifications in 
secretion patterns of cortisol and melatonin are common consequences of age-related 
changes in the circadian pacemaker that could potentially increase the likelihood of 
early sleep arousal of older adults.18 The episodes of awakening are normally very 
brief among younger individuals, occurring in REM sleep.20 REM sleep arousals that 
commonly occur among younger adults suggest that there is a protective mechanism 
that could potentially prevent awakening in NREM sleep amongst these individuals, 
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and that this gradually disappears as age increased. As during SWS, arousal thresholds 
are in the highest range and the length of SWS may gradually decrease with ageing; 
therefore older individuals experience frequent early awakenings.20  
Table 1-1. Summary of common causal factors for poor sleep quality in older 
individuals. 
Causal factors Examples 
Physiologic Age-related alteration in circadian 
rhythm, the menopause, deterioration in 
vision (light sensitivity), neuronal loss 
 
Medical disorders Arthritis, chronic cardiac or pulmonary 
disease, gastro-oesophageal reflux 
disorder, prostatic hypertrophy, 
medications (e.g. diuretics) 
 
Psychiatric disorders Depression, dementia 
 
Primary sleep problems Obstructive sleep apnoea (OSA), REM 
sleep behaviour disorder  
 
Behavioural and social factors 
 
Retirement (changes in wake up and 
sleep time), bereavement, napping 
 
Environmental factors 
 
Bedroom environment (e.g. noise, light, 
temperature, bedding) 
 
While the ability to sleep declines with ageing, it is important to consider that the need 
to sleep does not appear to fade out at any stages of life span. Sleep problems are highly 
prevalent among older adults.21 It has been found that disrupted sleep could negatively 
influence quality of life, mood and vigilance among older individuals.21 The majority 
of older adults experience difficulties initiating and maintaining sleep.22 Several health 
conditions such as depression, chronic respiratory disease, and physical disability may 
also contribute to alterations in sleep patterns of older individuals.21 However, a 
reduction in sleep efficiency has been detected among ‘healthy’ older individuals.23 
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The impact of ageing on sleep patterns differs significantly between men and women. 
A decline in SWS appears to predominantly affect men. By 70 years of age, women 
on average spend 20 per cent of their total sleep time in N3 sleep, while men spend 
less than 5 per cent of their total sleep time in N3 sleep.24 Older women have advanced 
body temperature rhythms, which could explain why they tend to go to bed earlier in 
evenings and wake up earlier in the mornings compared to older men.20 A reduction 
in REM sleep is consistent with ageing and is not affected by gender. A decline in 
circadian rhythms contributes to a reduction in melatonin levels among older 
individuals. Deterioration in sleep continuity and frequent episodes of awakening may 
be associated with sleep homeostasis impairment among the older population.21  
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1.1.4 The measurement of sleep and associated phenomena 
The current techniques for measuring sleep are summarised in Table 1-2. A self-report 
measure, due to its convenience, is the most common method that has been utilised to 
collect data on sleep, especially in large epidemiological studies. Individuals reporting 
sleep duration through questionnaires are generally poor at estimating sleep latency 
(time taken to get to sleep), sleep onset (time sleep starts), sleep duration, and sleep 
quality. The clearest demonstration of the inaccuracies associated with self-reported 
sleep measures is in insomnia. For example, findings from a study comparing 
subjective (using self-reported questionnaire) and objective (using polysomnography) 
measures of sleep perception among 92 individuals with insomnia, aged 19 to 84 years, 
showed that total sleep time was underestimated by a median of 81 minutes.25 Another 
inaccuracy with self-reported sleep measures occurs due to individuals rounding up 
their sleep timings, which will affect accuracy.  
Subjective sleep data may not be reliable and the possibility of recall bias cannot be 
completely ruled out. Recall bias could result in a differential misclassification of 
participants into certain categories. Ultimately, differential misclassification could 
result in an incorrect estimation of the association between exposure and outcome. The 
estimated measure of effect size can depart either towards or away from the null 
hypothesis as a result of recall bias of sufficient magnitude. If cases systematically 
report being exposed or more exposed individuals report developing a disease, the risk 
estimate is biased away from the null in case-control and retrospective cohort studies 
respectively. If, for instance, in the association between sleep duration and obesity, a 
great proportion of the cases are incorrectly classified as short sleepers, the association 
between short sleep duration and obesity may be overestimated. However, given that 
25 
 
the described association has not been widely reported, it would be less likely to be 
differentially reported.  Ideally, objective measures of sleep and measurements of 
adiposity could minimise the effect of recall bias in this association, thus providing 
true estimation of the effect size. 
Accurate and precise estimates of sleep parameters can be obtained via 
polysomnography (PSG), the ‘gold standard’ for measuring sleep. PSG can provide 
data on total sleep time, duration of each stage of sleep, number of arousals and sleep 
efficiency.26 However, using PSG may not be feasible in studies with a large sample 
size, as this method is expensive, very time consuming and requires technical 
expertise. Usually, overnight PSG requires participants to sleep in the laboratory and 
to be attached to several electrodes which may cause sleep disruption among these 
individuals.26 Population studies have been carried out successfully with PSG in the 
home environment, but are costly.27 
Another objective method for collecting data on sleep is using accelerometry 
(actigraphy). The actigraph device is worn on the non-dominant wrist to measure 
movement activity and can be worn continuously for prolonged periods depending on 
the battery life and memory size of the device employed. Unlike PSG, actigraphy is 
not able to capture transition from wake to sleep and vice versa.28, 29 Compared to PSG, 
actigraphy may provide more accurate and realistic information on sleep patterns, as a 
result of its portable and non-invasive feature which makes it practical for participants 
to use during their daily normal activity.28 However, there is a high probability that the 
overall total sleep duration could be overestimated as a result of sedentary behaviour 
(e.g. sitting and watching TV). Finally, there is a need for a software programme and 
trained person for data synthesis.29   
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Measures of sleep such as sleep diaries could efficiently capture data on habitual sleep 
duration, sleep satisfaction and daytime sleepiness, but it could result in individuals 
overestimating their sleep duration and inaccurately reporting on their sleep quality. 
In general, the Pittsburgh Sleep Quality Index (PSQI)30 and Epworth Sleepiness Scale 
(ESS)31 are two validated and reliable questionnaires that may provide insight into 
sleep and its quality.
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Table 1-2. Common techniques used to assess sleep.   
Technique Description Advantages Limitations 
Polysomnography A combination of electroencephalogram, 
electrooculogram, and electromyogram is used 
to obtain sleep data. Additional instrumentation 
is used for respiratory parameters, and 
behaviours and vocalizations during sleep 
 Objective 
 Obtain data on brain activity and 
physiological measures 
 Determine sleep stages 
 
 Not suitable for studies with large 
sample sizes 
 Intrusive 
 Expensive 
 Time consuming  
 Requires an expert to score data  
 
Actigraphy Worn on a non-dominant wrist to measure 
movement activity 
 Objective 
 Inexpensive 
 Provides data on sleep over 
prolonged period 
 
 Less accurate than PSG  
 Overestimates sleep duration and 
awakenings 
 Reliance on software 
Sleep diary Keeping a log of sleep-wake times and other 
relevant information by participants  
 Inexpensive 
 Applicable to large samples 
 Provide longitudinal data 
 Prone to bias 
 The validity and reliability of data 
depend on design and structure of the 
diary 
 
Pittsburgh  
Sleep Quality  
Index  
Categorises responses into seven sleep quality 
components providing a global sleep quality 
score 
 Inexpensive 
 Applicable to large samples 
 Provides subscale and total 
scores of sleep quality 
 
 Prone to bias  
Epworth  
Sleepiness  
Scale 
Eight-item scale assessing possibility of dozing 
off across eight different situations 
 Inexpensive 
 Applicable to large samples 
 Only provides information on one 
component of sleep (daytime 
sleepiness) 
 Not all situations are applicable to 
everyone 
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1.2 Overview of sleep and hypertension 
The prevalence of hypertension has increased in the past few decades.32 During the 
same period, average sleep duration has declined and evidence suggests that there is a 
potential link between reduced sleep and hypertension.33 Several cross-sectional32-36 
and longitudinal37-39 studies have previously investigated whether there is a link 
between sleep duration and hypertension. There is a high diversity in the findings of 
these studies. The results of these studies suggest that only short34, 35, 37-39 sleep 
duration or both short and long sleep duration32, 33 are associated with hypertension. 
Some studies have only found significant association in different age or gender groups 
and some have found no36, 40 association.  
In a recent large population-based study (more than 71,455 participants) Fang and 
colleagues33 assessed the link between sleep duration and hypertension by age and 
gender among US adults. Their overall findings showed that sleep duration and 
hypertension interacted in U-shaped manner in the whole sample, using 8 hours sleep  
as the referent, (odds ratios (95% CI), <6 hours: OR 1.49, 95% CI 1.34 – 1.64, 6 hours: 
OR 1.15, 95% CI 1.08 – 1.23, ≥10 hours: OR 1.20, 95% CI 1.05 – 1.37) manner in the 
whole sample. Further analysis, stratifying for age and gender demonstrated that sleep 
was associated higher probability of hypertension among short sleepers (<6 hours for 
men, OR 1.99, 95% CI 1.52 – 2.60, women: OR 2.13, 95% CI 1.66 – 2.74) and long 
sleeping adults (≥10 hours for men: OR 1.56, 95% CI 1.05 – 2.32) aged 45 years or 
younger.33 In a similar study, Gottlieb and colleagues32 analysed data from Sleep Heart 
Health Study, which involved 2,813 men and 3,097 women, aged 40 to 100 years. 
Following adjustment for potential factors including age, sex, race, obesity, and 
apnoea hypopnoea index (AHI; a measure of obstructive sleep apnoea), the authors 
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found that compared with sleep duration of 7 to <8 hours per night, both middle-aged 
and older individuals reported sleeping less than 7 hours per night or 8 hours or more 
per night had higher risk for hypertension (OR 1.19, 95% CI 1.02 – 1.39 and OR 1.19, 
95% CI 1.04 – 1.37, respectively). In China, Wang and colleagues41, in a study of 
1,033 men and 783 women 18 to 65 years, reported that compared to sleeping 7 to 
<9h, short sleep duration (<7 hours per night) in women and long sleep duration (≥9 
hours per night) in men were significantly associated with increased risk of 
hypertension (OR 3.0, 95% CI 1.4 – 6.6 and OR 1.5, 95% CI 1.1 – 2.2, respectively). 
An odds ratio of 3 is a large effect that may raise the question of biological plausibility. 
In the UK, results from a fully adjusted cross-sectional analysis of Whitehall II cohort 
study (n = 10,308)34 showed that compared to individuals sleeping 7 hours per night, 
only short sleep duration (≤5 hours per night) was associated with increased risk (OR 
2.01, 95% CI 1.13 – 3.58) for hypertension among women only and such a pattern was 
not found to be significant among men. In Norway, Bjorvatn and colleagues35 reported 
in a subgroup of 8,860 participants, aged 40 to 45 years, that that the mean of both 
systolic and diastolic blood pressure were higher among short sleepers, but this 
association no longer remained significant following adjustment for gender, age and 
smoking and only sleep duration of 5-<6 (regression coefficient β = -0.025, p<0.05) 
and 6-<7 (β = -0.027, p<0.05) hours were observed to have an inverse association with 
systolic blood pressure compared to the reference sleep group of 7-<8 hours. 
In the Rotterdam Study36 which involved 5,058 participants aged 58 to 98 years, both 
self-reported measures of sleep and objective measures of sleep via actigraphy were 
used to assess the potential link between sleep and hypertension and the findings 
demonstrated that there was no association between sleep duration and hypertension.  
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It is difficult to interpret the temporal association between sleep and hypertension from 
the results of cross-sectional studies; therefore longitudinal studies may help to draw 
a better conclusion about a potential causal pathway between sleep and hypertension. 
However, like cross-sectional studies, there is diversity between findings of the 
available longitudinal studies investigating the role of sleep duration and incidence and 
progression of hypertension.  
Results from the Coronary Artery Risk Development in Young Adults (CARDIA) 
cohort study37 showed that after 5-year follow-up, short sleep duration was a strong 
predictor for the incidence of hypertension among 578 African-Americans and Whites 
aged 33 to 45 years (Hazard Ratio [HR] 1.37, 95% CI 1.05 – 1.78). Using data from 
National Health and Nutrition Examination Survey (NHANES I), Gangwisch and 
colleagues38 reported that compared to 7 to 8 hours of sleep, short sleep duration (≤5 
hours per night) was associated with higher risk for incidence of hypertension (HR 
2.10; 95% CI 1.58 – 2.79) only among individuals between the ages of 32 and 59 years, 
and this association was not significant in those aged between 60 and 86 years.38 In 
Korea, Kim and colleagues39 reported that compared to sleep duration of 7 hours, short 
sleep duration (<5 hours per night) was associated with increased risk for incident of 
hypertension only among premenopausal women (HR 1.53, 95% CI 1.06 – 2.21). In a 
cohort study, which involved 3,608 older (≥60 years) Spanish people, Lopez-Garcia 
and colleagues40 could not observe any significant association between sleep duration 
and incidence of hypertension. 
A recent systematic review and meta-analysis42 was conducted to quantitatively 
investigate the association between sleep duration and hypertension in adults. The 
meta-analysis included 21 studies, which represented 225,858 participants. The pooled 
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results from cross-sectional studies showed that compared to average sleep duration, 
short and long sleep duration were associated with 21% (95% CI, 1.09 - 1.34) and 11% 
(95% CI, 1.04 - 1.18), respectively higher risk for hypertension. The pooled results 
from longitudinal studies indicate that only short sleep duration was associated with 
increased risk of incidence and development of hypertension by 23% (95% CI, 1.06 - 
1.42), but such an association was not found for long sleep duration. The authors also 
performed stratified analysis and examined the impact of gender on the association of 
sleep duration and hypertension and they found women who were short sleepers had 
higher risk to be hypertensive compared to men, but men who were long sleepers had 
higher risk for hypertension compared to women.42 
In general, subjective measures (i.e. self-reported questionnaire) of sleep were used by 
the most of the studies that assessed the link between sleep duration and hypertension, 
although one study36 used an objective measure of sleep (using actigraphy) and could 
not find any significant association between sleep and a higher risk for hypertension. 
The diversity of findings among these studies can be explained by differences in socio-
demographic and socio-economic characteristics of the sample. It has been suggested 
that the positive association between sleep and hypertension, which was observed 
among younger individuals, is not present among older individuals. Previous evidence 
suggests that short sleep duration may cause alteration in endocrine and metabolism 
system and cause weight gain and high blood pressure.43 It can be hypothesised that 
sleep loss may have different origins and have different consequences between 
younger and older individuals. Endogenous factors such as a fixed pattern of waking 
time to go to work may lead to sleep restriction among younger individuals, while the 
majority of older people are retired and their sleep loss may be due to other sleep 
problems such as insomnia.  
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The biological mechanism underlying the association between sleep duration and 
hypertension, if any, is yet to be found. It was previously suggested that short sleep 
duration may increase the activation of sympathetic nervous system, which may 
aggravate higher blood pressure.43 Additionally, short sleep duration may change the 
activity of the hypothalamic-pituitary-adrenal axis which regulates the secretion of 
cortisol; thus sleep loss may result high blood pressure via increased elevation of 
cortisol.44 It is likely that other hormones are also involved but these have not been 
investigated in detail. 
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1.3 Overview of sleep and diabetes 
Several cross-sectional45-51 and prospective52-60 studies have previously investigated 
the link between sleep duration and diabetes. The results of studies are diverse, but the 
majority of studies suggest that short sleep duration is associated with type 2 diabetes.  
In a recent cross-sectional study,45 compared to normal sleep duration (7-8 hours), only 
short sleep duration (≤6 hours) was associated with higher risk for type 2 diabetes 
among 16,893 Chinese men and women aged 18 to 75 years (OR 1.41, 95% CI 1.07 – 
1.85). In a similar study in Canada, Chaput and colleagues46 reported that sleeping 7 
hours or less was associated with diabetes (OR 1.58, 95% CI 1.13 – 2.31) among 740 
men and women aged 21 to 64 years and reported that short sleepers were more likely 
to have higher fasting plasma glucose and insulin levels. Similar findings from a cross-
sectional study47 in Japan suggested that those sleeping 6 hours or less were more 
likely to have type 2 diabetes compared to those who reported sleeping 6 to 7 hours 
per night and such associations were independent from lifestyle and metabolic risk 
factors (OR 2.32, 95% CI 1.18 – 4.55).  
In the US, using National Health Interview Survey data, Buxton and colleagues48 
found that both short (<7 hours) (Regression coefficient β = 0.103, p<0.05) and long 
(>8 hours) (β = 0.314, p<0.05) sleep duration were positively associated with diabetes. 
Similarly, Kachi and Colleagues49 studied 20,744 Japanese men aged 30 to 64 years 
and they reported that compared to those sleeping 7 hours per night, men who reported 
short (≤5 hours per night) or long (≥8 hours per night) sleep duration were more likely 
to have untreated type 2 diabetes (OR 1.52, 95% CI 1.22 – 1.90 and OR 1.39, 95% CI 
1.05 – 1.85, respectively). Findings from a cross-sectional study50 in Finland showed 
that both short (≤6 hours per night) (OR 2.55, 95% CI 1.21 – 5.35) and long (≥8 hours 
34 
 
per night) (OR 1.76, 95% CI 1.12 – 2.61) sleep duration were associated with increased 
risk of type 2 diabetes among women, but the observed trend among men was not 
statistically significant. Knutson and colleagues51 studied 670 men and women aged 
18 to 30 years and used objective measures of sleep (using actigraphy) and they could 
not find any significant association between sleep duration and diabetes.  
The impact of sleep on initiation and progression of diabetes has also been the main 
interest of several longitudinal studies. The association between self-reported sleep 
duration and incidence of diabetes was examined in the Nurses’ Health Study52 which 
involved 10-year follow-up of 70,026 American female nurses with a mean age of 52.8 
years old who were free of diabetes at baseline. The results from the univariate analysis 
demonstrated that both compared to normal sleep duration (7-8 hours), short (≤5 
hours) and long (≥9 hours) sleep duration were associated with a higher risk for the 
incidence of diabetes, but following adjustment for BMI and other potential 
confounders, the observed trend no longer remained significant for short sleep 
duration, and the risk of incidence and progression of diabetes was only found to be 
significant among long sleepers (OR 1.29, 95% CI 1.05 – 1.59). Recently, Beihl and 
colleagues53 found that compared to normal sleep duration, only short sleep duration 
was associated with higher risk for incident of diabetes in a cohort of 900 multi-ethnic 
participants aged 40 to 69 years (OR 2.36, 95% CI 1.11 – 5.00). 
A Swedish study54 followed a large group of healthy men aged 35 to 51 years old. 
Following multivariate adjustment for potential confounders, the results demonstrated 
that those who reported using sleep medication to promote sleep or had sleep 
difficulties were more likely to have an increased risk for type 2 diabetes (OR 1.52; 
95% CI 1.05 – 2.20).54 Another similar study55 in Sweden investigated the possible 
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link between sleep difficulties and onset of diabetes over a 12-year period among 1,187 
men and women with no diabetes at baseline. The risk of diabetes was relatively higher 
among men who reported sleeping less than 5 hours per night or experienced difficulty 
initiating sleep (OR 2.8, 95% CI 1.1 – 7.3), but this association was not detected among 
women.55  
A cohort of men from the Massachusetts Male Aging Study56 was followed for an 
average of 15 years. The results demonstrated that compared to 7 hours of sleep, both 
short sleep duration (≤5 hours) and long sleep duration (>8 hours) were strong 
predictors for incidence of diabetes (RR 2.60, 95% CI 1.28 – 5.27 and RR 3.63, 95% 
CI 1.79 – 7.38, respectively) and the findings remained consistent even after 
controlling for potential covariates including; age, high blood pressure, waist 
circumference, education level, smoking status and self-report health status. Similarly, 
Gangwisch and colleagues57 analysed data from First National Health and Nutrition 
Examination Survey (NHANES I) and found that those who reported sleeping 5 hours 
or less or 9 hours or more were more likely to develop diabetes over 8 to 10-year course 
of the study (RR 1.47, 95% CI 1.03 – 2.09, and RR 1.52, 95% CI 1.06 – 2.18, 
respectively). 
The results of an 8-year prospective study from Japan,58 demonstrated that subjective 
sleep disturbance (i.e. self-reported difficulty initiating sleep and/or difficulty 
maintaining sleep) was a strong predictor for the incidence of type 2 diabetes. 
Consequently, individuals who experienced frequent difficulty initiating sleep had a 
higher age-adjusted risk ratio for onset of type 2 diabetes (HR 2.98, 95% CI 1.36 – 
6.53). The results of a prospective study in Germany59 which involved 4,140 non-
diabetic men and 4,129 non-diabetic women, aged between 25 to 74 years old showed 
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that difficulty maintaining sleep was associated with an increased risk for the incident 
of diabetes among men (HR 1.60, 95% CI 1.05 – 2.45) and women (HR 1.98, 95% CI 
1.20 – 3.29). Bjorkelund and colleagues conducted a large prospective study, which 
involved following 1,462 Swedish women from birth for over 32 years. By the end up 
follow-up period, approximately 8.7% of the participants developed diabetes. No 
significant association was found between sleep problems and diabetes.60 
A recent systematic review and meta-analysis61 which involved 10 studies 
representing 107,756 participants estimated the risk of both sleep quantity and quality 
in the incidence and progression of type 2 diabetes. The pooled analysis showed that 
both short (≤5 hours) and long (>8 hours) sleep duration were associated with 
increased risk for incidence and progression of type 2 diabetes (Relative Risk [RR] 
1.28, 95% CI 1.03 – 1.60) and RR 1.48, 95% CI 1.13 – 1.96, respectively). 
Furthermore, difficulties initiating sleep and difficulties maintaining sleep were also 
associated with increased risk for incidence of diabetes (RR 1.57, 95% CI 1.25 – 1.97 
and RR 1.84, 95% CI 1.39 – 2.43, respectively).  
Despite the variation in geographical and sample characteristics across the studies 
discussed, it has been consistently suggested that short sleep duration could play an 
important role in the onset and progression of diabetes over time and that men could 
be at greater risk. The main limitation of the current epidemiological studies is using 
subjective sleep measures (i.e. self-reported questionnaire); therefore there is an 
extensive need for future longitudinal studies to use objective measures of sleep (i.e. 
actigraphy, polysomnography) to confirm the causal role of sleep loss in progression 
of diabetes. Another complicating factor is that sleep is not a unitary phenomenon, but 
a complex state. Thus, the majority of these studies have actually found associations 
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that refer to “time in bed” rather than sleep per se. Evidence indicates that both “time 
in bed” and “time asleep” are two different dimensions of sleep duration and using one 
instead of the other, may result different outcomes.62, 63Furthermore, the focus of the 
studies may not have been sleep and/or diabetes, which further complicates this area 
of research. Nevertheless, mechanistic studies in the sleep laboratory point to a 
relationship between sleep loss and diabetes.64, 65  
The potential mechanisms linking sleep duration to diabetes are yet to be fully 
elucidated, but are likely to involve multiple physiological pathways. It is hypothesised 
that short sleep duration may result an increase in activation of sympathetic nervous 
system which may oppose the actions of insulin, resulting in hyperglycaemia.66 
Additionally, the sleep-deprived brain may alter the activity of the hypothalamic-
pituitary-adrenal axis, which results in increased secretion of cortisol, which enhances 
gluconeogenesis and results in insulin resistance.67 It has also been suggested that short 
sleep duration would also influence regulation of appetite hormones such as leptin and 
ghrelin, which may increase appetite and reduce energy expenditure and facilitate 
weight gain and obesity and the development of insulin resistance and diabetes in the 
longer term. Other metabolic hormones including the incretin system have not been 
studied carefully in the context of sleep manipulation. Idris and colleagues,68 however, 
have reported an improvement in sleepiness with the GLP-1 analogue. Exenatide, 
suggesting a potential relationship between GLP-1 and sleep. 
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1.4 Overview of obesity 
Excess adiposity (obesity) has been identified as a pandemic with serious 
repercussions for affected individuals, health services, and economic resources.69 The 
key drivers of obesity such as diet and physical activity have been the focus of 
numerous research studies, but the role of sleep on progression of obesity is not fully 
understood. Further initiatives to understand the impact of sleep improvement may 
draw a new opportunity to tackle obesity and may achieve greater success compared 
to previous interventions.  
1.4.1 Definition and trends in obesity prevalence 
Obesity is defined by body mass index (BMI) [as weight in kilograms divided by the 
square of height in meters].70 The World Health Organization (WHO) classification of 
underweight, overweight and obesity in adults is presented in Table 1-3. 
Table 1-3. The WHO classification of bodyweight based on BMI.*  
          Classification          BMI (kg/m2) cut-off points  
Underweight  <18.5 
Normal weight  18.5 - 24.9 
Overweight ≥25 
Obese ≥30 
Class I 30.0 - 34.9 
Class II 35.0 - 39.9 
Class III (Extreme Obesity) ≥40 
* The cut-points refer to western Caucasian populations; different cut-points have been proposed for 
other ethnicities. 
 
The number of people with obesity is increasing at an alarming rate in UK and 
worldwide.70 According to the NHS Information Centre, in 2010, the prevalence of 
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obesity was 26% among both men and women, and the prevalence of overweight 
among men was 42% and among women was 32%.71  
The prevalence of obesity has been previously investigated by a number of 
epidemiological studies.70, 72-81 According to the results from Multinational 
Monitoring of Trends and Determinants in Cardiovascular Diseases (MONICA) study, 
the prevalence of obesity was highly varied among European countries, ranging from 
7% of the male population in Sweden to 45% of female population in Lithuania.72 The 
prevalence of obesity in the UK has doubled in the age group of 25 to 34 years old 
between the years 1993 (Male, Female 13.2% - 16.4%) to 2011 (Male, Female 23.6% 
- 25.9%).73 In 2004, almost 29% of white men and 50% of black women were obese 
in the US.74 The prevalence of obesity in US is continuously increasing, and it was 
previously estimated that the prevalence exceeds 30% across different age and sex 
groups. In 2009-2010 in the US, obesity was prevalent in 35.5% of men and 35.8% of 
women.70 Interestingly, the prevalence of obesity in the US, which was assessed 
approximately two decades ago by the Third National Health and Nutrition 
Examination Survey (NHANES) III survey, is comparable with current obesity 
patterns in Europe. Obesity is also a great concern in Latin America and a higher rate 
of obesity was observed among women compared to men. 75 Data from a national 
survey in 2000, in Brazil showed that obesity affects 7.2% and 16.4% of men and 
women, respectively.82 
The prevalence of obesity is also increasing in Asian countries. It was previously 
reported that in China, from 1993 to 2009 obesity prevalence increased in men (3% to 
11%) and women (5% to 10%).83 Interestingly, in Japan, the prevalence of obesity has 
not increased at the same pace as the rest of the world.76 Data from Saudi Arabia 
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indicate that 29% of men and 27% of women are overweight, while obesity is prevalent 
in 16% of men and 24% of women.77 
The majority of epidemiological studies that have assessed obesity prevalence are 
limited to one specific age group or region; therefore there might be a concern about 
overestimation and underestimation of prevalence. The prevalence of obesity may also 
vary in different socio-economic conditions or diet and lifestyle patterns.78 A study 
assessing physical activity assessment in 15 European countries demonstrated that 
sedentary lifestyle is a very strong risk factor for obesity/overweight.79  
Ethnicity is another factor that may increase the risk of obesity. The association 
between ethnicity and obesity is complex. A major consideration is methodological. 
The commonly used body mass index cut-points, for example, may underestimate 
excess adiposity in some populations e.g. the South Asian population.84 Another 
consideration is the distribution of adipose tissue. For example, fat deposition is greater 
around the hips in Afro-Caribbeans rather than around the abdomen (visceral 
adiposity) where it has the greatest metabolic impact.85 Despite methodological 
limitations, ethnic minority populations, appear to be at increased risk of excess 
adiposity and its complications such as diabetes.86 The Health Survey for England87 
shows clearly the ethnic differences in adiposity. Regarding diabetes, for example, 
Indian and Pakistani men are 3 times more likely to develop diabetes compared to the 
general population.87 The mechanisms mediating a potential association between 
ethnicity and obesity can be divided in biological and sociocultural factors. These are 
very briefly discussed below. 
Genetics is likely to play a role in the differential deposition and distribution of adipose 
tissue among ethnic groups. It is likely that multiple genes are involved. Gestational 
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diabetes is more common amongst ethnic minorities.88 This results in intrauterine 
changes that could ultimately result in obesity in the offspring through multiple 
mechanisms including epigenetics.89 Other biological factors include stress and 
activation of the stress axis, which, in the long-term, predisposes to obesity. 
Differential tissue sensitivity to insulin has also been implicated. Insulin resistance 
results in high circulating insulin, which promotes adiposity through insulin’s 
catabolic actions. After controlling for BMI and body composition, compared to white 
children, African-American children had lower insulin sensitivity (6.3 ± 0.6 vs. 4.5 ± 
0.5 × 10−4 min−1/(μIU/ml) (p = 0.05).90 Evidence suggests that biological differences 
may potentially increase the risk of obesity by race/ethnicity; however, the 
relationships are far from definitive.90 
Minority ethnic population often experience poverty, lower socioeconomic status, 
lower access to education, and stigma, important factors that have been associated with 
obesity.91 In some cultures, food is a dominant aspect of the identity of members of a 
community and there is a belief that consumption of traditional food may lower the 
risk of obesity.92 Cultural factors also have an influence on preference and engagement 
in physical activity. For example, in a culture that parents’ viewpoint is that the rest 
following a working day is as healthy as exercise is less likely to encourage their 
children to uptake physical activity for their health and wellbeing.93 Furthermore, body 
image perceptions may differ among different ethnic/cultural groups. For example, 
perceived ideal body size is significantly larger among African women compared to 
whites, and African men are more likely to express higher preference for women with 
larger body size compared to non-Hispanic white men.94 
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It must be taken into account that it is relatively difficult to compare the prevalence of 
obesity among different countries, as there is significant variation in sampling and 
design. It has been postulated that the wide variations in obesity prevalence in 
Canada80 and Sweden81 may be attributed to immigration patterns in these countries.  
Based on measured data, it has reported that levels of obesity are much higher in the 
United States compared to England and Canada.95  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
43 
 
1.4.2 The measurement of adiposity 
Different measures for adiposity, which vary by feasibility, accuracy and cost, are 
summarised in Table 1-4. The most common measures for adiposity are BMI and waist 
circumference (WC). The majority of studies that previously evaluated the association 
between sleep and obesity in adults have used both BMI and WC, and evidence 
indicates that they are highly correlated (r = 0.60 – 0.80) with laboratory-based 
measures such as hydrometry.96 However, neither of these measures may not 
accurately reflect the true estimates of health risks related to obesity. For instance, 
BMI is not a good representative of body fat percentage and body fat distribution and 
could potentially vary across different age categories, fitness and ethnicity.97 It is 
known that visceral fat may result in higher health risk compared to subcutaneous fat;96 
therefore other measures than BMI should be utilised to determine visceral and 
subcutaneous fat. Self-reported height and weight measures were used to calculate 
BMI by several studies, which may introduce a serious potential bias.97   
WC is considered to be a better measure of adiposity compared to BMI, since it is a 
better estimate of abdominal fat, which is a strong predictor for major health threats 
such as diabetes and cardiovascular complications.98 It is more useful if WC can be 
used alongside BMI to estimate health risks among individuals within different BMI 
ranges.99 Like BMI, WC is also unable to fully determine the differences between 
visceral and subcutaneous fat.98 Measurement of WC will become more and more 
inaccurate with increasing adiposity as body landmarks for measurements become 
obscured. In order to have a better understanding of a potential link between sleep and 
obesity, it is very important to obtain accurate measures of body fat levels. Skin-fold 
thickness measurements are another measure for obesity, but these cannot be utilised 
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in large epidemiological studies, since it is relatively intrusive and required trained 
personnel.96 The most precise and detailed information on body composition can be 
captured via imaging-based methods (e.g. computed tomography [CT], magnetic 
resonance imaging [MRI], dual energy absorptiometry [DEXA]), but these are not 
practical for studies with large sample size. Bio-electrical impedance devices are 
feasible alternatives as they are relatively inexpensive, non-invasive and portable. It 
has been previously reported that the accuracy of these devices are highly correlated 
with results from laboratory-based techniques (r = 0.73 – 0.92).100 In practice, many 
factors such as levels of hydration and time of day interfere in accuracy and 
reproducibility of bioimpedance measures of body composition. Also the algorithms 
used by bioimpedance machines may not be true for the population under study. 
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Table 1-4. Summary of current measures for body fat and body composition. 
Technique Description Advantages Limitations 
Body mass index (BMI) BMI is calculated by dividing 
weight (in kilograms) by height (in 
metres) squared 
 Inexpensive 
 Determines whether an 
individual is within healthy 
weight range 
 Applicable for both adults and 
children 
 Allows people with different 
body types to be within each 
classification   
  In children BMI z-scores are 
utilised 
 
 
 Does not measure body fatness  
 Not appropriate for very short 
individuals and also pregnant 
women  
 
 
Waist circumference A surrogate measure for 
abdominal fat 
 Inexpensive 
 Better indicator of obesity-
related problem compared to 
BMI 
 Applicable for both adults and 
children 
 
 
 Does not differentiate between 
subcutaneous and visceral fat 
 Becomes difficult to measure 
as adiposity increases   
 
Skinfold thickness  A technique for determining body 
fat composition 
 Inexpensive 
 Differentiate between 
subcutaneous and visceral fat 
 Uncomfortable 
 Trained personnel required 
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Table 1-4 cont’d    
Technique Description Advantages Limitations 
Bioelectrical impedance Provides estimates of body fat 
percentage and fat-free mass 
 Inexpensive 
 Easy and simple  
 Portable 
 The ratio of body water to fat-
free mass may alter during acute 
weight loss 
 Not as accurate as other 
measures 
 Not suitable for individuals 
with BMI of 35 kg/m2 or higher  
 
Dual energy  
X-ray absorptiometry 
Provides two dimensional 
estimates of fat mass, fat-free 
mass, and bone mineral density   
 Accurate   Expensive 
 Not suitable for large sample 
sizes 
 Does not differentiate between 
subcutaneous and visceral fat   
 
Imaging techniquesa Provide most accurate measure 
including  
  
 Information on body fat 
distribution  
 Not suitable for large sample 
sizes 
 Exposure to radiation (CT scan) 
 Expensive 
 
Hydrometry  Provides fat mass, fat-free mass, 
and percentages of body fat using 
total body water  
 
 Can be used for extreme obese 
individuals (BMI≥40 kg/m2) and 
pregnant women 
 Not suitable for large sample 
sizes 
 The ratio of body water to fat-
free mass may alter during acute 
weight loss 
a 
The imaging techniques included magnetic resonance imaging (MRI) and computerized tomography (CT).
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1.4.3 Causes and consequences of obesity 
In normal physiology, adipocytes store energy in the form of triglycerides.101 An 
imbalance between energy input and energy expenditure could lead to hypertrophy and 
hyperplasia of adipocytes which results in obesity in the long run.101 The aetiology of 
obesity is complex and involves multiple factors. Common risk factors for obesity are 
genetic predisposition and family history, metabolism, behaviour, physical activity, 
and the environment.102 In recent years, other factors such as epigenetic, increased 
maternal age, and sleep debt have been found to be associated with obesity.102 The 
mechanisms between advanced maternal age and increased risk of childhood obesity 
is not clear. Obesity and insulin resistance are more common in older mothers, which 
may affect foetal metabolism and increase the availability of nutrients to the foetus.103 
High exposure to insulin in utero results in macrosomia due to the growth-promoting 
effects of insulin.104 Other factors that predispose to placental insufficiency result in 
small for gestational age babies.103  Both large and small for gestational age babies are 
predisposed to future metabolic derangements and obesity.104 Although not proven, 
epigenetic factors could also be involved.102 
Obesity per se is known to be a risk factor for multiple health problems including 
cardiovascular complications, diabetes, cancer, depression, and OSA.105 These serious 
health problems contribute to obesity increasing the risk of premature death 
(Figure 1-2).102 It has been previously estimated that life expectancy of 
overweight/obese individuals is reduced significantly (approximately three years for 
both men and women) compared to those who are not overweight/obese and obesity 
at early adulthood may be a strong predictor of mortality at later stages of the 
lifespan.106 The negative consequences of obesity are not limited to health but also 
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influence the economy. In US, it was estimated that almost 6% of annual medical 
expenditures which is equal to $75 billion is devoted to direct cost of obesity.69 
Moreover, the indirect cost of obesity is around $64 billion.69 In the UK, it is also 
estimated that the direct cost and indirect cost of obesity are approximately £0.5bn and 
£2bn respectively.107  
 
Figure 1-2. Effect of increasing BMI on premature mortality.102 
Printed with the permission of Dr E Calle. 
The causes and consequences of obesity are complex and without understanding these 
contributing factors to energy balance, it will not be possible to develop effective 
strategies to stem the rise in obesity. As a result of the complexity of obesity, it is 
known that a single approach to manage excess body weight will be inadequate. Sleep 
duration and quality may be important contributors to obesity that has been 
overlooked. Addressing risk factors for obesity such as sleep and conducting 
randomised controlled studies to assess the effect of sleep on obesity as part of a 
complex intervention is needed. The findings of such studies could enhance our 
understanding of obesity and its natural history, and allow development of preventive 
measures. The relationship between sleep and obesity is discussed in detail later. 
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1.5 Overview of sleep and obesity 
The associations among sleep duration, sleep quality, and obstructive sleep apnoea 
(OSA), and obesity are discussed below.   
1.5.1 Sleep duration and obesity 
In order to tackle obesity, there is a need to identify and fully understand all the factors 
that contribute, to the increased risk for obesity. In recent years, a great number of 
studies have evaluated the link between sleep and obesity. Previous reviews108-113 and 
meta-analyses114, 115 have confirmed a positive strong link between sleep duration and 
obesity (Table 1-5). The findings of these reviews indicate that short sleep duration is 
an independent risk factor for weight gain/or obesity in both children and middle-aged 
individuals, but such findings have not been observed among older individuals. 
Different approaches have been used for data analysis by these reviews. Some of them 
are data synthesis of the current evidence on the association between sleep duration 
and obesity; some used meta-analysis, while some of them are systematic reviews of 
current systematic reviews. There is a mild heterogeneity among studies that are 
included in the two meta-analyses by Chen and colleagues115 and Cappuccio and 
colleagues;114 therefore Patel and Hu113 did not use such analysis.  
In general, all the reviews suggest that greater future research is needed to understand 
the nature of the association between sleep and obesity, as there is diversity among 
findings of different studies, which limit the interpretation of causality. Some of the 
reviews have highlighted several methodological problems with epidemiological 
evidence including measures of obesity and sleep and also confounding factors. In this 
section, the summary of findings from epidemiological studies is provided and then 
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the possible mechanisms between sleep and obesity are discussed and the limitations 
of these studies are addressed. 
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Table 1-5. Summary of recent review papers and meta-analyses on assessing a potential link between sleep and obesity.  
Author, Year Characteristics Total number of included studies Findings 
 
Guidolin and Gradisar, 
2012108 
 
Systematic review of studies 
(cross-sectional and 
longitudinal)  focusing on 
adolescents (age 10 to 19 
years) 
14 (12 cross-sectional,  
2 longitudinal) 
Approximately 92% of cross-sectional studies 
found that there is a strong link between short 
sleep duration and obesity, but longitudinal 
studies did not support these findings. 
 
Magee and Hale, 2012109 Systematic reviews of 
longitudinal studies in adults 
and children 
 
20 (13 adults,  
7 children) 
In children, short sleep duration was 
consistently observed to be an important marker 
of weight gain, although the results from adult 
studies were not consistent. 
 
Beccuti and Pannain, 
2011110 
Literature review of 
epidemiological (cross 
sectional and longitudinal) and 
experimental studies in adults 
21  (15 epidemiological,  
6 experimental) 
Both experimental and epidemiological studies 
have shown that both short sleep duration and 
poor sleep quality may potentially increase the 
risk of weight gain/obesity. 
 
Nielson et al, 2011111 Review of systematic reviews 
(during year 2008), 
longitudinal studies in children 
and adults 
22 (7 systematic reviews, 
15 longitudinal)                           
          
Short sleep duration is a strong predictor of 
obesity among children, but in adults, some 
studies suggest only short sleep duration and 
some suggest that both short and long sleep 
duration are associated with obesity while some 
studies found no significant association.  
 
Monsata et al, 2010112 Review of systematic reviews 
focused on early-life markers 
of obesity 
23 systematic 
 reviews 
 
Important early-life determinants of obesity 
included; maternal smoking, breastfeeding, 
infant size and growth, television watching, and 
short sleep duration. 
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Table 1-5 Cont’d  
Author, Year Characteristics Total number of included studies Findings 
 
Patel and Hu, 2008113  Systematic reviews of cross-
sectional and longitudinal 
studies in children and adults 
36 (31 cross-sectional,  
5 longitudinal) 
Results from cross-sectional and longitudinal 
studies consistently suggest that short sleep is 
associated with concurrent and future obesity. 
In adults, 17 out of 23 cross-sectional studies 
suggest a potential link between short sleep 
duration and obesity, however all 3 longitudinal 
studies suggest that short sleep duration is an 
independent predictor of future obesity. 
 
 
Cappuccio et al, 2008114 Systematic review and meta-
analysis of epidemiological 
studies (cross-sectional) in 
children and adults 
 
30 (18 adults,  
12 children) 
Short sleep duration could potentially increase 
the risk for obesity in children (OR 1.89, 95% 
CI 1.46 – 2.43) and adults (OR 1.55, 95% CI 
1.43 – 1.68). No publication bias was observed, 
but there was a mild heterogeneity among 
studies. 
 
 
Chen et al, 2008115 Systematic review and meta-
analysis of epidemiological 
studies (cross-sectional, case-
control, longitudinal) in 
children 
17 (12 cross-sectional, 
 2 case controls,  
3 longitudinal) 
A dose-response association exists between 
short sleep duration and overweight/obesity. 
Shortest sleep duration (OR 1.92, 95% CI 1.15 
– 3.20), Much shorter sleep duration (OR 1.60, 
95% CI 1.22 – 2.10), Shorter sleep duration 
(OR 1.43, 95% CI 1.07 – 1.91), compared to 
normal sleep duration (7-8 hours). 
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1.5.1.1 Cross-sectional studies on sleep duration and obesity 
A summary of the major studies that evaluated the association between sleep duration 
and obesity cross-sectionally is provided in Table 1-6. In general, findings from such 
studies suggest that short sleep duration is positively associated with obesity. A survey 
by the American Cancer Society, which involved 1.1 million participants was the 
largest of these studies,3 reporting that sleep duration and BMI interacted in a U-shaped 
manner and individuals who reported sleeping 7 hours per night had the minimum 
BMI.  Compared to 7 hours of sleep, sleep duration of 4 hours was associated with 
higher BMI in both men (0.57 kg/m2) and women (1.39 kg/m2).3 This association was 
not explored in detail in the published study that concentrated on the relation between 
sleep and mortality. The second largest study was by Tamakoshi and colleagues116 in 
Japan, which involved over 100,000 participants. The authors reported that in both 
men and women, short sleep duration was associated with a reduction in BMI. The 
mean BMI of those who slept ≤4 hours was 22.4 kg/m2 compared to 22.9 kg/m2 of 
those who slept 7 hours.116 To date, no other study could detect similar findings. Again, 
weight was not a primary outcome for this study.  Results from the Sleep Heart Health 
Study (SHHS)32 showed that there was a U-shaped link between sleep duration and 
weight. Individuals with sleep duration of 6 hours or less had greater BMI compared 
to those sleeping 7 to 8 hours (29.1 kg/m2 vs. 28.4 kg/m2). In Sweden, Bjorkelund and 
colleagues60 reported that sleep duration was inversely correlated with BMI (β = -0.06) 
and waist-hip ratio (β = -0.07). Population-based sampling techniques were utilised by 
two studies. Singh and colleagues117 analysed data from 3,158 participants and found 
that there was an inverse association between sleep duration and BMI, and sleep 
duration of 8 to 9 hours was associated with the lowest risk. Moreover, compared to 
sleep duration of 7-8 hours, individuals who reported to sleeping ≤5 hours (OR 1.70, 
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95% CI 1.31 – 2.35) and 5-6 hours (OR 1.44, 95% CI 1.12 – 1.87) per night had higher 
risk of being obese.117 Similarly, in a representative sample of 1,772 men and women, 
Vioque and colleagues118 found that, compared to sleep duration of 6 hours or less, 
those who reported sleeping 9 hours or more per night had a lower risk of being obese 
(OR 0.43, 95% CI 0.27 – 0.67). 
In a cohort of 4,878 Brazilian truck drivers, Moreno and colleagues119 evaluated the 
association between sleep and weight and found that short sleep duration (<8 hours 
per night) was associated with an increased the risk for obesity (OR 1.24, 95% CI 1.07 
– 1.43). In a similar study, Ko and colleagues120 analysed data from 4,793 Hong Kong 
union members and reported that sleep duration and BMI were inversely correlated (β 
= -0.03, p = 0.02).  Based on data using sleep diaries, it was observed that sleep 
duration and BMI interacted in a U-shaped manner among 1,024 government workers 
in Wisconsin.121 The results of a similar study demonstrated that each hour reduction 
in total sleep duration was associated with a 0.42 kg/m2 increase in BMI among a 
cohort of 990 employed US adults.122  
In a Canadian family-based cohort study, Chaput and colleagues123 utilised several 
measures for obesity including; BMI, waist-hip ratio, body fat mass and skinfold 
thickness, and the results showed that sleep duration and obesity interacted in a  U-
shaped manner and compared to 7 to 8 hours sleep, men who slept 5 to 6 hours and 9 
to 10 hours had 72% and 18% higher risk for obesity, and women had 63% and 51% 
increased risk of obesity. In France, Ohayon and Vecchierini124 analysed data from 
1,026 older (≥60 years) individuals and they reported that weight may be a predictor 
for short sleep duration, as their findings indicated that overweight/obese individuals 
(BMI>27 kg/m2) were almost 4 times more likely to report short sleep duration 
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compared to those who had a BMI of 20 to 25 kg/m2. Results of a similar study by 
Vorona and colleagues125 involving 924 middle-aged American showed that longer 
sleep duration was prevalent among those with BMI<25 kg/m2. Recently, Buxton and 
Marcelli48 reported that self-reported sleep duration of 7 hours or less was associated 
with 6% of increased risk for obesity among 56,507 American adults aged 18 to 85 
years.  
The majority of studies to date, which have utilised subjective sleep duration (i.e. self-
reported questionnaire), while several studies used objective measures (i.e. actigraphy, 
polysomnography) and reported mixed findings on the association between sleep 
duration and obesity. Lauderdale and colleagues126 used actigraphy to evaluate the 
sleep patterns of 669 middle-aged participants and reported that there was no 
significant association between sleep duration and BMI. In a similar study, Theorell-
Haglöw and colleagues127 used overnight PSG and found an inverse correlation 
between sleep duration and waist circumference among 400 women who aged from 
40 to 70 years (β = -1.22, p = 0.016).   
In summary, evidence from cross-sectional studies suggests that short sleep duration 
was associated with obesity in adults. The disparity amongst studies may stem from 
several factors including the use of different measures of sleep and obesity, the study 
design, differences in the populations studied, and the statistical methods employed. It 
is very difficult to assess sleep duration and obesity with reliable and valid measures. 
The current techniques and measures of obesity and sleep have been discussed earlier. 
As the association between sleep and obesity has emerged slowly over a long period 
of time, it was not feasible to utilise detailed and more accurate methods to assess 
exposure and outcome for large groups of people. Other potential obstacles have been 
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study cost and time. Additionally, measurement errors could potentially weaken the 
association between sleep and obesity. For instance, measuring sleep duration using 
self-report methods such as sleep diaries may be prone to subjective errors. Cross-
sectional studies128-130 that used objective measures (i.e. actigraphy, 
polysomnography) showed stronger associations between sleep and obesity compared 
to those cross-sectional studies that only used self-reported data which may suggest 
that the results of these studies may be influenced by measurement errors.  
Some potential biases may be introduced as a result of interaction between settings 
and measurement procedures for sleep and obesity. Self-report data may be very well-
known biases that may not differ between obese and non-obese populations. The other 
common biases that may be less appreciated by researchers is social desirability bias 
that could be potentially introduced by obese individuals when answering questions 
on physical activity and eating habits which may lead to underestimation the obesity. 
The other bias, which is very difficult to prevent, is alterations in behaviours through 
time especially in prospective studies. Changes in behaviours such as deliberate dieting 
or increase in physical activity levels may also influence the results of the studies 
focusing on either sleep or obesity. 
It is believed that ethnic difference may explain the negative association between sleep 
duration and obesity among Japanese. However, the effect of ethnicity has not been 
directly examined by many studies. It was previously found that obesity and sleep 
deprivation were more prevalent among African-Americans compared to 
Caucasions.117, 126 Moreover, the effect of gender on sleep duration is not very clear. It 
was previously found that there is a link between female gender and increased 
susceptibility for sleep deprivation.123, 125  
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Table 1-6. Cross-sectional studies evaluating the link between sleep and obesity in adults. 
Author, 
Year 
Sample 
characteristics 
Country Sleep measure Obesity 
measure 
          Results 
Vioque et al, 
2000118 
1,772 M,F 
Age >15 years 
Spain Self-reported sleep 
duration “Hours of sleep 
per day” 
BMI 
 
≥9 hours sleep per day presented a lower probability of 
obesity compared to ≤6 hours sleep per day. (OR 0.43, 
95% CI 0.27 – 0.67) 
 
Shigeta et al, 
2001131 
453 M,F 
Mean age 53 years 
 
Japan Self-reported sleep 
duration 
 
BMI Short sleep duration (≤6 hours per night) was 
associated with increased BMI. (OR 1.98, 95% CI 1.03 
– 3.82) compared to normal sleep duration (7-8 hours) 
 
Kripke et al, 
20023 
1.1 million M,F 
Mean age 57.5 years 
US Self-reported sleep 
duration “On average, how 
many hours do you sleep 
each night?” 
BMI 
(calculated based 
on self-reported 
height and 
weight) 
 
U-shaped association was found between sleep 
duration and obesity in females only, and negative 
association between sleep duration and obesity was 
found in males. 
Taheri et al,  
2004121 
1,025 M,F 
Mean age 57.1 years 
US Polysomnography, self-
reported sleep duration 
“How many hours of sleep 
do you get on work-day 
nights and non-work-day 
nights?”, sleep diary 
 
BMI Sleep duration (sleep diary) and BMI was interacting in 
U-shaped manner. Short sleep duration (PSG) was 
associated with an increase in ghrelin. Short sleep 
duration (usual sleep) was associated with lower leptin. 
Tamakoshi  
et al, 2004116 
 
104,010 M,F 
Ages ranged from 40 to 
79 years 
 
Japan Self-report sleep duration BMI Short sleep duration was associated with decreased 
BMI. 
Bjorkelund 
et al, 200560 
1,462 F 
Ages ranged from 38 to 
60 years 
Sweden Self-reported sleep 
duration “How many hours 
do you sleep during one 
24-h period?” 
 
 
BMI, WHR Subjective sleep problems and short sleep duration (<6 
hours per 24 hours) was negatively correlated with 
BMI and WHR. (The regression coefficient (β) = -0.06, 
p = 0.03 and β =   -0.08, p = 0.004, respectively)  
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Table 1-6 Cont’d    
Author, 
Year 
Sample 
characteristics 
Country Sleep measure Obesity 
measure 
          Results 
Ohayon and 
Vecchierini, 
2005124 
1,026 M,F 
Mean age 60 years 
France Self-report sleep duration  
 
BMI A positive link was found between short sleep duration 
(4 hours and 30 minutes or less) and obesity (OR 3.6, 
95% CI 1.0 – 13.1), compared to sleep duration of 7 
hours. Short sleep duration was also associated with 
poor health and insomnia, which result in excessive 
daytime sleepiness and cognitive function impairment.  
 
Singh et al, 
2005117 
3,158 M,F 
Ages ranged from 18 to 
65 years 
US Self-report sleep duration  
 
BMI The prevalence of obesity was significantly higher 
among individuals with shorter sleep duration. After 
multivariate adjustment for potential confounders, 
sleep duration of 5 hours of sleep and less was 
associated with 40% higher risk for obesity.   
 
Vorona et al,  
2005125 
924 M,F 
Mean age 48 years 
US Self-report sleep duration 
(bed time, wake time, and 
total estimated sleep time 
per 24 hours) 
 
BMI Compared to individuals with normal BMI, those who 
had higher BMI was more likely to report short sleep 
duration and also obese women reporter shorter sleep 
duration than obese men (434 ± 89 minutes vs. 469 ± 
95 minutes). 
 
Gottlieb 
et al, 200632 
 
2,813 M and 3,097 F 
Mean age 63.7 years 
US Self-report sleep duration 
“How many hours of sleep 
do you usually get at  
night (or your main sleep 
period) on weekdays or 
workdays?” 
 
BMI A U-shaped association was found between sleep 
duration and BMI.  
Kohatsu  
et al, 2006122 
 
990 M,F 
Mean age 48.3 years 
US Self-report sleep duration 
“How many hours of sleep 
do you get in a typical 
workday?” 
BMI Following multivariate adjustment, sleep duration was 
negatively associated with BMI among rural 
populations. (β = -0.42, 95% CI -0.77 – -0.07). 
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Table 1-6 Cont’d    
Author, 
Year 
Sample 
characteristics 
Country Sleep measure Obesity 
measure 
          Results 
Lauderdale 
et al,126 
2006 
 
284 M and 385 F 
Mean age 43.4 years 
 
US  
 
Actigraphy, sleep log  
 
BMI No significant association was observed among sleep 
duration and BMI (β 0.01, 95% CI - 0.02 – 0.01). 
 
Moreno et al, 
2006119 
4,878 M 
Mean age 40 years 
Brazil Self-report sleep duration  
 
BMI Compared to 7 hours of sleep, short sleep duration (<8 
hours per night) was associated with an increased risk 
for obesity. (OR 1.24, 95% CI 1.07 – 1.43).  
 
Chaput et al, 
2007123 
323 M and 417 F 
Ages ranged from 21 to 
64 years 
Canada Self-report sleep duration  
 
BMI, WHR, 
skinfold 
thickness, body 
fat mass 
 
In full adjustment, compared to 7 to 8 hours sleep, only 
short (5 to 6 hours per night) found to be associated 
with an increased risk for obesity. (OR 1.69, 95% CI 
1.15 – 2.39). The association was no longer found to be 
significant with long sleep duration (9 to 10 hours per 
night) (OR 1.38, 95% CI 0.89 – 2.10). 
   
Ko et al, 
2007120 
2,353 M and 2,440 F 
Mean age 42.4 years 
China Self-report sleep duration  BMI, WC Sleep duration was inversely correlated with BMI and 
waist circumference (β = -0.037, p = 0.02). 
 
 
Fogelholm  
et al, 2007132 
7,642 M,F 
Mean age 54.3 years 
 
Finland Self-report sleep duration  
 
BMI, WC Compared to 7 to 8 hours sleep, short sleep duration 
(≤6 hours per night) was associated with an increased 
risk for obesity. Men (OR 1.46, 95% CI 1.13 – 1.88), 
Women (OR 1.75, 95% CI 1.36 – 2.25). 
 
Buxton and 
Marcelli, 
201048 
56,507 M,F 
Ages ranged from 18 to 
85 years 
US Self-report sleep duration  
 
BMI 
 
Short sleepers (<7 hours sleep per night) had 6% and 
long sleepers (>8 hours sleep per night) had 3% higher 
risk for obesity compared to those who reported 
sleeping between 7 to 8 hours per night. 
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Table 1-6 Cont’d    
Author, 
Year 
Sample 
characteristics 
Country Sleep measure Obesity 
measure 
          Results 
Magee et al, 
2010133 
45,325 M,F  
Ages ranged from 55 to 
95 years 
Australia  Self-report sleep duration 
“About how many hours in 
each 24-hr day do you 
usually spend sleeping 
(including at night and 
naps)?” 
 
 
 
BMI A U-shaped association was found between sleep and 
BMI among male and female aged 55 to 64 years, but 
such trend was not observed among older individuals 
(≥65 years). <6 hours sleep (OR 1.30, 95% CI 1.10 – 
1.53), ≥9 hours sleep (OR 1.17, 95% CI 1.07 – 1.26). 
Anic et al, 
2010134  
5,549 F 
Ages ranged from 20 to 
75 years 
 
 
 
US Self-report sleep duration  
 
BMI Following multivariate adjustment for potential 
confounders, short sleepers (<6 hours sleep per night) 
were 3 times more likely to be extreme obese (OR 
3.12, 95% CI 1.70 – 5.75), compared to 7 hours of 
sleep. 
Theorell-
Haglow et al, 
2010127 
400 F 
Ages ranged from 20 to 
70 years 
 
 
Sweden PSG BMI, WC There was as an inverse correlation between short sleep 
duration and obesity (β = -1.22, p = 0.016). 
Female (F), male (M), polysomnography (PSG), body mass index (BMI), waist hip ratio (WHR), waist circumference (WC).
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1.5.1.2 Longitudinal studies on sleep duration and obesity 
A summary of major studies that evaluated the association between sleep duration and 
obesity longitudinally is provided in Table 1-7. The findings of such studies are 
inconsistent. Four studies135-138 have reported that only short sleep duration is 
associated with weight gain/obesity. In a cohort which involved 496 adults and 13-
year follow-up period, Hasler and colleagues135 conducted interviews when 
participants were at ages of 27, 29, 34 and 40 years and the results showed that the 
odds ratio of obesity for short sleepers at age of 27 years was 8.2 (95% CI 1.92 – 
36.30), compared to normal sleepers and the association remained persistent even after 
controlling for potential confounders including demographic variables, physical 
activity levels and family history of weight problems, and sleep duration and obesity 
were no longer associated after age 34 years. Using data from Nurses' Health Study, 
Patel and colleagues136 found that women who reported sleeping 5 hours or less (OR 
1.28, 95% CI 1.15 – 1.42) and 6 hours per night (OR 1.10, 95% CI 1.04 – 1.17) had 
higher odds of developing obesity (BMI>30 kg/m2) over 16 years duration of the study 
compared to those reported sleeping 7 hours per night. In another study, Gunderson 
and colleagues137 assessed the effects of short sleep duration on maternal postpartum 
weight retention among 940 women and they suggested that women slept ≤5 hours per 
night during 6 months postpartum period, were more likely to gain ≥5 kg weight at 1 
year postpartum (OR 3.13, 95% CI 1.42 – 6.94), compared to those sleeping 7 hours. 
Recently, in Japan, Nishiura and Hashimoto138 analysed data from 3,803 middle aged 
male workers and they reported that compared to those who reported sleeping 7 hours, 
those sleeping 5 hours or less were more likely to gain 0.15 kg/m2 following 
multivariate adjustment for age, baseline BMI, lifestyle factors and medication (β 0.01, 
95% CI 0.03 – 0.27).  
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Four studies139-142 found that both short and long sleep duration were associated with 
an increased risk for obesity (U-shaped association). The longitudinal analysis of the 
Quebec Family Study139 demonstrated that compared to the average duration sleep 
group (7-8 hours), short (5-6 hours) and long duration (9-10 hours) sleepers gained 
1.84 kg (95% CI 1.13 – 2.62) and 1.49 kg (95% CI 0.92 – 2.48) more over the 6-year 
period of the study. A similar finding was found among a cohort of older individuals 
(≥60 years) in Spain and individuals who slept ≤5 hours (OR 3.41, 95% CI 1.34 – 8.69) 
and 8 hours (OR 3.77, 95% CI 1.55 – 9.17) had higher risk of severe obesity compared 
with individuals who slept 7 hours.140 Recently, Hairston and colleagues141 utilised 
imaging techniques to measure obesity and they found that both short and long sleep 
duration were associated a greater accumulation of subcutaneous adipose tissue (SAT) 
and visceral adipose tissue (VAT), and that such associations were only significant 
among those younger than 40 years. The results of a study which involved 35,247 
Japanese company employees demonstrated that there was no significant association 
between sleep duration and obesity among women; however, among men, short 
sleepers and long sleepers had 5.8% higher risk of becoming obese following the 1 
year course of the study (<5 hours, β 0.01, 95% CI 0.02 – 0.14 and ≥9 hours β 0.01, 
95% CI 0.07 – 0.34).142  
Finally, six studies143-148 have reported that there was no significant association 
between sleep duration and obesity and among these studies, only one study conducted 
by Lauderdale and colleagues144 used objective measures for sleep (using actigraphy). 
The inverse association between sleep and obesity was only observed by one study, 
which involved 1,579 Italian men, and women aged 45 to 64 years.149 
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In summary, the results from most longitudinal studies have shown that there is a 
temporal association between short sleep duration and higher risk for development of 
obesity. In line with findings from cross-sectional studies, longitudinal studies have 
also confirmed that such associations are stronger among younger individuals 
compared to older individuals. While there is as yet no scientific confirmation, it can 
be hypothesised that the impact of sleep duration on body weight is attenuated in long 
run. The other limitations of current studies are lack of adjustment for appropriate 
confounding variables, detection of potential mediators, and measurement pitfalls, 
which are going to be fully described later on this chapter.  
The association between sleep duration and obesity is relatively complex and although 
longitudinal designs are very useful in terms of understanding causal factors, it is not 
clear whether short or long sleep duration can cause obesity. Future randomised 
controlled trials are needed to provide detailed knowledge of the role of sleep loss in 
causing weight gain. It is not possible to assess the chronic effects of sleep curtailment 
on weight change due to ethical and practical limitations. However, recent on-going 
randomised controlled studies have aimed to assess the impact of sleep extension on 
health and well-being. 
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Table 1-7. Longitudinal studies evaluating the link between sleep and obesity in adults.  
Author, 
Year 
Sample 
characteristics 
Country Sleep measure Obesity 
measure 
Follow-up 
period 
Results 
Hasler et al, 
2004135 
496 M,F 
At baseline age was 27 
years  
Switzerland Self-report sleep duration  
 
Not Reported 13 years At age 27 years, short sleep duration 
had the highest odds ratio (OR 8.2, 
95% CI 1.9 – 36.3) to obesity 
compared to ages 29, 34 and 40 
years. 
 
Gngswich  
et al, 2005143 
3,208 M,F 
At baseline ages ranged 
from 32 to 49 years 
US Self-report sleep duration  
 
BMI 8-10 years No significant longitudinal was 
detected between sleep duration and 
change in BMI (β = -0.05, p = 0.27) 
 
Patel et al, 
2006136 
68,183 F 
At baseline ages ranged 
from 39 to 65 years 
US Self-report sleep duration  
‘‘indicate total hours of 
actual sleep in a 24-hour 
period.’’ 
BMI 16 years Women who reported sleeping 5 
hours or less (OR 1.28, 95% CI 1.15 
– 1.42) and 6 hours per night (OR 
1.10, 95% CI 1.04 – 1.17) had 
higher risk of a 15-kg weight gain 
across the course of the study 
compared to those sleep 7 hours. 
 
Littman et al, 
2007145 
 
173 F 
At baseline ages ranged 
from 50 to 75 years 
US Self-report sleep duration  
 
BMI 1 year No significant association was 
found between sleep duration and 
changes in body weight.  
 
Chaput et al, 
2008139 
276 M,F 
At baseline ages ranged 
from 21 to 64 years  
Canada Self-report sleep duration 
“On average, how many 
hours do you sleep a day?” 
 
 
 
BMI, WC, 
hydrometry 
6 years Short sleepers (5-6 hours per night) 
gained 1.84 kg more (95% CI 1.13 – 
2.62) and long sleepers (9-10 hours 
per night) had gained 1.49 kg more 
(95% CI 0.92 – 2.48) compared to 
7-8 hours sleep per night. 
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Table 1-7 Cont’d      
Author, 
Year 
Sample 
characteristics 
Country Sleep measure Obesity 
measure 
Follow-up 
period 
Results 
Gunderson  
et al, 2008137 
940 F 
Baseline age was not 
reported 
US Self-report sleep duration 
“In the past month, how 
many hours of sleep do you 
get in an average 24-hour 
period?” 
 
BMI 1 year Those who sleeping 5 hours were 
three times more likely to gain 5 kg 
over 6 month period compared to 
those who sleeping 7 hours (OR 
3.13, 95% CI 1.42 – 6.94).  
Lopez-
Garcia et al, 
2008140 
3,235 M,F  
At baseline mean age of 
60 years and above 
Spain Self-report sleep duration 
“How many hours do you 
usually sleep per day 
(including sleep at night 
and during the day)?” 
 
BMI 2 years There was a U-shaped association 
between sleep duration (≤5 hours 
vs. 7 hours, OR 3.41, 95% CI 1.34 – 
8.69 and 9 hours vs. 7 hours, OR 
3.77, 95% CI 1.55 – 9.17) and ≥5 
kg weight gain among women, but 
such trend was not observed among 
male and total participants.  
 
Stranges  
et al, 2008146  
4,378 M,F 
At baseline ages ranged 
from 35 to 55 years 
England Self-report sleep duration BMI 5 years There was no link between short 
sleep duration (≤5 hours per night) 
and changes in BMI.  
 
Lauderdale et 
al, 2009144 
612 M,F 
At baseline ages ranged 
from 33 to 45 years 
US Actigraphy BMI 5 years No significant association was 
found between sleep duration and 
BMI.  
 
Hairston  
et al,2010141 
 
1,107 M,F  
At baseline ages ranged 
from 18 to 81 years 
US Self-report sleep duration 
“On average, about how 
many hours of sleep do you 
get a night?” 
Imaging 
techniques 
(computed 
tomography) 
 
 
 
 
5 years A U-shaped association was found 
between sleep duration and BMI 
only among those who aged 40 
years or younger.  
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Table 1-7 Cont’d      
Author, 
Year 
Sample 
characteristics 
Country Sleep measure Obesity 
measure 
Follow-up 
period 
Results 
Marshall  
et al, 2010147 
 
2,091 M,F 
At baseline ages ranged 
from 37 to 60 years 
Sweden Self-report sleep duration 
“How many whole hours 
during the night do you 
usually sleep?” 
BMI 10 years No significant association was 
found between sleep duration and 
changes in weight.  
 
 
Nishiura and 
Hashimoto, 
2010138 
3,803 M  
At baseline ages ranged 
from 40 to 59 years 
Japan Self-report sleep duration 
“How many hours, on 
average, do you 
sleep each night?” 
 
BMI 4 years Compared to those who sleeping 7 
hours per night, short sleepers (≤5 
hours sleep) had increased risk for 
obesity (β 0.01, 95% CI 0.03 – 
0.27). 
  
Watanabe  
et al, 2010142 
34,852 M,F  
At baseline ages ranged 
from 30 to 60 years 
Japan Self-report sleep duration 
“How many hours do you 
sleep on weekdays 
(workdays)?” 
“How many hours do you 
sleep on the weekend (non-
workdays).” 
 
BMI 1 year A U-shaped association was found 
between sleep duration (<5 hours, β 
0.01, 95% CI 0.02 – 0.14 and ≥9 
hours β 0.01, 95% CI 0.07 – 0.34) 
and BMI among men, but not 
among women.  
Bo et al, 
2011149 
1,597 M,F 
At baseline, ages ranged 
from 45 to 64 years 
 
 
Italy Self-reported sleep 
duration  
BMI 6 years An inverse association was detected 
between sleep duration and BMI.  
Nagai et al, 
2013148 
13,6296 M,F 
At baseline, ages ranged  
from 40 to 79 years 
Japan Self-reported sleep 
duration 
BMI 10 years  No association was observed 
between sleep duration and weight 
gain. Only long sleep duration was a 
strong predictor of 5-kg weight gain 
among obese individuals (OR 1.36, 
95% CI: 1.09 - 1.70).  
Female (F), male (M), polysomnography (PSG), body mass index (BMI), waist circumference (WC)
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1.5.2 Consideration of confounding variables 
A major obstacle in drawing definitive conclusions for causal link between exposure 
and outcome in epidemiological studies is confounding by other factors. Previous 
reviews71, 110 have recognised multiple potential confounding factors for the 
relationship between sleep duration and obesity. These factors include: age, alcohol 
consumption, caffeine consumption, smoking, physical activity levels, television 
viewing, video gaming, chronic diseases, and psychological problems. Yet there are 
important limitations for inclusion of appropriate confounding variables. The 
conflicting results of the studies that assessed the association between sleep duration 
and obesity could be attributable to the great variation in the confounders included in 
the analyses. Different confounders that have been adjusted for among studies showing 
U-shape association between sleep duration and obesity is summarised in Table 1-8.  
The majority of these studies are controlled for age, gender, exercise, smoking, and 
alcohol consumption. Depression and emotional health appear to be more strongly 
associated with BMI than short sleep duration,150 but only two studies have controlled 
for these factors. Work-related factors are another factors that are not considered. Shift 
work could be a prime reason for obtaining insufficient sleep151 and only two studies 
adjusted for that variable. Furthermore, the literature assumes short sleep duration is a 
choice152 and little attention has been paid to the role of sleep disorders and in 
particular sleep apnoea, a common condition, which can influence sleep duration.153 
In fact, one plausible explanation for the association between long sleep duration and 
weight gain is due to the confounding effect of obstructive sleep apnoea.153 Increased 
pro-inflammatory cytokines in individuals with sleep apnoea may contribute to 
sleepiness and develop obesity in long run.154 Only one study adjusted for sleep 
68 
 
problems (waking up during sleep and the use of anxiolytic medication). Lopez-Garcia 
and colleagues140 found that compared to 7 hours of sleep, women sleeping ≤5 hours, 
(OR 3.41, 95% CI 1.34 - 8.69), 8 hours (OR 3.03, 95% CI 1.29 - 7.12) and 9 hours 
(OR 3.77, 95% CI 1.55 - 9.17) were more likely to have weight gain of ≥5 kg; a similar 
trend was not observed in men or in the total study participants. Only one study 
adjusted for that variable. Lopez-Garcia and colleagues140 found that compared to 7 
hours of sleep, women sleeping ≤5 hours, (OR 3.41, 95% CI 1.34 - 8.69), 8 hours (OR 
3.03, 95% CI 1.29 - 7.12) and 9 hours (OR 3.77, 95% CI 1.55 - 9.17) were more likely 
to have weight gain of ≥5 kg; a similar trend was not observed in men or in the total 
study participants. Controlling for snoring, Lauderdale and colleagues144 found no 
significant association between sleep duration and change in BMI  (p>0.05). 
Controlling for sleep medication, Stranges and colleagues146 found no significant 
association between sleep duration and changes in BMI (β= −0.06, 95% CI -0.26 - 
0.014).
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Table 1-8. Summary of confounding variables that are controlled for in studies showing U-shape negative association between sleep duration 
and risk of obesity. 
 Kripke et al, 
20023  
Taheri et 
al,2004121 
Gottlieb et 
al, 200632 
Chaput et 
al, 2008139 
Lopez-Garcia et 
al, 2008140 
Hairston et 
al, 2010141 
Watanabe et 
al, 2010142 
Magee et al, 
2010133 
 
Age X X X X X X X X 
Gender X X X X X X X X 
Race X     X  X 
Education X   X  X  X 
Total income   X X     
Occupation X   X     
Marital status  X       X 
Exercise X   X X X X X 
Smoking intake X  X X X X X X 
Alcohol consumption   X X X  X X 
Coffee consumption   X X X    
Baseline fat      X   
Total calories      X   
Arousal from sleep     X    
Perceived health X    X    
Leg pain X        
History of chronic disease     X   X 
History of heart disease X  X      
History of hypertension X        
History of cancer X        
History of diabetes X  X      
History of  psychological distress        X 
Shift worker    X   X  
Depression   X  X    
Sleeping disorders     X    
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Finally, evidence suggests short sleep and obesity also may be related to the amount 
of time spent watching television and using social media. Media use was not adjusted 
for in any of the adult studies, while 63% of children studies controlled for this 
covariate. In recent years, the use of media is increased extensively worldwide, and 
the early evidence indicates that television viewing is associated with both sleep and 
obesity. In the US, in 2009, television compromised 58% of total media use for 
youths.155 It would seem essential that a broader range of media use as well as 
television viewing be routinely included as potentially confounding variables. It has 
been reported that a combination of low sleep and high television viewing in children 
are associated with increased risk of being overweight at 2 years old (OR 2.00, 95% 
CI 1.19 – 3.36).156 
It can be difficult to distinguish between a confounder and a mediator. Generally, a 
tentative distinction is made based on the interpretation of the results of the analyses. 
A mediator is a variable that lies on the casual pathway between a predictor of interest 
and the outcome, and thus to mediate the predictor’s effect.  
 
Figure 1-3. A simple statistical mediation model 
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In the figure above (Figure 1-3), by using simple regression technique, one can 
estimate the total causal effect of exposure A on outcome of B, by ignoring the 
intermediate variable of C. However, if one controls (i.e. adjust, stratifies, restricts) for 
the intermediate C, which is on causal pathway between exposure A and outcome B, 
the total effect of the exposure and the outcome cannot be fully estimated. The 
observed association between exposure A and outcome will typically be a null-biased 
estimate of the total causal effect, after controlling for the intermediate C. As discussed 
by Patel and Hu,113 sleep deprivation is associated with higher calorie intake because 
of increased appetite. Increased opportunity to eat because of a drop in body 
temperature and increased fatigue, may lead to less physical activity and lower energy 
expenditure. If this hypothetical model were true and provided a mechanism by which 
sleep duration mediates the development of obesity, then adjustment for any of the 
factors above would diminish or obscure the association between sleep duration and 
obesity.  
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1.5.3 Sleep quality and obesity 
In recent years, the importance of sleep quality as well as sleep quantity and its impact 
on health and wellbeing has been appreciated in a number of studies. Cross-
sectional127, 157, 158 and longitudinal159, 160 studies have found that poor sleep quality 
was associated with an increased risk for obesity.  
In a cross-sectional study, Jennings and colleagues157 studied 210 participants (57% 
men) with a mean age of 46 years and they found that Pittsburgh Sleep Quality Index 
(PSQI) global scores was significantly associated with increased BMI (β = 0.19, 
p<0.001) and all the other components of metabolic syndrome (OR 1.44, 95% CI 1.01 
- 2.06).  
The results of a recent cross-sectional study127 involving 400 adult women 
demonstrated that both sleep duration and sleep quality, defined by sleep efficiency 
and sleep architecture (minutes of SWS and REM sleep) were inversely associated 
with waist circumference following multivariate adjustment for potential confounders 
including age, physical activity level, smoking, alcohol consumption and apnoea 
hypopnoea index (AHI) (SWS, adj. β = -0.058 cm/min; p = 0.025, REM β = -0.062 
cm/min; p = 0.002). However, such associations were less robust among older age 
women (age >50 years).127 
Bidulescu and colleagues158 analysed data from the Cardiovascular Health 
Epidemiology Study (CHES) which involved 1,515 African-American aged 30-65 
years. They found that poor sleep quality (measured using PSQI) was associated with 
increased BMI in women only (OR 1.08, 95% CI 1.03 – 1.12). The authors suggested 
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that such an association may have been mediated by stress.158 The impact of gender on 
the association of poor sleep quality and obesity has been confirmed in a longitudinal 
study conducted among 7,000 Finnish adults who aged between 40 to 60 years old.159 
The findings demonstrated that sleep problems including trouble falling asleep (OR 
1.65, 95% CI 1.22 – 2.22), early awakening (OR 1.48, 95% CI 1.16 –1.89) and trouble 
maintaining asleep (OR 1.41, 95% CI 1.13 – 1.75) were strong predictors of major 
weight gain over the 5 to 7 year course of the study.159 Using data from the Alameda 
county study, Nordin and Kaplan examined the impact of different stages of sleep 
discontinuity on body weight over 30 years among 7,000 middle-age adults.160 Based 
on subjective measures (using self-reported questionnaire), study participants were 
assigned into four categories (sleep continuity, good sleep continuity, discontinuity, 
impaired discontinuity). After adjusting for potential confounders such as 
demographic and lifestyle factors, sleep discontinuity was associated with 70% (95% 
CI 1.04 –2.90) increased risk for transition to obesity.160 
Sleep quality is a complex phenomenon and is difficult to define and objectively 
measure. Sleep duration, sleep latency, or the number of awakenings can be classified 
as quantitative aspect of sleep quality, and other aspects such as “depth” or “restfulness 
of sleep” are subjective aspects. PSG and actigraphy measures of sleep quality include 
sleep onset latency, sleep efficiency (time asleep over total time in bed), wake after 
sleep onset (amount of wakefulness after sleep has been initiated), and sleep duration.  
As stated earlier, evidence suggests that both shorter sleep duration and poor sleep 
quality are associated with a higher risk of obesity as well as several other adverse 
health outcomes such as hypertension, diabetes, and cardiovascular complications 
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among individuals with different age, ethnicity, and socioeconomic background.113, 114 
However, the psychosocial consequences of poor sleep have been underestimated. 
These may, for example, predispose to maladaptive eating such as emotional food 
intake, and anhedonia, which may result in reduced physical activity. 
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1.5.4 Obstructive sleep apnoea and obesity  
Obstructive sleep apnoea (OSA) is defined as complete or partial obstruction of upper 
airways followed by increased respiratory effort to make the airways patent again. 
Intermittent hypoxia accompanies the frequent episodes of cessation/reduction in 
airflow. Evidence indicates that an increase in body weight plays an important role in 
the incidence and progression of OSA. Results from the Wisconsin Sleep Cohort study 
suggest that a 10% weight gain from baseline to the end of the follow-up was 
associated with a 6 times greater risk for the development of OSA.161 
As the prevalence and severity of obesity is increasing, it would be expected that the 
prevalence of other obesity-related conditions including OSA would potentially 
increase at the same pace. It was previously reported that in the US, OSA is prevalent 
in 4% of men and 2% of women, but a rise in the prevalence of obesity has also led to 
an increase in prevalence of OSA among obese individuals (affecting 84% men and 
72% women in one study162). It is believed that obesity may lead to OSA through 
several mechanisms: 1) alterations of the upper airway structure by increased fat 
deposition around the neck area, 2) decreased neural compensation and increased 
susceptibility to airway, 3) instability of the respiratory control system, 4) respiratory 
muscle weakness, and 5) instability of caudal traction as a result of reduced functional 
residual capacity.163 
It is known that obesity may play an important role in the development of OSA, but 
recently it has been suggested that OSA itself may also increase the risk for obesity. 
Prolonged sleep loss, sleep disturbance, and daytime sleepiness associated with OSA 
may result in excessive weight gain, which can thus worsen obesity. There are several 
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hypotheses that may explain how OSA leads to obesity: 1) reduced basal energy 
expenditure could potentially contribute to excessive weight gain among individuals 
with OSA,164 2) higher preference for energy dense food and increased calorie intake, 
3) OSA may also be associated with alterations in the regulation of appetite 
hormones,165 and 4) excessive daytime sleepiness and reduced physical activity 
levels.166A potential mechanism that may likely works as a vicious cycle on 
association between OSA and obesity is presented in Figure 1-4. 
 
 
 
 
 
 
 
 
 
Figure 1-4. Potential mechanisms that may likely works as a vicious cycle in the     
pathogenesis of OSA and obesity.167  
Used with permission from Dr Carter. 
Evidence also suggests that obesity can effect sleepiness independent of OSA.154 
Vgontzas and colleagues168 previously assessed the subjective sleepiness of 73 obese 
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patients without OSA compared with 45 healthy controls with normal weight. The 
results showed that compared with controls, obese patients were sleepier during the 
day and also their night sleep was more disrupted. In addition, individuals were 
provided with 2 daytime napping opportunities. Compared to controls, obese patients 
had shorter sleep latency, less awakening after onset of sleep during the nap time, 
longer sleeping time, and more REM sleep (p<0.001).168 In a similar study, Resta and 
colleagues evaluated the sleep quality, sleep-related symptoms and excessive daytime 
sleepiness in 78 severely obese patients, ages 16 to 75 years without sleep apnoea and 
in 40 healthy matched controls. The findings showed that loud snoring was present in 
46.7% and 8.1% of obese patients and control individuals respectively (p<0.01). 
Moreover, excessive daytime sleepiness was reported by 34.7% of the obese, but only 
2.7% of the control individuals (p<0.01).169 As the findings of these studies suggest 
that obese patients without OSA had higher levels of daytime sleepiness and they were 
habitual snorers, thus it can be hypothesised that snoring may contribute to sleepiness 
among obese people. It was previously found that snoring per se is a risk factor of 
daytime sleepiness independent of obesity and OSA.170 In contrast, the effect of 
obesity independent of diabetes on daytime sleepiness is less well understood. 
Recently, it has been reported that pharmacological intervention, which could result in 
weight reduction and improved glycaemic control, has a significant reduction in 
sleepiness in diabetic obese patients without OSA.68 
Despite the high prevalence of OSA among obese individuals, the condition is largely 
undiagnosed and untreated. Under recognition of the disorder in both public and 
clinical settings may lead to multiple adverse social and health outcomes such as road 
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and work accidents that may cause premature death.171 Continuous positive airway 
pressure (CPAP) is known as the gold standard treatment for OSA treatment and is 
recommended by the national and international guidelines. However, adherence to 
CPAP has been found to be suboptimal.172 Evidence suggests that weight loss may 
reduce the severity of OSA. Bariatric surgery is recommended for those with the 
greatest severity of obesity and accompanying co-morbidities.173 Indeed, severe OSA 
is considered to be an indication for bariatric surgery. Bariatric surgery, however, is 
not without risk, is not widely available, and its long-term outcomes are unknown. For 
the majority of patients with OSA, lifestyle change and weight loss are recommended 
by guidelines,174 but supportive evidence for this recommendation remains 
unexamined through systematic review and meta-analysis.  
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1.5.5 Potential mechanisms explaining sleep-obesity link 
The underlying mechanisms mediating the link between sleep and obesity are complex 
and not fully understood. According to a hypothesised model by Taheri,175 sleep loss 
may result in 2 major changes: 1. An alteration in regulation of appetite hormones 
which could result in higher food intake; and 2. Fatigue that may lead to a decrease in 
physical activity (Figure 1-5). Insulin resistance as a result of weight gain would also 
contribute to greater adiposity. Several potential mechanisms have been examined and 
are discussed below. 
 
Figure 1-5. Potential mechanisms that short sleep duration may link with increased 
risk for obesity.175 
Printed with the permission of Dr S Taheri. 
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1.5.5.1 Sleep and regulation of appetite hormones 
Alteration in activity of sympathetic nervous system may result in alterations in the 
release of appetite hormones such as leptin and ghrelin. 
1.5.5.1.1 Leptin 
Leptin, secreted primarily from fat cells (adipocytes), is a peptide hormone that 
promotes satiety, and has been found to play an important role in metabolism.176 In 
energy deficit conditions, low leptin levels strongly signal energy deficit to the 
hypothalamus (the central homeostatic regulator), which would increase hunger and 
food intake (Figure 1-6).176  
 
 
Figure 1-6. Effect of leptin on regulation of energy balance.176 
Used with permission from Dr Taheri. 
 Food intake  
Energy expended 
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There are two groups of neurons within the hypothalamic arcuate nucleus (ARC) that 
are particularly influenced by leptin. The melanocyte stimulating hormone 
(MSH)/cocaine and amphetamine regulated transcript (CART) neurons mediate 
satiety.177 These neurons are activated by leptin. Neuropeptide Y (NPY)/Agouti-
related peptide (AGRP) neurons mediate appetite and their activity as well as peptide 
gene expression are reduced by leptin.177 Obesity results in high leptin levels 
suggesting a state of leptin resistance. This may be because of reduction of leptin 
transport into the central nervous system (CNS). Thus, low leptin, signalling low fat 
stores, which has a potential to threaten reproductive function, is a much more 
powerful signal than high leptin levels.176  
Evidence from early epidemiological121, 123 and experimental studies suggested 178 that 
sleep loss is associated with reduced leptin levels. Taheri and colleagues121 observed 
15.5% lower leptin levels (p for slope = 0.008) in those with shorter sleep (5 hours vs. 
8 hours) sleep in a large population study (n = 1,024). Spiegel and colleagues179 studied 
12 healthy men after 6 days of sleep restriction (total sleep duration was 4 hours per 
night), followed by 6 days with total sleep opportunity of 12 hours per night. The study 
was conducted under constant calorie provision. They found that 4 hours sleep was 
associated with a reduction in leptin levels by 18% (2.6 ng/mL vs. 2.1 ng/mL; p = 0.04) 
compared to 12 hours of sleep. The reduction in leptin observed by both the Taheri121 
and Spiegel179 studies are equivalent to levels of leptin observed after significant 
calorie restriction (1000 kcal/day). With calorie restriction, as commonly practiced 
with various diet plans, leptin levels diminish, providing a strong energy deficit signal 
that subsequently promotes weight regain.176 
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In contrast, Omisade and colleagues180 reported that sleep restriction was associated 
with an increase in leptin levels among 15 healthy women (aged 18-25 years). The 
participants’ sleep duration and eating habits were monitored a week prior to the study. 
The change in leptin levels was assessed after two consecutive days: a) after a 10-hour 
sleep opportunity and b) after a night of sleep restriction with total sleep duration of 3 
hours. Participants were asked to complete an appetite questionnaire on both days. The 
level of hungers was estimated using 10 cm scales (0 indicated “not all hungry” and 
10 indicated “extremely” hungry). Morning leptin levels increased significantly after 
sleep restriction compared to baseline (z = −1.98, p = 0.04). While, hunger and 
increased appetite for high caloric density food did not significantly differ between 
these conditions using Wilcoxon Signed Ranks analyses. In a similar study, Pejovic 
and colleagues181 assessed the effect of a 7-day sleep protocol (four nights of normal 
sleep, one night sleep restriction, and two nights of sleep recovery) among 21 
overweight men and women, and they found that the plasma leptin levels significantly 
increased after one night sleep loss (mean difference of leptin levels, post deprivation 
minus baseline: 3.43 ± 0.89 (ng/mL), p = 0.001) and the mean plasma levels were non-
significantly higher impact women compared to men (mean ± SD, 17.8 ± 4.3 (ng/mL) 
vs. 13.5 ± 2.5 (ng/mL), p>0.05). No significant change was observed in hunger and 
appetite levels. Results from an epidemiological study182 also reported that leptin 
levels had a 7% (95% CI, 1.01 – 1.11) increase for every 1-hour decrease in total sleep 
time among 561 adults using PSG measured sleep in full adjusted model, controlling 
for potential confounders including: age, gender, ethnicity, waist circumference, 
apnoea hypopnoea index, hypertension, and diabetes. Moreover, the mean leptin level 
for short sleepers (<5.5 hours) was 50.4 ng/mL (95% CI, 42.2 -60.2, while it was 39.4 
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ng/mL (95% CI, 34.2 - 45.4) for long sleepers (>7 hours), compared to normal sleepers 
(7-8 hours). 
Overall, based on the highlighted evidence, the relation between sleep duration and 
change in leptin levels is inconsistent, and may be due to differences in study design, 
patient population examined, degrees of adiposity, and the sleep restriction protocol. 
Importantly, leptin is a hormone that signals long-term energy deficit and is unlikely 
to change after very short sleep restriction. It is of note that the study by Taheri and 
colleagues found associations between leptin levels and habitual sleep rather than the 
sleep on the night before venepuncture.121  
Only a small number of epidemiological and experimental studies have evaluated the 
association between sleep loss and change in leptin levels. Some of the factors that 
may be responsible for inconsistent findings from these studies is discussed in detail 
below.   
In the study by Spiegel and colleagues,179 sleep loss was chronic and partial (restriction 
of sleep to 4 hours for six days).179 In contrast, Pejovic and colleagues181 did not 
observe any change in leptin or cortisol level or evening levels of blood pressure/heart 
rate following one night of sleep loss. In the study by Spiegel and colleagues,179 
restricted sleep duration was found to be associated with reduced leptin levels after 
one week of sleep restriction and extension of bedtimes and their findings are in 
agreement with findings from two epidemiological studies, which reported that a 
reduction in leptin levels occurred with habitual (longer term) sleep, independent of 
BMI.83, 85 Leptin signals long-term state of adipose stores and is more likely to be 
associated with longer term changes in sleep duration. Finally, results from studies180, 
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181with female participants suggest that females have a significantly greater leptin 
response or the opposite response to men to sleep restriction compared to men.183, 184 
The observed sex differences is yet to be understood, however it is believed that 
women maybe more vulnerable to health risks from behavioural factors such as 
restricted sleep. 
Overall, inference from experimental studies is limited, due to several factors 
including; their small sample size (<12 participants), quantity and duration of sleep 
deprivation, method of sleep deprivation, setting for the sleep deprivation (e.g. sleep 
laboratory), limited generalizability (many restricted to young healthy males), failure 
to control for or capture changes in calorie intake and energy expenditure within 
periods of experimental studies, and use of historical blood samples, which may have 
resulted in lack of difference in leptin levels between experimental conditions. It is 
also important to consider that cross-sectional design of epidemiological studies on 
association between sleep duration and leptin limits the ability to infer the temporal 
relationship between sleep duration and plasma leptin concentrations. 
In general, the cross-sectional study design is a very efficient approach to evaluate a 
large number of people. There are also a few issues that need to be considered in 
evaluating cross-sectional studies. The main limitation is that the interpretation of 
causal association between exposure (e.g. sleep duration) and outcome (e.g. change in 
leptin levels) is impossible using a cross-sectional study design, because sleep duration 
and leptin levels are assessed simultaneously. Although, results from epidemiological 
studies83, 85 showed that decreased sleep time was associated with decreased leptin, it 
is still impossible to make any conclusion, whether sleep loss can cause a decrease in 
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serum leptin concentrations. The other major issue is that sample in a cross-sectional 
study may not be a representative of the population, and the results of the study may 
differ if another time frame has been chosen. 
Cross-sectional design is susceptible to bias due to low response and misclassification 
due to recall bias. The other limitation is that a cross-sectional study is more 
appropriate to evaluate prevalent rather than incident outcomes, as the population from 
which the subjects are drawn would be unclear. Lack of knowledge of the actual 
population means that the cases and exposure cannot be certain. Whereas, population 
is defined in cohort and the number of the subjects that are exposed or have the disease 
is certain, thus incident can be calculated. 
1.5.5.1.2 Ghrelin 
Ghrelin is a gastric hormone that signals hunger acutely to the hypothalamus, and over 
time, promotes adiposity.185 Ghrelin has opposing actions to leptin on hypothalamic 
neurons.185 Taheri and colleagues,121 in their population study, found that short PSG-
measured sleep (sleep duration<5 hours) predicted 14.9% higher ghrelin levels 
compared to sleeping of 8 hours per night. Recently, Hogenkamp and colleagues186 in 
a randomised cross-over study, assessed the effect of two conditions (8 hours of sleep 
vs. 24-hour total sleep deprivation) and they found that in the morning of total sleep 
deprivation, the plasma ghrelin levels were 13% higher (p = 0.04) and sleep-deprived 
individuals tended to choose larger portion sizes for all food items (kcal mean ± SD, 8 
hours of sleep 359 ± 31 vs. 400 ± 36 total sleep deprivation, p<0.05). Sleep-deprived 
participants also chose larger portion of snacks after breakfast (310 ± 29 vs. 337 ± 30, 
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p<0.05 respectively). No difference was observed in food selection between the two 
conditions.   
In a similar study,187 nine healthy men were examined under three different conditions; 
a) one night with total sleep time of 7 hours, b) one night with total sleep time of 4.5 
hours, and c) one night with total sleep deprivation. Participants were asked to score 
their hunger from scale of 0 (not at all) to 9 (extremely). The findings showed that 
hunger rates (3.9 ± 0.7, 2.2 ± 0.5 vs. 1.7 ± 0.3; p<0.05) and plasma ghrelin levels (0.85 
±0.06 ng/mL, 0.77 ± 0.04 ng/mL vs. 0.72 ± 0.04 ng/mL, p<0.05) were significantly 
higher after total sleep deprivation compared to 7 hours sleep or 4.5 hours sleep 
conditions. No changes were observed in serum leptin levels across the three 
conditions.  
In a study involving 10 overweight healthy men under calorie restriction, Nedeltcheva 
and colleagues188 observed an increase in ghrelin levels (mean (SD), 75 (40) ng/L vs. 
84 (47) ng/L) but no change was detected in leptin levels between two conditions of 
seven nights of sleep restriction (5.5 hours sleep per night) followed by seven night 
sleep recovery (8.5 hours sleep per night).  
Evidence on the association between sleep duration and ghrelin is relatively consistent. 
Only, the result of a recent experimental study189 showed that there was no association 
between sleep duration and ghrelin and leptin levels. The study was relatively small (n 
= 12) and the participants were lean (mean body max index = 22.3 kg/m2) and no 
calorie restriction was applied.  
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1.5.5.2 Sleep and food intake 
The selection of unhealthy foods and shifting toward foods that quickly release their 
energy is another potential consequence of sleep deprivation. It has been previously 
reported that individual’s appetite ratings on the 10-cm visual analogue scale for high 
carbohydrate content foods (sweet, salty, and starchy) increased between 33% to 45% 
after sleep restriction.190 Brondel and colleagues189 assessed alterations in energy 
intake after acute partial sleep restriction among 12 men (mean age (SD): 22 (3) years, 
mean BMI: 22.30 (1.83) kg/m2) under ad libitum diet. The findings showed that 
participants consumed higher energy (mean± SD, kcal 559 ± 617 (i.e. 22%) p<0.01) 
after sleep restriction compared to 8 hours sleep session.  In a randomised cross-over 
study, Nedeltcheva and colleagues188  examined whether sleep restriction could reduce 
the effect of a low-calorie diet among 10 overweight participants (mean age (SD): 41 
(5) years, mean BMI (SD): 27.4 (2.0) kg/m2) over 14 days with either 8.5 hours or 5.5 
hours sleep. During 14 days, individuals consumed their same dietary pattern with 
calorie restriction up to 90% of their resting metabolic rate at baseline. Total 
individualised calorie was divided among breakfast (25%, 8:00 – 9:00 am), lunch 
(30%, 12:30 – 1.30 pm), dinner (35% 6:30 - 7:30 pm), and snacking (10%, 9:00 pm). 
In order to determine the actual consumption, the food was weighted before each meal. 
Participants were asked to determine their level of hunger using a 10-cm visual 
analogue scale, before each meal and at 11:00 pm. Findings showed that approximately 
half of the weight loss occurred during the 8.5 hours sleep, while only 25% of the 
weight loss occurred during 5.5 hours sleep condition (Mean (SD) reduction in fat loss 
(kg) 8.5 hours vs. 5.5 hours sleep: 1.4 (0.9) vs. 0.6 (0.6) kg, p = 0.043). Moreover, 
sleep deprived individuals tending to snack particularly during night, when food intake 
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preferences normally decrease during evenings such increased vulnerability to 
overeating could potentially promote weight gain.188 Energy needs were also found to 
be increased following sleep restriction,191 and sleep deprived individuals may 
potentially tend to compromise this energy need by selecting foods that quickly release 
their energy. However, higher intake of some nutrients such as carbohydrates may 
exceed the energy needed and promote weight gain. 
1.5.5.3 Sleep and energy expenditure 
Energy expenditure is another possible underlying mechanism mediating the 
interaction between sleep and obesity. Excessive daytime sleepiness and fatigue as a 
result of insufficient sleep may potentially limit levels of physical activity and increase 
the probability of engaging in sedentary behaviours such as sitting and watching 
TV.128, 192 
It has been previously reported that the impact of disrupted sleep on daily physical 
activity is even higher among younger age groups.193 In a large population-based 
study, Ortega and colleagues192 assessed the sleep patterns of 2,179 (1,139 females) 
Spanish adolescents (ages ranged from 13 to 18.5 years) and also examined the 
association between sleep duration and morning tiredness. Findings showed that 
female participants who slept 8 hours or longer were less likely to report morning 
tiredness (OR 0.49, 95% CI 0.34 – 0.71), but no association was found among male 
participants (OR 0.87, 95% CI 0.58 – 1.31). Additionally, sleeping less than 8 hours 
was associated with lower probability of engaging in any physical activities (OR 0.64, 
95% CI 0.45 – 0.93) and higher probability of excessive hours of watching TV (≥3 
hours per day) (OR 2.15, 95% CI 1.42 – 3.27) in males only. Results of a similar study 
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in a sample of 383 adolescents (aged 11 to 16 years) showed that each hour reduction 
in total sleep time was associated with 80% increased risk for obesity (95% CI 0.11 – 
0.34). Additionally, sleep disturbance was significantly (Regression coefficient β = -
7.48, p = 0.001) associated with decreased physical activity levels among these 
individuals.128  
On the other hand, findings from experimental studies188, 194, 195 have been relatively 
controversial. Nedeltcheva and colleagues188 found no significant difference in total 
energy expenditure of their 10 overweight participants under two sleep conditions, 
(2136 (342) vs. 2139 (393) kcal/day, 8.5 hours vs. 5.5 hours respectively). In another 
study, Jung and colleagues194 found that energy expenditure during 40 hours of sleep 
deprivation significantly increased by 7% compared to 24 hours normal sleep (total 
sleep time was 8 hours (approximately 134 ± 2.1 vs. 228 ± 23 kcal) among 7 healthy 
volunteers. Benedict and colleagues195 in a crossover design examined 14 healthy men 
during a 24-hour consecutive sleep restriction followed by sleep recovery and found 
that energy expenditure, was significantly reduced by approximately 20% after acute 
sleep loss (mean (SD) kJ/min, 1.06 ± 0.06 vs. 1.32 ±6 0.07 kJ/min; p<0.0001). There 
are several reasons for discrepancies in the findings from experimental studies 
including variations in protocol such as duration of sleep restriction and participant 
characteristics. There is a need to study the impact of sleep restriction under more 
realistic conditions. 
The exact mechanism underlying any associations between sleep loss and energy 
expenditure are largely unknown. It has been consistently reported that sleep loss is 
associated with a decrease in leptin levels, which could explain a reduction in energy 
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expenditure following sleep loss. Moreover, sleep restriction also found to be 
associated with an increase in ghrelin levels, which are associated with lower levels of 
resting and energy expenditure.194 Sleep has an important role in thermoregulation. 
Body temperature reduces during sleep suggesting energy dissipation. Sleep restriction 
may affect this reduction in body temperature, thus avoiding energy dissipation. This 
could contribute to weight gain. This hypothesis, however, has not been examined.  
1.5.5.4 Sleep and circadian disruption  
Disruption in sleep-wake cycle and sleep patterns similar to those observed among 
shift-workers is another possible hypothesis that can explain how sleep may be linked 
to obesity.196 As previously described, circadian rhythms are controlled by the central 
circadian pacemaker, which is located in the suprachiasmatic nucleus in the 
hypothalamus. Physiological functions within cells are synchronised by the central 
oscillator. In a recent experimental study, Scheer and colleagues197 studied 10 adults 
(5 female) under a 10-day laboratory protocol, which participants ate and slept through 
the entire circadian cycle followed by 28 hours of total wakefulness. Findings showed 
that circadian misalignment was associated with decreased leptin level (−17%, p 
<0.001), increased glucose (+6%, p <0.001), increased mean arterial blood pressure 
(+3%, p = 0.001), and reversed daily cortisol rhythm. It has been previously shown 
that sleep restriction was associated with a decline in the diurnal amplitude of leptin. 
Spiegel and colleagues178 evaluated 11 subjects (mean age (SD), 22 (1) years; mean 
BMI (SD), 23.4 ± 0.5 kg/m2) under different bed conditions (three nights with total 
sleep duration of 8 hours, six nights with total sleep duration of 4 hours and seven 
nights with total sleep duration of 12 hours). The findings showed that rhythm 
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amplitude of leptin significantly decreased during sleep restriction compared to sleep 
extension (-19%, -26%, and -20%, respectively). Their results also indicated there was 
an alteration between the pattern of regulation of leptin and cortisol in the 24-hour, 
following the sleep restriction with declining leptin levels significantly associated with 
elevation of cortisol levels at the beginning of the sleep time.  
The disruption in body’s internal clock may also disrupt metabolic mechanisms in 
different cells, tissues and organs of the body and alteration in regulation of  several 
nutrients (e.g. glucose, fatty acids and triglycerides) and hormones (e.g. leptin, ghrelin, 
and insulin) may also influence appetite, satiety, and also modify food intake.178, 198-
200  
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1.6 Aims of thesis 
The growth in the prevalence of overweight and obesity is a major challenge for public 
health worldwide.70 Obesity is an important risk factor for several adverse health 
outcomes including; diabetes, hypertension, cardiovascular disease, several cancers, 
and mental health problems.201 It is also known that there is a close link between 
obesity and obstructive sleep apnoea (OSA).105 To date, a substantial number of studies 
have investigated the various determinants that are potentially associated with an 
increased risk of obesity.202 Clearly energy imbalance is the cause of 
overweight/obesity, therefore the majority of health interventions, designed to tackle 
obesity have targeted directly the energy balance equation, concentrating on diet and 
physical activity. Unfortunately, despite concerted efforts to tackle obesity in this way, 
limited success has been achieved.202 Therefore, a greater understanding of factors that 
alter diet and physical activity is needed. Emerging evidence suggests that the 
contribution of factors such as sleep quantity and quality to obesity need to be studied 
in more detail as sleep disturbance could contribute to alterations in the energy balance 
equation. In recent years, the important potential role of sleep duration in the 
promotion of obesity has been identified by numerous epidemiological studies.114 
Thus, identifying the determinants of factors that drive short and long sleep duration 
may be beneficial for designing approaches to obesity prevention and treatment.  
The focus of this thesis is to investigate the association between sleep and obesity, and 
its impact on health and wellbeing. The detailed hypotheses and the approach to assess 
such hypotheses for each chapter are discussed below: 
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Chapter 2: Based on evidence provided earlier, there is a positive link between sleep 
duration and increased risk for obesity. However, the majority of studies have been 
among younger or middle-aged individuals and it is not known whether sleep and 
obesity are significantly associated among older individuals who are at greater risk of 
chronic disorders such as diabetes. Sleep patterns may dramatically change across the 
life span; therefore the sleep duration may not be associated with alteration in 
metabolism and development of chronic diseases such as obesity among these 
individuals. It is also hypothesised that gender may also have an impact on association 
between sleep duration and obesity, but there is a gap in current knowledge for drawing 
any confirmative conclusion in this matter.  
The focus of this chapter is on evaluating factors that are associated with both short 
and long sleep duration among 10,088 older Chinese individuals. It is hypothesised 
that demographic, socio-economic, health behaviours and medical condition variables 
may be associated with sleep duration among these individuals. I also investigated the 
cross-sectional associations between sleep duration and chronic conditions including 
obesity, hypertension, and diabetes following adjustment for potential confounders are 
assessed.  
Chapter 3: It is believed that sleep quality as well as sleep quantity may increase the 
risk for obesity. It is hypothesised that poor sleep quality has a negative impact on 
mood and quality of life among individuals with extreme obesity. In this chapter, I 
investigated the cross-sectional associations among sleep disturbance, quality of life, 
anxiety and depression in 270 patients with extreme obesity attending a specialist 
weight management service in the UK.  
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Chapter 4: There is a close link between obstructive sleep apnoea (OSA) and obesity. 
Excessive daytime sleepiness is a well-known feature of OSA and may worsen the 
obesity per se. Early treatment of OSA may prevent its further adverse health 
complications. Evidence on effectiveness of lifestyle interventions as treatment 
approaches for OSA has not been systematically reviewed. In this chapter, it is 
hypothesised that lifestyle modification strategies and weight loss through the 
application of diet and exercise or their combination may be effective for the treatment 
of OSA. A systematic review and meta-analysis approach was conducted to examine 
the above hypothesis. 
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2 PREDICTORS OF TOTAL SLEEP DURATION IN OLDER 
CHINESE ADULTS- THE GUANGZHOU BIOBANK COHORT 
STUDY (GBCS) 
 
2.1 Abstract  
Introduction: It has been reported that both short and long sleep duration are 
associated with an increased risk for multiple adverse health outcomes and even 
mortality. The mechanisms underlying these associations remain unknown. The 
present study explored the potential socio-demographic, socio-economic, and medical 
condition variables associated with short and long sleep duration and also examined 
whether sleep duration is associated with the common chronic disorders of obesity, 
hypertension, and diabetes mellitus.  
Methods: Participants (n = 10,088) were of Chinese origin and aged ≥50 years. 
Logistic regression was used to estimate the strength of associations of potential 
factors linked to short and long sleep duration.  
Results: In males, sleep duration of 6-<7 hours and ≥9 hours were inversely associated 
with increased risk of obesity (6-<7 hours: Odds Ratio (OR) 0.61, 95% CI 0.38 – 0.99, 
≥9 hours: OR 0.51, 95% CI 0.28 – 0.91, respectively). In females, sleep duration of ≥9 
hours was positively associated with obesity (OR 1.45, 95% CI 1.16 – 1.80). 
Additionally, sleep duration of 6-<7 hours was associated with increased risk of 
hypertension among males (OR 1.55, 95% CI .105 – 2.29), while in females, sleep 
duration of 8-<9 hours was associated with hypertension (OR 1.19, 95% CI 1.01 – 
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1.41). Females, who reported sleeping 6-<7 hours per night were more likely to have 
diabetes compared to those reported 7-<8 hours (OR 1.55, 95% CI 1.07 – 2.25).  
Conclusion: This study showed that short sleep duration was associated with female 
gender, older age, being widowed, and having lower education and income levels, and 
that long sleep duration was associated with hypertension. Understanding factors that 
are associated with both short and long sleep duration may inform the design of 
interventions aiming to improve sleep. This, in turn, allows us to test the hypothesis of 
whether altering sleep duration can have an impact on health. The gender differences 
in factors associated with both short and long sleep duration require further 
exploration. 
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2.2 Introduction 
The role of sleep in health and wellbeing is increasingly appreciated.3 A group that is 
particularly vulnerable to sleep problems is the older population who also carry an 
increasing burden of chronic disorders.21 There is increasing evidence that extremes 
of sleep duration are associated with adverse health outcomes. This is supported by 
detailed study of putative mechanisms within sleep laboratories.190 If sleep is indeed 
an important lifestyle factor that contributes to various aspects of health and wellbeing, 
then improving sleep could have beneficial effects, particularly in vulnerable groups 
such as the older population.21  
As previously stated in Chapter 1, sleep patterns change significantly across the 
lifespan. In general, evidence suggests that older people sleep less and may experience 
fragmented sleep compared to younger people.21 The decline in sleep continuity may 
negatively influence mood, cognition and overall functioning.203 It was previously 
reported that approximately half of individuals over the age of 65 years suffer from at 
least one sleep problem, and in particular insomnia.204 Data from epidemiological 
studies conducted in Western countries suggest that the prevalence of insomnia ranges 
between 6% and 10%.204, 205  
There is a lack of data on sleep habits and the prevalence of insomnia among older 
Chinese people. Two previous epidemiological studies conducted in Hong Kong206 
and Taiwan207 reported a diverse estimate of insomnia prevalence (38.2% vs. 6%). A 
recent epidemiological study208 assessed the prevalence of insomnia among 5,001 
Chinese living in mainland China aged ≥18 years. The authors found that insomnia 
affected 39.4% of the participants and that the prevalence was slightly higher among 
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older and socio-economically deprived individuals. They also found that non-
employed groups and housewives had the highest rates of insomnia (≥43.7%).208 The 
observed difference in prevalence of insomnia among Hong Kong, Taiwan, and 
mainland of China inhabitants may be explained by difference in social and socio-
economic factors, and healthcare assessment and delivery across these regions.  
The mechanisms underlying the onset and development of sleep problems among older 
people are not fully understood but are likely to be a combination of ageing itself 
combined with other biological and/or psychosocial factors.209 Retirement from work 
is normally associated with reduced daily activity, which may cause irregular 
schedules of sleeping and increased napping. Chronic health conditions such as 
cardiovascular disease, diabetes, chest diseases, arthritis, and the menopause are also 
prevalent among older people and may further disrupt sleep.209 Moreover, major life 
events such as the death of a spouse, financial strain, reduced coping skills, reduced 
cognitive function, disability, and medication side effects may also contribute to sleep 
disturbance.63 Sleep may also be disrupted as a result of poor lifestyle including lack 
of physical activity, smoking, excessive alcohol consumption, and napping.63, 210 
Social and cultural factors may also contribute to poor sleep among older 
individuals.211 Evidence from numerous epidemiological studies in the United States 
has also confirmed the impact of ethnicity on sleep duration, sleep complaints and 
other sleep problems among older individuals.21, 209 In some cultures, including 
Mediterranean, Chinese and South American countries, afternoon napping (siesta) is a 
traditional practice. In China, it is widely accepted among all Chinese, particularly in 
older Chinese, that afternoon napping is a robust activity and can improve the health 
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of older people. The effect of napping on health has yet to be confirmed; however it 
was previously reported that sleeping during the day “siesta” may increase the risk of 
cardiovascular morbidity and mortality. Results from analysis of prospective data 445 
older residents (mean age: 70 years) of Jerusalem, Israel showed that total mortality 
rate (20% vs. 11%, p = 0.001) of those who practiced the siesta was significantly higher 
compared to those who did not. In a full-adjusted for potential confounders, the siesta 
remained as a strong predictor of total mortality (OR 2.1, 95% CI 1.1 – 3.9).212 
Findings from a recent large population-based study213 among 3,079 Taiwanese aged 
64 years and older showed that compared to individuals with night-time sleep only, 
those older individuals who reported taking a nap during the day, regardless of duration 
of nap, did not have any differences in mortality risk. However, a recent study from 
the Guangzhou Biobank Cohort Study (GBCS) showed that frequency of daytime 
napping was significantly associated with increased risk of type 2 diabetes, among 
19,567 older Chinese men and women (OR 1.28, 95% CI 1.15 – 1.44).214  
Understanding factors that correlate with both short and long sleep duration may be 
beneficial for designing health interventions to address and modify those factors in 
order to improve sleep and eventually prevent further health complications. For 
example, Sherrill and colleagues215 investigated the impact of moderate physical 
activity on sleep problems among 722 adult men and women participants and they 
found that regular activity at least once a week was associated with a lower risk for 
difficulties maintaining sleep (OR 0.71, 95% CI 0.50 – 0.99) and also for any other 
sleep problem (OR 0.62, 95% CI 0.44 – 0.87). In another study, Merill and 
colleagues216 assessed whether an intensive lifestyle modification programme (diet 
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and physical activity) can reduce sleep problems among 2,624 individuals aged 30 to 
80 years. The findings showed that from baseline to end of four-week programme the 
percentage of people with insomnia significantly reduced by 64%. Thus, it is possible 
to improve sleep through specific interventions with potential downstream health 
benefits. Studying sleep patterns in a well-established and well-characterised cohort 
can help identify modifiable factors that are associated with both short and long sleep 
duration, which can inform the development of future interventions. The aim of the 
work in this chapter was to examine factors associated with sleep duration among the 
older Chinese and also determine the role of sleep in common and emerging chronic 
disorders including obesity, hypertension, and diabetes mellitus. 
2.2.1 The impact of sleep on health 
Sleep is a normal and restful condition for both brain and body, in which the awareness 
and body movement decreases. On average, a third of adult life is spent sleeping. 
Acquiring sufficient sleep is recognised as an important part of a healthy lifestyle as 
well as diet and physical activity. The impact of sleep on health and well-being has 
been a main interest of numerous studies. Kripke and colleagues3 found that a sleep 
duration of 7 to 8 hours was associated with lowest risk of mortality among 636,095 
women, aged 30 to 102 years old (Figure 2-1). It has been found that deviation from 
this range of sleep may be associated with adverse health outcomes such as obesity, 
cardiovascular disease, diabetes, and even death. 
Recently, Cappuccio and colleagues217 systematically reviewed prospective 
population-based studies and quantified the impact of short and long sleep duration on 
all-cause mortality. The authors identified 17 studies, which represented 
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1,382,999 individuals from eight different countries. Self-reported sleep measures (i.e. 
self-reported questionnaire), rather than objective measures (i.e. actigraphy, 
polysomnography), were used across all the studies. The pooled analysis demonstrated 
that compared to sleep duration of 7 to 8 hours, hazard ratio for all-cause mortality for 
short sleep duration (<5 hours sleep per night) and long sleep duration (≥8 hours sleep 
per night) was 1.12 (95% CI, 1.06 - 1.18) and 1.30 (95% CI, 1.22 - 1.38), respectively. 
The link between sleep and mortality is yet to be understood fully and requires further 
investigations. Some mechanisms for this relationship have been proposed and are 
discussed in the thesis. There are several interrelated aspects of sleep including sleep 
duration and quality that need to be considered when studying the impact of sleep on 
health. Increasing evidence highlights the importance of sleep quality as well as 
quantity for optimal health.4  It is believed that the potential adverse physiological 
outcomes of shorter and or poor quality sleep such as obesity, diabetes, and 
cardiovascular may mediate the pathways between sleep and mortality.4 Despite these 
hypotheses, it is important to note that there are no data examining the relationship 
between mortality and objective sleep measures (i.e. actigraphy, polysomnography). 
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Figure 2-1. The average BMI and hazard ratios for mortality according to self-reported 
sleep duration among 636,095 women3, The hazard ratios (95% CI) for 3 hours of 
sleep and 10 hours of sleep are 2.05 (1.68 – 2.50) and 2.14 (2.04 – 2.28), compared to 
7 hours of sleep respectively.  
Used with permission from Professor Daniel Kripke. 
2.2.2 Physiological consequences of sleep loss 
Evidence indicates that sleep loss is associated with alterations in metabolic and 
endocrine function.218 Sleep plays an important role in regulation of body temperature; 
therefore sleep loss is associated with absence of nocturnal drop in body temperature 
and inability to dissipate body heat.219 This may result in energy retention that could, 
over a prolonged period, predispose to obesity. It was previously found that sleep 
restriction may result in activation of the sympathetic nervous system and may also 
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alter the activity of the hypothalamic-pituitary-adrenal axis which leads to higher 
secretion of cortisol (stress hormone) levels.44  
Sleep loss appears to influence circulating appetite hormones (leptin and ghrelin) in a 
direction, which could result in higher calorie intake and lower energy expenditure, 
eventually resulting in excessive weight gain and obesity.187, 190 It has also been found 
that sleep curtailment is associated with an increase in cortisol secretion, impaired 
glycaemic control, and impaired growth hormone secretion.220 It is known that thyroid 
hormones are an important regulator of carbohydrate metabolism, oxygen 
consumption, and cardiac output.221 Alterations in regulation of thyroid-stimulating 
hormones as a result of sleep loss may result in the development of glucose 
dysregulation and insulin resistance and predispose to diabetes in the longer term.221 
Thus, hormonal changes with sleep deprivation are likely to be key to adverse 
metabolic outcomes and obesity. 
Findings of epidemiological studies that previously explored the possible link between 
sleep duration, obesity, hypertension and diabetes are fully discussed in Chapter 1. A 
summary of methodological limitations of these studies is discussed as below.  
2.2.2.1 A summary of methodological limitations of previous studies that assessed 
the link between sleep duration, obesity, hypertension and diabetes  
In sum, a large body of evidence provides strong support for associations between 
sleep duration, obesity, hypertension, and diabetes. However, the underlying 
mechanisms for such associations are yet to be fully understood. It is very important 
to note the limitations of pervious work, in order to inform future research. The two 
key methodological limitations of previous studies are the reliance upon cross-
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sectional studies to support a link between sleep and risk of obesity, hypertension and 
diabetes, and the almost exclusive reliance on self-report measure of sleep. Although 
longitudinal associations between sleep and these adverse health outcomes have been 
previously assessed by several large epidemiological studies, it is still unknown, 
whether short sleep duration, or long sleep duration or both cause any of these adverse 
health outcomes. Evidently, future experimental and intervention studies are needed 
to carefully manipulate sleep length for effective treatment purposes. Moreover, 
objective measures of sleep such as actigraphy and polysomnography are needed to 
strengthen the validity and reliability of previous findings. Beyond these two key 
limitations, it is also important to note some inconsistencies across studies. Only a few 
studies assessed the impact of gender on associations between sleep duration, obesity, 
and hypertension and the findings were inconsistent. Furthermore, few studies have 
suggested that the positive association between sleep duration, obesity, hypertension 
and hypertension, which were observed among younger individuals, are not present 
among older individuals. The above noted limitations and inconsistencies suggest that 
there is a need to think critically about design of future work, including consideration 
of key factors that may influence study findings. 
2.2.3 Psychosocial consequences of sleep loss 
The pivotal role of sleep in the relationships among extreme obesity, and mood and 
quality of life are discussed in Chapter 3.  It is known that sleep loss may also have 
adverse effects on mental health. Chronic sleep deprivation could potentially result in 
anxiety, distress, depression and excessive alcohol use among adults.222 A meta-
analysis including 19 studies222 investigated the impact of sleep loss on performance, 
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and showed that the adverse effect of sleep loss on mood was much higher compared 
to cognitive and motor performance. Sleep loss may also have deleterious effects on 
several cognitive tasks such as concentration, attention and vigilance.223 Moreover, 
insufficient sleep has previously been found to be associated with significant 
impairment in a variety of tasks that need higher cognitive processes including 
complex decision making, problem solving, and inhibitory control.223 It is believed 
that adverse consequences of prolonged wakefulness on the prefrontal cortex may 
mediate the casual pathways between sleep loss and impairment in those tasks.224 
Evidence suggests that the prefrontal cortex is relatively sensitive to the effects of 
prolonged of wakefulness that occurs with chronic sleep loss.225 Lack of sufficient 
sleep can cause a decline in neural processes within the prefrontal cortex;224 therefore 
there is a cumulative need for other brain regions to compensate for these deficits.224 
It was previously found that even sleep loss for one or two nights could result in 
decrements in cognitive performance of tasks requiring involvement of the prefrontal 
region.226 It has been found recently that there is a positive link between sleep 
deprivation and deficits in moral judgment, reaction to frustration, emotional decision 
making, and mood regulation.223 It could be interpreted that adverse effects of sleep 
loss are not only limited to cognitive abilities but may also negatively influence 
personality and social interaction. 
2.2.4 Consequences of long sleep duration 
The majority of studies have placed greatest emphasis on short sleep duration, and 
mainly on insomnia. Therefore, the consequences of sleeping longer than average is 
less well understood.227 PSG sleep data have shown that long sleepers have shorter 
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SWS, while they have prolonged wakefulness and REM sleep compared to normal 
sleepers.228 As stated earlier, there is a U-shaped association between sleep duration 
and mortality,217 which highlights sleeping longer than the average amount may 
potentially increase the risk for death. The causal role and mechanisms of long sleep 
duration in mortality is yet to be understood. The possible link between long sleep 
duration and mortality can be explained by the fact that prolonged sleep is associated 
with increased sleep fragmentation which could potentially have a negative impact on 
overall health and well-being.229 The other possible explanation is that long sleepers 
feel sleepy and lack energy; this could dramatically reduce stress tolerance and 
increase susceptibility of disease.227 Finally, it has been hypothesised that lack of day 
light exposure (short photoperiod) due to extended time in bed could increase the risk 
for mortality in long run.227  
2.2.5 Rationale for assessment of factors associated with short and long 
duration among older individuals  
Both adverse physiological and psychosocial consequences as a result of deviation 
from recommended and average sleep duration (7 to 8 hours per night) have been 
observed. It has been previously found that demographic, socio-economic background 
and medical conditions may have an impact on sleep duration. For example, Kruger 
and colleagues63 investigated factors that contributed to short and long sleep duration 
among 110,441 American men and women. They reported that both short and long 
sleep duration were associated with black ethnicity (≤5 hours vs. 7 hours: OR 1.39, 
95% CI 1.84 – 2.17, and ≥9 hours vs. 7 hours: OR 1.72, 95% CI 1.59 – 1.87), lower 
income levels (≤5 hours vs. 7 hours: OR 0.91, 95% CI 0.87 – 0.95, and 8 hours vs. 7 
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hours: OR 0.96, 95% CI 0.93 – 0.98), current smoking (≤5 hours vs. 7 hours: OR 1.46, 
95% CI 1.34 – 1.59, and  ≥9 hours vs. 7 hours: OR 1.32, 95% CI 1.20 -1.45), depressive 
symptoms (5 hours vs. 7 hours: OR 1.23, 95% CI 1.18 – 1.27, ≥9 hours vs. 7 hours: 
OR 1.30, 95% CI 1.25 – 1.35), diabetes (≤5 hours vs. 7 hours: OR 1.19, 95% CI 1.07 
– 1.33, ≥9 hours vs. 7 hours: OR 1.25, 95% CI 1.13 – 1.38), and heart disease (≤5 
hours vs. 7 hours: OR 1.24, 95% CI 1.16 – 1.33, ≥9 hours vs. 7 hours: OR 1.11, 95% 
CI 1.03 – 1.19). They also observed that having long working hours (≥41 hours per 
week) (OR 1.52, 95% CI 1.34 – 1.72), obesity (OR 1.39, 95% CI 1.29 – 1.51) were 
strongly associated of short sleep duration. In Australia, Magee and colleagues210 
examined the sleep patterns in a sample of 49,405 adults aged 45 to 65 years. Their 
results indicated that short sleep is prevalent in this population. Moreover, sleep 
duration was associated with poorer self-rated health (<6 hours vs. 7 hours: OR 3.02, 
95% CI 2.56 – 3.66, 6 vs. 7 hours: OR 1.68, 95% CI 1.51 – 1.88, ≥9 vs. 7 hours: OR 
2.11, 95% CI 1.90 – 2.34) lower income levels (<6 hours vs. 7 hours: OR 1.74, 95% 
CI 1.48 - 2.04, 8 hours vs. 7 hours: OR 1.49, 95% CI 1.39 - 1.59, ≥9 vs. 7 hours: OR 
3.0, 95% CI 2.79 - 3.37), being single (<6 hours vs. 7 hours:  OR 1.27, 95% CI 1.13 - 
1.44, 6 hours vs. 7 hours OR  1.24, 95% CI 1.16 - 1.33), current cigarette smoking (<6 
hours vs. 7 hours: OR 1.58, 95% 1.34 - 1.86, 6 hours vs. 7 hours: OR 1.53, 95% CI 
1.38 - 1.70) alcohol consumption (<6 hours vs. 7 hours: OR 1.26, 95% CI 1.06 - 1.49, 
≥9 vs. 7 hours: OR 1.72, 95% CI 1.57 - 1.89), and obesity (<6 hours vs. 7 hours: OR 
1.2, 95% CI 1.05 - 1.40, 6 hours vs. 7 hours  OR 1.29, 95% CI 1.19 - 1.41). Similarly, 
the results of a recent study of 4,411 Korean adults aged 19 years and older, 
demonstrated that socio-economic characteristics, lifestyle factors such as smoking, 
and health-related characteristics, such as depression, are associated with short sleep 
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duration. Socio-economic characteristics and depression are also shown to be 
associated with long sleep duration.230  
Previous studies have found a positive association between sleep duration and chronic 
disorders including hypertension, obesity, and diabetes. The majority of these studies 
looked at such associations in both men and women; some investigated the effect of 
gender and specific age group and observed different results. For example, Fang and 
colleagues33 found that the probability of hypertension for those men (45-64 years) 
who slept <6 hours was higher compared to those who slept 8 hours (OR 1.29, 95% 
CI 1.05 – 1.60). In middle-aged women (45 to 65 years), the risk of hypertension was 
higher among those who slept >9 hours (OR 1.45, 95% CI 1.06 – 1.98). In another 
study, Lopez-Garcia and colleagues40 could not observe any significant association 
between sleep duration and incidence of hypertension among older individuals (≥60 
years). Tuomilehto and colleagues50 found that there was a U-shaped association 
between sleep duration and type 2 diabetes among women (≤6 hours vs. 7 hours: OR 
2.55, 95% CI 1.21 – 5.35, ≥8 hours vs. 7 hours: OR 1.76, 95% CI 1.12 – 2.61), but the 
observed trend among men was not statistically significant.  
Data on sleep patterns of older Chinese are relatively sparse. Understanding factors 
that contribute to either short or long sleep duration or also understanding the impact 
of gender and age on such association may help the design of future interventions to 
improve sleep. These interventions can then be employed in studies to examine 
whether altering sleep can have an impact on health.  
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2.3 Aim and study questions 
The purpose of the present study was to examine the sleep pattern of 10,088 older 
Chinese adults aged ≥50 years and examine a potential link between several factors 
(including demographic, socioeconomic, lifestyle and medical conditions), and sleep 
duration. Additionally, the potential association between sleep duration and 
hypertension, obesity and diabetes and the impact of gender and age was investigated.  
The study questions included: 
 What percentage of the participants of the study reported sleeping less or more 
than the average recommended sleep (7 to 8 hours)?  
 What factors are associated with short or long sleep duration among older 
Chinese people? 
 Is there any association between sleep duration and hypertension, obesity and 
diabetes among these individuals?  
 Is there any difference between gender and also age group on association 
between sleep duration and hypertension, obesity and diabetes?  
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2.4 Methods 
2.4.1 Study design 
Details of the methods of the Guangzhou Biobank Cohort Study (GBCS), including 
sample characteristics and recruitment techniques have been published elsewhere.231 
In summary, the GBCS is a large population-based study, which started in October 
2003, in joint collaboration between the Guangzhou Number 12 People's Hospital, 
University of Hong Kong, and University of Birmingham, that recruited older (≥50 
years) residents in Guangzhou, which is the provincial capital of Guangdong province 
in Southern part of China and is one the most economically developed regions of China 
(Figure 2-2).  
 
Figure 2-2. Geographical location of major urban areas in China (Approximate 
populations was 10 million in 2000). 
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The main objective of the study was identifying determinants such as genetic, lifestyle, 
occupational and environmental factors associated with chronic diseases. Participants 
were selected from a local social community centre named “Guangzhou Zunlao 
Xiehui” (“Guangzhou Health and Happiness Association for the Respectable Elders”). 
This is a very large non-governmental organization with open membership to anyone 
age 50 years or older for a minimal monthly membership of 4 yuan (1 USD = 8 yuan) 
with many branches throughout Guangzhou. After 18 months from initial recruitment 
of the first 11,000 participants, a pilot follow-up study achieved re-attendance of 
72.2% and telephone interview with a further 22.4%. Information on the remaining 
individuals were collected through family members and only 0.4% of individual were 
lost to follow-up. Informed, written consent was obtained prior to commencement of 
study measurement. Volunteers were interviewed by a trained nurse to collect data on 
demographic, socioeconomic, health behaviours and medical conditions. The blood 
samples were collected from the participants in fasting state. Breakfast was provided 
for the participants after taking blood samples and after being guided to stations 
designed for the interview and physical measurements including, anthropometry, 
blood pressure, 12-lead electrocardiography, pulmonary function testing, and chest 
radiography. A vacutainer tube was used to draw blood samples. C-reactive protein, 
glucose, lipids, markers of liver were determined automatically in the hospital 
laboratory using standard clinical laboratory methods.  
Ethical approval was obtained from Guangzhou Medical Association Ethics 
Committee. In total, across three phases of the study, 30,499 participants were 
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recruited. Since more precise sleep questions were included in phase 3 of the study, 
data from phase three, which involved 10,088 participants, were used for this study.   
2.4.2 Variables  
Data on sleep duration were acquired via self-administered questionnaire. The 
question formulation was “During the past 24-hour, how many hours of sleep did you 
get at night?” The participants were classified in five sleep categories; <6 hours, 6-<7 
hours, 7-<8 hours, 8-<9 hours, and ≥9 hours. Sleep data from only phase three of the 
GBCS were used as previous sleep data collected in earlier phases included total sleep 
duration that included naps. In phase three only, data were collected regarding night-
time sleep and was more reflective of published studies.  
The aim of the current study was to assess the factors associated with short and long 
sleep duration. The list of these factors was chosen based on the data available of a 
particular variable in the study and also based on literature search and findings of the 
studies that assessed similar trends. All other independent variables were categorised 
into two groups and the reference category is specified. Waist circumference was 
measured in horizontal state, and the measure of smallest circumference between ribs 
and iliac crest was recorded. Obesity was determined by waist circumference 
according to the International Diabetes Federation (IDF) guidance on waist 
circumference thresholds as a measure of central adiposity for Chinese (≥80 cm for 
women, ≥90 cm for men).232 Shimadzu CL-8000 Automatic Chemical Analyser was 
used to determine glucose level in the hospital laboratory. Type 2 diabetes was defined 
as fasting blood glucose ≥7.0 mmol/l or being on glucose-lowering medications.233 
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Blood pressure was measured three times with Omron 705CP sphygmomanometer in 
the seated state, giving 1 to 3 minutes break between each reading. The average of the 
three readings was used for analysis. Hypertension was defined as systolic blood 
pressure (SBP) ≥140 mmHg or diastolic blood pressure (DBP) ≥90 mmHg or being on 
blood pressure lowering medications.234 The Chinese validated International Physical 
Activity Questionnaire (IPAQ short version) was utilised to assess the level of physical 
activity, which was subsequently dichotomised into “active” and “non-active”.235  
2.4.3 Statistical Analysis 
The first aim of the current study was to assess the factors (i.e. socio-demographic, 
socio-economic, health behaviour, medical conditions) associated with short and long 
sleep duration. A list of the factors (age, gender, marital status, education level, income 
level, smoking, alcohol consumption, physical activity, obesity, hypertension, and 
diabetes) was chosen based on the data available of a particular variable in the study 
and also based on a literature search and findings of the studies that assessed similar 
trends (Kruger and Friedman,63 Magee and colleagues,210 Ryu and colleagues230).  
After deciding upon inclusion of appropriate factors, two steps were taken to assess 
the association of such factors with sleep duration. The first step involved, looking at 
the crude association between predictor variables (age (≥65 years, <65 years (ref)), 
gender (female, male (ref)), marital status (widowed, married (ref)), education level 
(<secondary school, ≥secondary school (ref)), income level (<15,000 Yuan, ≥15,000 
Yuan (ref)), smoking status (ever smoking, never smoking (ref)), alcohol consumption 
(ever drinking, never drinking (ref)), physical activity (active, not active (ref)), obesity 
(yes, no (ref)), hypertension (yes, no (ref)), diabetes (yes, no (ref)), and categories of 
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sleep duration (<6 hours, 6-<7 hours, 8-<9 hours, ≥9 hours), taking category of 7-8 
hours as a reference (evidence shows that sleeping between 7 to 8 hours was associated 
with the lowest mortality;3 therefore, this was used as the reference group), using 
multinomial logistic regression. All the predictor variables were categorised into two 
groups and the reference category is specified. The reference category was selected 
based on the research question. The second step, entering all the above variable into 
one single model, in order to determine the independent association between factor(s) 
with short sleep duration, or long sleep duration, or both. 
The other objective of the study was to assess the association between sleep duration 
(exposure) and obesity (outcome), hypertension (outcome), and diabetes (outcome). 
The above associations were adjusted for a number of potential confounders. The 
selection of confounding variables was based on the results from other previous 
studies33, 140 that evaluated similar associations and also was based on comparing 
adjusted and unadjusted effect estimates (e.g. 10% change in OR).236 If the relative 
change after adjustment for a certain variable was greater than 10 percent, then the 
variable was selected. After exclusion of variables that were found not to be 
confounders, the association between sleep duration, obesity, hypertension and 
diabetes were adjusted for following variables; age, gender, marital status, education 
level, income level, smoking, alcohol consumption, physical activity, obesity (not 
appropriate for assessing the association between sleep duration and obesity), 
hypertension (not appropriate for assessing the association between sleep duration and 
hypertension), and diabetes (not appropriate for assessing the association between 
sleep duration and diabetes).  
115 
 
 
The chi-square test was used to assess the association between characteristics of the 
participants (i.e. age, gender, marital status, education, annual income, physical 
activity, smoking status, alcohol use, obesity, hypertension, diabetes) by sleep duration 
(i.e. <6 hours, 6-<7 hours, 7-<8 hours, 8-<9 hours, ≥9 hours). The design of the present 
study is cross-sectional. The data were analysed using SPSS version 18 (SPSS, 
Chicago, IL) and results are reported as odds ratios (with 95% confidence intervals). 
A 2-tailed p value of less than 0.05 was considered statistically signiﬁcant.   
The analysis of data on this chapter was conducted in three steps. 1) The univariable 
analyses between independent variables (age, gender, marital status, education level, 
income level, smoking, alcohol consumption, physical activity, obesity, hypertension, 
and diabetes) and dependant variables (sleep duration categories of <6 hours, 6-<7 
hours, 8-<9 hours, ≥9 hours compared with 7-8 hours) were assessed. 2) The 
multivariable analyses with all the independent variables from above and sleep 
categories as dependant variables were assessed. 3) The multivariable analyses 
between sleep duration categories as independent variables and medical conditions 
including obesity, hypertension, and diabetes as dependant variables, adjusted for age, 
gender, marital status, education level, income level, smoking, alcohol consumption, 
physical activity, obesity, hypertension, and diabetes were assessed.  
2.4.3.1 Univariable analyses 
The univariate association between several independent variables including, age, 
gender, marital status, education level, income level, smoking status, alcohol 
consumption, physical activity, obesity, hypertension and diabetes with sleep duration 
was assessed. Multinomial logistic regression was used to calculate odds ratios to 
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assess the association between independent variables and with short or long sleep 
duration compared to 7-<8 hours of sleep per night (reference group).  
When disease incidence is rare (<10%), odds ratios can be used to estimate relative 
risk. In settings such as cross-sectional studies, where the population denominator is 
unknown and there are also uncertainties about the population from which subjects are 
drawn, the cases and exposure cannot be certain due to lack of knowledge about the 
actual population. Logistic regression, which utilises the logs of the odds ratio can be 
used to calculate odds ratios, while controlling for several potential confounders. 
However, using logistic regression to compute an estimated odds ratio and the 
subsequent interpretation of this estimate as a relative risk can be problematic when 
the outcome is more common. In studies of common outcomes, the estimated odds 
ratio can substantially overestimates the relative risk.  This can mean there are issues 
in the interpretation of either the associated risk (believing the exposure is of greater 
harm than is the case) or risk reduction (believing the exposure is of great benefit than 
is the case) depending on the analyses being performed. 
2.4.3.2 Multivariable analyses 
All the independent variables listed above was entered into one single model, in order 
to determine the independent association between factor(s) with short sleep duration, 
or long sleep duration, or both. The multinomial logistic regression was used to 
calculate the odds ratios.  
117 
 
 
2.4.3.3 Multivariable analyses between sleep duration, obesity, hypertension and 
diabetes 
The association between sleep duration as an independent variable with obesity, 
hypertension, and diabetes as an outcome variable were assessed after adjusting for 
multiple potential confounders (age, gender, marital status, education level, income 
level, smoking, alcohol consumption, physical activity). The association between 
hypertension, obesity, and diabetes with sleep duration was then assessed after 
stratifying by age and gender based on published literature demonstrating age and 
gender differences.  
 
 
 
 
 
 
 
 
 
 
 
118 
 
 
2.5 Results 
The descriptive characteristics of the participants within each sleep-duration category 
are presented in Table 2-1. Interestingly, only 30% of older adults reported sleeping 
between 7 to 8 hours per night (‘normal’ sleepers), while 14% were short sleepers (<6 
hours of sleep per night), and 10% were long sleepers (≥9 hours of sleep per night). 
Compared to sleep category of 7 to 8 hours of sleep, 38.8% of adults aged 65 years 
and older (vs. 23.9%), 81% of females (vs. 74.9%), 23.8% widowed (vs. 15.4%), 
76.1% of those with lower education (vs. 61.5%), 81.3% of those with lower annual 
income (vs. 73.6%), 12.0% diabetics (vs. 9.9%), were short sleepers while 23.2% of 
ever smokers were long sleepers (vs. 17.7%). Physical activity levels, obesity, and 
diabetes did not significantly differ across different sleep categories. 
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Table 2-1. Descriptive characteristics of 10,088 Chinese adults aged ≥50 years according to 
total sleep duration, Guangzhou Biobank Cohort Study, 2003-2008. Characteristics of 
participants by sleep duration using chi square test. 
                                     Total sleep duration 
Characteristics <6 hrs 6-<7 hrs 7-<8 hrs 8-<9 hrs ≥9 hrs Total p value 
 (n =1,467) 
14.5% 
(n = 2,256) 
22.4% 
(n = 2,955) 
29.3% 
(n = 2,337) 
23.2% 
(n = 992) 
9.8% 
N =10,088  
Age (%)       <0.001 
   <65yrs 61.2 70.1 76.5 75.4 70.1 71.9  
   ≥65yrs 38.8 29.9 23.5 24.6 29.9 28.1  
Sex (%)       <0.001 
  Male 19.0 23.7 25.1 28.0 34.0 25.4  
  Female 81.0 76.3 74.9 72.0 66.0 74.6  
Marital status (%)       <0.001 
   Married 76.2 81.6 84.6 85.4 83.8 82.8  
   Widowed 23.8 18.4 15.4 14.6 16.2 17.2  
Education       <0.001 
< Secondary School 76.1 67.7 61.5 61.6 66.0 65.5  
≥ Secondary School  23.9 32.3 38.5 38.4 34.0 34.5  
Annual Income (%)       <0.001 
   <15,000 Yuan 81.3 78.7 73.6 72.7 75.3 28.0  
   ≥15,000 Yuan 18.7 21.3 26.4 27.3 24.7 72.0  
Physical activity (%)       0.087 
  Not active 37.6 35.2 35.0 33.8 37.3 7.9  
  Active 62.4 64.8 65.0 66.2 62.7 92.1  
Smoking status (%)       <0.001 
  Never 85.5 82.7 82.3 81.1 76.8 82.0  
  Ever 14.5 17.3 17.7 18.9 23.2 18.0  
Alcohol use (%)       0.004 
  Never 53.2 49.8 47.3 48.8 51.1 49.4  
  Ever 46.8 50.2 52.7 51.2 48.9 50.6  
Obesity (%)       0.281 
   Yes         33.8 31.9 31.1 31.0 33.4 31.9  
   No 66.2 68.1 68.9 69.0 66.6 68.1  
Hypertension (%)       <0.001 
Yes 42.3 40.6 36.1 39.4 42.3 39.1  
No 57.7 59.4 63.9 60.6 57.7 60.9  
Diabetes (%)       0.053 
Yes 12.0 11.2 9.9 9.3 10.7 10.5  
No 88.0 88.8 90.1 90.7 89.3 89.5  
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Table 2-2. Odds ratios and 95% confidence intervals from the univariate multinomial logistic regression models predicting sleep duration. 
  Self-reported Sleep Hours  
 <6 hrs vs. 7-8 hrs 6-<7 hrs vs. 7-8 hrs 8-<9 hrs vs. 7-8 hrs ≥9 hrs vs. 7-8 hrs 
 Risk ratio (95% confidence interval) Risk ratio (95% confidence interval) Risk ratio (95% confidence interval) Risk ratio (95% confidence interval) 
Age (years)     
≥ 65 years 2.06 (1.80 – 2.35)** 1.38 (1.22 – 1.56)** 1.06 (0.93 – 1.20) 1.39 (1.18 – 1.63)** 
< 65 years (ref) 1.00 1.00 1.00 1.00 
Sex     
Female 1.43 (1.22 – 1.67)** 1.07 (0.94 – 1.24) 0.86 (0.76 – 0.97)* 0.65 (0.55 – 0.76)** 
Male (ref) 1.00 1.00 1.00 1.00 
Marital status     
Widowed 1.71 (1.46 – 2.00)** 1.24 (1.07 – 1.43) 0.93 (0.80 – 1.09) 1.06 (0.87 – 1.29) 
Married (ref) 1.00 1.00 1.00 1.00 
Education level     
< Secondary School 1.98 (1.72 – 2.29)** 1.31 (1.16 – 1.47)** 1.00 (0.89 – 1.12) 1.21 (1.04 – 1.41)* 
≥ Secondary School (ref) 1.00 1.00 1.00 1.00 
Income level     
< 15,000 Yuan  1.56 (1.33 – 1.83)** 1.32 (1.15 – 1.51)** 0.95 (0.84 – 1.08) 1.09 (0.92 – 1.29) 
≥ 15,000 Yuan 1.00 1.00 1.00 1.00 
Smoking status     
Ever smoking 1.27 (1.07 – 1.51)** 1.02 (0.89 – 1.18) 0.92 (0.80 – 1.06) 0.71 (0.59 – 0.85)** 
Never smoking (ref) 1.00 1.00 1.00 1.00 
Alcohol consumption     
Ever drinking 1.26 (1.11 – 1.43)** 1.10 (0.99 – 1.23) 1.06 (0.95 – 1.18) 1.16 (1.00 – 1.34)* 
Never drinking (ref) 1.00 1.00 1.00 1.00 
Physical activity     
Active 1.12 (0.98 – 1.27) 1.01 (0.90 – 1.13) 0.95 (0.84 – 1.06) 1.10 (0.95 – 1.28) 
Not active (ref) 1.00 1.00 1.00 1.00 
Obesity 1.14 (0.90 – 1.42) 1.10 (0.90 – 1.34) 0.94 (0.77 – 1.16) 1.23 (0.96 – 1.59) 
Hypertension    1.29 (1.14 – 1.47)**     1.20 (1.07 – 1.35)**   1.15 (1.02 – 1.28)*     1.29 (1.12 – 1.50)** 
Diabetes  1.23 (1.01 – 1.51)* 1.15 (0.96 – 1.37) 0.93 (0.77 -1.12) 1.09 (0.86 – 1.38) 
* p < 0.05 , ** p < 0.01 
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Table 2-3. Odds ratios and 95% confidence intervals from the fully adjusted multinomial logistic regression model predicting sleep duration. 
       Self-reported Sleep Hours  
 <6 hrs vs. 7-8 hrs 6-<7 hrs vs. 7-8 hrs 8-<9 hrs vs. 7-8 hrs ≥9 hrs vs. 7-8 hrs 
 Risk ratio (95% confidence interval) Risk ratio (95% confidence interval) Risk ratio (95% confidence interval) Risk ratio (95% confidence interval) 
Age (years)     
≥ 65 years 1.87 (1.59 – 2.18)** 1.32 (1.15 – 1.53)** 1.02 (0.88 – 1.18) 1.13 (0.94 – 1.36) 
< 65 years (ref) 1.00 1.00 1.00 1.00 
Sex     
Female 1.37 (1.09 – 1.73)** 1.06 (0.87 – 1.29) 0.83 (0.69 – 1.00) 0.58 (0.46 – 0.74)** 
Male (ref) 1.00 1.00 1.00 1.00 
Marital status     
Widowed 1.22 (1.02 – 1.45)* 1.00 (0.85 – 1.18) 0.91 (0.77 – 1.08) 1.06 (0.86 – 1.32) 
Married (ref) 1.00 1.00 1.00 1.00 
Education level     
< Secondary School 1.65 (1.41 – 1.93)** 1.21 (1.06 – 1.37)** 1.01 (0.89 – 1.14) 1.14 (0.97 – 1.35) 
≥ Secondary School (ref) 1.00 1.00 1.00 1.00 
Income level     
< 15,000 Yuan  1.16 (0.97 – 1.38) 1.20 (1.04 – 1.39)* 0.97 (0.85 – 1.11) 1.14 (0.97 – 1.35) 
≥ 15,000 Yuan (ref) 1.00 1.00 1.00 1.00 
Smoking status     
Ever smoking 0.89 (0.69 – 1.14) 0.99 (0.80 – 1.22) 0.96 (0.78 – 1.18) 0.97 (0.75 – 1.25) 
Never smoking (ref) 1.00 1.00 1.00 1.00 
Alcohol consumption     
Ever drinking 0.92 (0.80 – 1.06) 0.94 (0.83 – 1.06) 0.92 (0.81 – 1.03) 0.82 (0.70 – 0.97)* 
Never drinking (ref) 1.00 1.00 1.00 1.00 
Physical activity     
Active 1.13 (0.98 – 1.30) 0.99 (0.87 – 1.20) 0.93 (0.82 – 1.05) 0.97 (0.83 – 1.14) 
Not active (ref) 1.00 1.00 1.00 1.00 
Obesity 0.91 (0.72 – 1.16) 0.97 (0.78 – 1.21) 0.94 (0.75 – 1.17) 1.30 (0.99 – 1.71) 
Hypertension 1.08 (0.94 – 1.24) 1.14 (1.00 – 1.28)* 1.15 (1.01 – 1.29)* 1.14 (0.97 – 1.34) 
Diabetes 1.10 (0.89 – 1.37) 1.07 (0.88 – 1.29) 0.88 (0.72 -1.07) 1.00 (0.78 – 1.28) 
* p < 0.05 , ** p < 0.01      Note: All the independent variables were all fitted into one single model.
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Table 2-4. Odds ratios (95% conﬁdence intervals) for obesity, hypertension, and diabetes by reported usual sleep duration in the whole sample. 
 Obesity Hypertension Diabetes 
Risk ratio (95% confidence interval)a Risk ratio (95% confidence interval)b Risk ratio (95% confidence interval)c 
< 6 hours                     0.92 (0.79 – 1.06)                1.09 (0.95 – 1.26)                 1.11 (0.90 – 1.37) 
6-<7 hours                     0.94 (0.83 – 1.07)                1.15 (1.01 – 1.30)*                 1.08 (0.89 – 1.30) 
7-<8 hours (ref)                                  1.00                            1.00                            1.00 
8-<9 hours                    1.02 (0.89 – 1.15)                1.14 (1.01 – 1.29)*                 0.88 (0.72 – 1.07) 
≥9 hours                    1.19 (1.00 – 1.40)*                     1.13 (0.96 – 1.33)                 1.00 (0.78 – 1.29) 
a Adjusted for age, gender,  marital status, education level, income level, smoking, alcohol consumption, physical activity, hypertension, and diabetes. b Adjusted for age, gender,  marital status, education level, income level, 
smoking, alcohol consumption, physical activity, obesity, and diabetes, c Adjusted for age, gender, marital status, education level, income level, smoking, alcohol consumption, physical activity, obesity, and hypertension. *p<0.05 
 
 
 
Table 2-5. Odds ratios (95% conﬁdence intervals) for hypertension, obesity, and diabetes by reported usual sleep duration in males by age 
(<65/≥ 65 years). 
 Obesity Hypertension Diabetes 
 Risk ratio (95% confidence interval)a Risk ratio (95% confidence interval)b Risk ratio (95% confidence interval)c 
< 65 years    
< 6 hours    (n = 100) 0.96 (0.52 – 1.76) 1.25 (0.79 – 1.98) 1.14 (0.55 – 2.34) 
6-<7 hours (n = 279) 1.12 (0.74 – 1.68) 1.13 (0.82 – 1.56) 1.11 (0.67 – 1.83) 
7-<8 hours (n = 424, ref) 1.00 1.00 1.00 
8-<9 hours (n = 369) 0.79 (0.53 – 1.18) 1.22 (0.91 – 1.64) 1.02 (0.64 – 1.65) 
≥9 hours     (n = 171) 0.95 (0.58 – 1.57) 1.10 (0.75 – 1.61) 1.00 (0.54 – 1.84) 
    
≥ 65 years    
< 6 hours    (n = 151) 0.83 (0.50 – 1.37) 1.10 (0.72 – 1.67) 1.09 (0.62 – 1.92) 
6-<7 hours  (n = 205) 0.61 (0.38 – 0.99)*   1.55 (1.05 – 2.29)* 0.75 (0.42 – 1.31) 
7-<8 hours (n = 248, ref) 1.00 1.00 1.00 
8-<9 hours (n = 229) 0.69 (0.44 – 1.10) 0.99 (0.68 – 1.43) 0.61 (0.35 – 1.08) 
≥9 hours     (n = 131) 0.50 (0.28 – 0.91)* 1.22 (0.79 – 1.90) 0.79 (0.42 – 1.51) 
a Adjusted for marital status, education level, income level, smoking, alcohol consumption, physical activity, hypertension, and diabetes. b Adjusted for marital status, education level, income level, smoking, alcohol 
consumption, physical activity, obesity, and diabetes. c Adjusted for marital status, education level, income level, smoking, alcohol consumption, physical activity, obesity, and hypertension. *p<0.05 
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Table 2-6. Odds ratios (95% conﬁdence intervals) for hypertension, obesity, and diabetes by reported usual sleep duration in females by age 
(<65/≥ 65 years). 
 Obesity Hypertension Diabetes 
 Risk ratio (95% confidence interval)a Risk ratio (95% confidence interval)b Risk ratio (95% confidence interval)c 
< 65 years    
< 6 hours    (n = 779) 0.87 (0.72 – 1.06) 1.14 (0.94 – 1.39) 1.25 (0.92 – 1.70) 
6-<7 hours (n = 1,259) 0.97 (0.82 – 1.15) 1.07 (0.90 – 1.27) 0.93 (0.70 – 1.23) 
7-<8 hours (n = 1,782, ref) 1.00 1.00 1.00 
8-<9 hours (n = 1,347) 1.06 (0.91 – 1.25) 1.19 (1.01 – 1.41)* 0.82 (0.62 – 1.09) 
≥9 hours     (n = 502)    1.45 (1.16 – 1.80)** 1.24 (0.99 – 1.56) 1.12 (0.78 – 1.60) 
    
≥ 65 years    
< 6 hours    (n = 409) 1.00 (0.75 – 1.33) 0.94 (0.70 – 1.26) 0.98 (0.65 – 1.47) 
6-<7 hours  (n = 459) 0.94 (0.71 – 1.24)   1.16 (0.87 – 1.54) 1.55 (1.07 – 2.24)* 
7-<8 hours (n = 431, ref) 1.00 1.00 1.00 
8-<9 hours (n = 331) 1.17 (0.86 – 1.58) 1.01 (0.74 – 1.38) 1.07 (0.70 – 1.63) 
≥9 hours     (n = 151) 1.13 (0.76 – 1.67) 0.88 (0.59 – 1.32) 0.88 (0.50 – 1.58) 
a Adjusted for marital status, education level, income level, smoking, alcohol consumption, physical activity, hypertension, and diabetes. b Adjusted for marital status, education level, income level, smoking, alcohol 
consumption, physical activity, obesity, and diabetes. c Adjusted for marital status, education level, income level, smoking, alcohol consumption, physical activity, obesity, and hypertension. *p<0.05, **p<0.01 
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2.5.1 Univariable analyses 
Odds ratios and 95% confidence intervals from the univariate analysis are presented 
in Table 2-2. The results indicate that individuals aged 65 years and older were more 
likely to sleep <6 hours (OR 2.06, 95% CI 1.80 – 2.35), 6-<7 hours (OR 1.38, 95% CI 
1.22 – 1.67), and ≥9 hours (OR 1.39, 95% CI 1.18 – 1.63) compared to individuals 
aged below 65 years (prevalence percentages: <6 hours; 38.8% ≥65 years vs. 61.2% 
<65 years, ≥9 hours; 29.9%  ≥65 years vs. 70.1% <65 years). Females had a higher 
risk of shorter sleep duration (<6 hours, OR 1.43, 95% CI 1.22 – 1.67), compared to 
males (prevalence percentages: 81% females vs. 19% males). Compared to married 
individuals, those widowed had a higher risk of being short sleepers (OR 1.71, 95% 
CI 1.46 – 2.00) (prevalence percentages: 23.8% widowed vs. 76.2% married).  Having 
an education level of lower than secondary school was associated with sleep duration 
of <6 hours (OR 1.98, 95% CI 1.72 – 2.29), 6-<7 hours (OR 1.31, 95% CI 1.16 – 1.47), 
and ≥9 hours (OR 1.21, 95% CI 1.04 – 1.41), compared to higher education level 
(≥secondary school) (prevalence percentages: <6 hours; 76.1% lower education vs. 
23.9% higher education, 6-<7 hours; 67.7% lower education vs. 32.3% higher 
education, ≥9 hours; 66.0% lower education vs. 34.0% higher education). Compared 
to higher annual income level (≥15,000 Yuan), lower annual income level (<15,000 
Yuan) was also associated with sleep duration of <6 hours and 6-<7 hours (prevalence 
percentages: <6 hours; 81.3% lower income vs. 18.7% higher income, 6-<7 hours; 
78.7% lower income vs. 21.3% higher income). Ever smokers had increased risk for 
short (<6 hours) sleep duration (OR 1.27, 95% CI 1.07 – 1.51), compared to never 
smokers (prevalence percentages: 14.5% ever smokers vs. 85.5% never smokers). 
Those who ever consumed alcohol had a higher risk of being both short sleepers (<6 
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hours) and long (≥9 hours) sleepers, compared to those who never consumed alcohol, 
(prevalence percentages: <6 hours; 46.8% ever drinkers vs. 53.2% never drinkers, ≥9 
hours; 50.6% ever drinkers vs. 49.4% never drinkers). Hypertension was also 
associated with all 5 sleep categories (prevalence percentages: <6 hours, 42.3% 
hypertension vs. 57.7% no hypertension, 6-<7 hours; 40.6% hypertension vs. 59.4% 
no hypertension, 8-<9 hours; 39.4% hypertension vs. 60.6% no hypertension, ≥9 
hours; 43.3% hypertension vs. 57.7% no hypertension). However, individuals with 
diabetes were more likely to be short sleepers (<6 hours), (OR 1.23, 95% CI 1.01 – 
1.51), compared to individuals without diabetes (prevalence percentages: 12.0% 
diabetes vs. 88.0% no diabetes). No significant association was found between 
physical activity, obesity and sleep.  
2.5.2 Multivariable analyses 
The multivariate adjustment between socio-demographic, socio-economic, lifestyle 
and medical conditions variables was also assessed. Some associations that were found 
to be significant in univariate model no longer remained significant. A summary of 
results is presented in Table 2-3. Individuals who were aged 65 years and older were 
more likely to sleep <6 hours (OR 1.87, 95% CI 1.59 – 2.18) and sleep 6-<7 hours (OR 
1.32, 95% CI 1.15 – 1.53), compared to individuals aged below 65 years. Females had 
a higher risk for <6 hours sleep (OR 1.37, 95% CI 1.09 – 1.73), compared to males. 
Those widowed had higher risk of sleep duration of <6 hours (OR 1.22, 95% CI 1.02 
– 1.45), compared to married individuals. Individuals with lower education level 
(<secondary school) were more likely to sleep <6 hours (OR 1.65, 95% CI 1.41 – 1.93) 
and 6-<7 hours (OR 1.21, 95% CI 1.06 – 1.37), compared to individuals with higher 
education level (≥ secondary school). Compared to higher income (≥15,000 Yuan) 
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level, lower annual income (<15,000 Yuan) was associated with sleep duration of         
6-<7 hours (OR 1.20, 95% CI 1.04 – 1.39). Those who ever consumed alcohol had a 
lower risk for sleep duration of ≤9 hours, (OR 0.82, 95% CI 0.70 – 0.97), compared to 
those who never consumed alcohol. Individuals with hypertension were more likely to 
sleep 6-<7 hours (OR 1.14, 95% CI 1.00 – 1.28) and sleep 8-<9 (OR 1.15, 95% CI 
1.01 – 1.29), compared to individuals without hypertension. 
2.5.3 Multivariabe analyses between sleep duration, obesity, hypertension and 
diabetes  
Results from multivariate analysis demonstrated that compared to normal sleep 
duration (7-8 hours), long sleep duration (≥9 hours) was significantly associated with 
obesity after adjustment for potential confounders (OR 1.19, 95% CI 1.00 – 1.40). 
Moreover, sleep duration of 6-<7 hours (OR 1.15, 95% CI 1.01 – 1.30) and 8-<9 hours 
(OR 1.14, 95% 1.01 – 1.29), compared to normal sleep duration (7-8 hours), were 
associated with increased risk of hypertension (Table 2-4). No association was 
detected between sleep duration and diabetes in whole sample. The analysis was          
re-ran by stratifying for age and gender and results demonstrated that in males aged 65 
years and older, short (6-<7 hours) (OR 0.61, 95% CI 0.38 – 0.99) and long sleep 
duration (≥9 hours) (OR 0.51, 95% CI 0.28 – 0.91), compared to normal sleep duration 
(7-8 hours) were inversely associated with obesity (Table 2-5). In younger (<65 years) 
females, hypertension was associated with sleep duration of 8-<9 hours (OR 1.45, 95% 
CI 1.16 – 1.80) and sleep duration of ≥9 hours (OR 1.30, 95% CI 1.04 – 1.63), 
compared to normal sleep duration (7-8 hours) (Table 2-6). Moreover, compared to 
normal sleep duration (7-8 hours), sleep duration of ≥9 hours was strongly associated 
with obesity among these women (OR 1.45, 95% CI 1.16 – 1.80). Thus, long sleep has 
an important factor associated with obesity and hypertension in younger women in the 
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GBCS. On the other hand, in females aged 65 years and older, a sleep duration of 6-
<7 hours was associated with an increased risk of diabetes (OR 1.55, 95% CI 1.07 – 
2.24), compared to sleep duration of 7-8 hours (Table 2-6). The findings suggest an 
important contribution of age and gender to the associations between sleep and 
important chronic disorders. 
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2.6 Discussion  
Evidence indicates that both sleep quantity and quality play an important role in health 
and well-being. Results from previous studies indicate that on average the mean sleep 
duration of older (≥50 years) individuals from China237 (mean usual sleep duration = 
5.5 hours per night) is lower compared to Spain238 (mean usual sleep duration = 8.1 
hours per night), US239 (mean usual sleep duration = 6.8 hours per night), and 
Australia240 (mean usual sleep duration = 8.3 per night). It can be suggested that 
demographic, socio-economic, and medical conditions may have an influence on sleep 
duration across different countries.  
The findings of the present study showed that 37% of older Chinese people reported 
sleeping 6 hours or less per night. It was also found that being female, older, being 
widowed, having a lower education, and a lower income level are strongly associated 
with short sleep duration, while hypertension is strongly associated with long sleep 
duration. Additionally, the results of the logistic regression model controlling for age, 
gender, marital status, education level, income level, smoking, alcohol consumption, 
physical activity, obesity, hypertension and diabetes showed that long sleep duration 
was significantly associated with obesity and both short and long sleep duration were 
associated with hypertension in the whole sample. No significant association was 
found between sleep duration and diabetes in the whole sample. The results of my 
stratified analysis by gender and age showed that there was an inverse association 
between short and long sleep duration and obesity among males aged 65 years and 
older. In females, aged below 65 years, only long sleep duration was positively 
associated with obesity. Short sleep duration was associated with hypertension among 
older males, while in younger females, long sleep duration was associated with 
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increased risk of hypertension. Moreover, in older females, only short sleep duration 
was positively associated with increased risk of diabetes. 
2.6.1 Demographic and socio-economic factors and sleep  
2.6.1.1 Age 
In the present study, individuals who were aged 65 years and older were 87% (95% CI 
1.59 – 2.18) more likely sleep <6 hours and also 32% more likely to sleep 6-<7 hours 
(95% CI 1.15 – 1.53), compared to those aged <65 years. Several studies have noted a 
relationship between ageing and shorter sleep duration. Explanations for this 
observation have been discussed above (see Chapter 1). Additionally, sleep problems, 
and especially insomnia are common in older individuals.22 The results from analyses 
of cross-sectional data from the Established Populations for Epidemiologic Studies of 
the Elderly (EPESE), involving 9,000 American participants, demonstrated that almost 
half the individuals aged 65 years or older had longer sleep latency and difficulties in 
sleep continuity.241 Results from another study from US, among 10,050 participants 
with mean age of 74.4 years, suggested that sleep problems including; difficulties 
falling sleep (36.7%) difficulties maintaining asleep (28.7%), and early morning 
awaking (19.1%) are relatively pevalent.242 However, following multivariate 
adjustment for chronic conditions, the prevalence of sleep problems reduced 
significantly. This suggests that the increased numbers of co-morbid conditions among 
older individuals might be responsible for poor sleep quality rather than ageing per 
se.243 Apart from chronic conditions, ageing is also associated with circadian rhythm 
changes, which could be responsible for low sleep efficiency, poor sleep quality, and 
short sleep duration among older adults.21 Other endogenous factors such as retirement 
may also change the patterns of waking and sleeping time among older individuals. 
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My analysis shows that shorter sleep duration with ageing in the GBCS cohort was 
independent of a number of factors including common chronic disorders such as 
obesity, hypertension and diabetes. This suggests that ageing per se is associated with 
shorter sleep duration supporting a biological explanation. However, there is a need 
for future studies to examine sleep duration and quality in more detail including an 
assessment of common sleep disorders such as insomnia and obstructive sleep apnoea.  
2.6.1.2 Gender  
The results from both univariate and multivariate analysis showed that, compared to 
male gender, female gender was associated with 37% (95% CI 1.09 – 1.73) increased 
risk for short sleep (<6 hours). It was previously found that women may be more 
susceptible to develop sleep problem compared to men.244 Results of a recently 
published meta-analysis on the impact of gender differences in insomnia, including 31 
studies representing 1,265,015 participants showed that compared to male gender, 
being female is associated with an increased risk for insomnia (OR 1.41, 95% CI 1.28 
- 1.55).245 The exact mechanism underlying the effect of gender on sleep disturbance 
is unknown. It is believed that difficulties initiating sleep or maintaining sleep may be 
a manifestation of psychiatric disorders such as anxiety and depression and women are 
more vulnerable to mental health problems;244 therefore it was previously suggested 
that anxiety and depression symptoms may be causal factors for development of sleep 
disturbance such as insomnia among women.244 However, the prior hypothesis cannot 
be fully accepted since the association between female gender and insomnia still 
remained significant even after controlling for psychiatric status.246 Depressed women 
are more likely to report somatic symptoms such as body pain and sleep disturbances 
compared to men.247 Sex differences in sleep symptoms could be due to the specific 
role of women as caregivers that may predispose them for higher risk of emotional 
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distress.245 Additionally, women have an increased vulnerability for sleep disturbances 
due to the menopause.248-250 It has been previously found that menopause is associated 
with changes in sleep architecture, which may increase sleep complaints among 
women. In a study of 436 healthy women, Hollander and colleagues found that hot 
flushes and oestradiol levels were strong predictors for poor sleep (OR 1.52, 95% CI 
1.08 - 2.12).249 The negative impact of the menopause on sleep duration and sleep 
efficiency may increase the risk for weight gain and cause further sleep impairment.248 
2.6.1.3 Marital status 
The current study found, in the univariate analysis, that compared to married 
individuals, those who were widowed had 71% (95% CI 1.46 – 2.00) increased risk 
for short sleep duration (<6 hours). In the multivariate analysis, this attenuated to 22% 
(95% CI 1.02 – 1.45). Similar to findings from this study, previous evidence also 
indicates that being single or divorced/widowed was associated with increased risk for 
short sleep duration among 49,405 Australian adults aged 45 to 65 years (OR 1.47, 
95% CI 1.31 - 1.66).210 Ursin and colleagues studied 8,860 subjects, aged 40 to 45 
years, and reported that married men were more likely to sleep longer than single 
men.239 The analysis of data collected over 34 years from habitants of Alameda 
Country in California demonstrated that non-married status had a 2-fold higher risk of 
short sleep duration (≤6 hours).251 Kronholm and colleagues252 assessed the 
determinants of both short and long sleep duration in 8,028 Finnish adults and reported 
that the prevalence of short sleep (≤6 hours) duration was higher among non-
married/divorced group (13% among short sleepers vs. 6.4% and 10.0% among normal 
and long sleepers).252 In contrast, Patel and colleagues153 previously investigated the 
factors that correlate with long sleep duration in 60,028 middle-aged women, and they 
reported that compared to married women, those who have been divorced or never 
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have been married had higher risk of being long sleepers (divorced; OR 1.21, 95% CI 
1.10 – 1.32 and never married; OR 1.37, 95% CI 1.22 – 1.54).  It is difficult to explain 
the reverse findings by Patel and colleague, it can be argued that never married or 
divorced women are less likely to have a role as caregiver and in particular never 
married women may not have any children, as it was previously found that increased 
number of children may reduce total sleep duration.210  
2.6.1.4 Education and income level 
The present study showed that compared to those with higher education level, 
individuals with a lower education level (<secondary school) were 65% (95% CI 1.41 
– 1.93) more likely to belong to sleep category of <6 hours and also 21% (95% CI 1.07 
– 1.37) more likely to sleep 6-<7 hours. Lower annual income (<15,000 Yuan) was 
associated with 20% (95% CI 1.04 – 1.39) higher risk for sleep duration of 6-<7 hours. 
In line with my findings, Friedman and colleagues253 studied 94 women, aged 61 to 90 
years and found that more years of education and a higher household income was 
significantly associated with a decrease in sleep latency (years of education; β = - 0.50, 
p<0.001, household income; β = -0.33, p<0.05) and an increase in sleep efficiency 
(years of education; β = 0.21, p<0.05, household income; β = 0.26, p<0.05). This 
association remained significant even after controlling for potential confounders 
including: demographic factors, health status, and psychosocial characteristics. In a 
similar study, Lauderdale and colleagues126 objectively (using actigraphy) assessed 
sleep patterns of 669 participants from the Coronary Artery Risk Development in 
Young Adults (CARDIA) study. Participants were aged 38 to 50 years, and 58% were 
women. The authors found that income was significantly associated with sleep latency 
(β 3.13, 95% CI 4.87 - 1.39, p<0.001) and sleep efficiency (β 0.79, 95% CI 0.18 - 1.41, 
p<0.01) among these individuals.  
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The effect of socio-economic status on sleep can potentially be explained by the 
potential impact of psychiatric disorders and in particular, depression.254 Lower 
education and income levels are associated with an increased risk for anxiety and 
depression symptoms that may have an inverse effect on both sleep quantity and 
quality.253 Surprisingly, the psychological impairment as a result of lower education 
level was found to be more severe compared to the psychological impairment as a 
result of lower income level.253 It can therefore be argued that education levels are 
likely to have a stronger impact on sleep. Educated individuals are more likely to seek 
medical treatment for their sleep problems. Acquiring higher education needs many 
years of effort and its impact on health and well-being is potentially lasting, whereas 
the association between health and income level may be on-going. In order to achieve 
a higher salary, individuals with lower income level may tend to be hired in jobs that 
require shiftwork, which may result inconsistent sleep habits However, such 
hypotheses may not be applicable to the individuals in present study, since they were 
at retirement and were no longer working. The pathways linking education and income 
with sleep require further evaluation. A qualitative approach is necessary to explore 
potential linking factors across different age groups. 
2.6.2 Lifestyle behaviours and sleep 
2.6.2.1 Alcohol consumption 
In univariate analyses, I found that alcohol consumption was positively associated with 
both short and long sleep duration. However, in the full model, compared to never 
alcohol consumption, ever alcohol consumption was associated with lower risk (OR 
0.82, 95% CI 0.70 – 0.97) for sleep duration of ≤9 hours. Evidence suggests that there 
is a link between sleep duration and alcohol consumption.255 Recently, Chaput and 
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colleagues255 investigated the relation between sleep duration and alcohol 
consumption in a representative sample of 703 men and women aged between 18 to 
64 years. Alcohol consumption was assessed using a 3-day food record. According to 
relevant guidelines, alcohol intake was dichotomised on the basis of whether it 
exceeded the recommended limit for men and women. Sleep duration was assessed 
using a self-administered questionnaire. The results revealed that sleeping 6 hours and 
less per night was associated with excessive alcohol consumption among men and 
women (OR 1.87, 95% CI 1.03 – 3.54) and the prevalence of binge drinking was higher 
among short sleeping men. The authors also found that disinhibited eating behaviour 
was highly prevalent among short sleepers.255 Results from an epidemiological 
study210 that assessed factors associated with sleep duration among 49,405 Australian 
adults aged 45 to 65 years showed that compared to 7 hours sleep, both short (<6 hours; 
OR 1.26, 95% CI 1.06 – 1.49) and long (≥9 hours; OR 1.72, 95% CI 1.57 – 1.89) sleep 
duration were associated with higher alcohol consumption. In the US, Krueger and 
colleagues63 found that only short sleep duration was associated with higher risk for 
excessive alcohol consumption (OR 1.09, 95% CI 1.05 – 1.14). Findings from a similar 
study230 among 4,411 Korean adults demonstrated that there was no significant 
association between alcohol consumption and sleep duration among these individuals.  
It is difficult to explain the diversity among findings of these epidemiological studies, 
as the measures of alcohol consumption (including type, amount, frequency, and 
timing in relation to sleep) and also cut-points for sleep varies across these studies.  
The biological explanation between effects of alcohol consumption on sleep is yet to 
be fully understood. It is hypothesised that alcohol dramatically reduces the action of 
glutamate (a common neurotransmitter) via its receptor which can lead to reduction in 
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the brain’s activity.255 Evidence indicates that there is a dose-response relationship 
between alcohol and the frequency of arousals during the second half of night-time 
sleep period.256 The term “rebound effect” is generally used to describe second-half 
sleep disruption and it means that the sleep pattern and in particular length of REM 
sleep, alters with the initiation of alcohol metabolism and REM period gets even longer 
than normal once the alcohol is cleared from the bloodstream.257 It has been 
consistently suggested that alcohol consumption could potentially alter the length of 
different sleep stages.257  
2.6.2.2 Smoking 
Although the earlier results from univariate logistic regression models showed that 
compared to never smoker, ever smokers had 25% (95% CI 1.07 – 1.51) increased risk 
of short (<6 hours) sleep duration, this association was no longer significant in the 
fully adjusted model. Data on the effect of smoking on sleep among older individuals 
are lacking. Results from epidemiological studies among younger populations258-260 
consistently indicate that cigarette smoking is associated with increased risk for poor 
sleep quality among men and women. In a large longitudinal population-based study, 
including 7,960 participants aged 12 to 18 years old at baseline, Patten and 
colleagues258 investigated the factors related to sleep problems among these 
individuals. After a 5-year follow-up, findings showed that compared to non-smokers, 
established smokers had higher risk of developing sleep problems over the course of 
the study (OR 2.18, 95% CI 1.63–2.91). Similarly, Wetter and colleagues259 in a study 
involving 3,516 adults (age ≥18 years) found that, compared to non-smokers, both 
male and female current smokers had an increased risk of developing insomnia 
symptoms compared to never smokers (males: OR 2.32, 95% CI 1.04 – 5.16, females: 
OR 1.88, 95% CI 1.09 – 3.23). In a cross-sectional analysis describing the association 
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between cigarette smoking and sleep disturbance, Phillips and colleagues261 studied 
484 individuals aged 14 to 84 years and found that habitual smokers are more likely 
to experience difficulties initiating sleep and maintaining sleep compared to non-
smokers. Mak and colleagues260 investigated the association between smoking and 
sleep problems among 29,397 Chinese students and reported that compared to never 
smokers, experimental smokers who smoked once or a few times had a higher risk of 
insomnia (OR 1.39, 95% CI 1.25 - 1.54).  
There are several hypotheses on the effects of cigarette smoking on sleep patterns. It 
was previously found that habitual smokers tend to be single/unmarried, depressed and 
financially deprived compared to non-smokers258 and it is well known that depression 
is an important risk factor for insomnia.262 Similarly, medical conditions including 
pain, chronic chest diseases and obstructive sleep apnoea (OSA) may be more 
prevalent among smokers compared to non- and former smokers. Many of these 
medical conditions may also cause sleep problems.260 Negative life events including 
death of a spouse, financial constraints, and marriage or work problem may trigger a 
causal pathway between smoking and insomnia.263 Evidence indicates smokers with 
sleep problems are less likely to seek coping strategies other than cigarette smoking 
and therefore may be more susceptible develop further sleeping problems.263 There are 
two biological effects associated with smoking (short- and long-term), which may 
negatively influence sleep. The short-term effects include regulation of certain 
neurotransmitters such as serotonin that is involved in the sleep-wake cycle 
regulation.264 The long-term effects include frequent nocturnal awakening. During 
sleep, as a result of acute nicotine withdrawal, smokers, and in particular heavy 
smokers, may experience sleep fragmentation and frequent awakening.264  
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The present study did not find any significant association between sleep duration and 
smoking among the older Chinese people in GBCS. It is difficult to compare these 
findings with the current literature, since the majority of studies previously assessed 
the impact of smoking on sleep in younger individuals. The other possible explanation 
is that two important factors, duration and dose of smoking were not assessed in these 
studies. For example, if a person smokes a cigarette a day and another smokes a pack 
of cigarette, both would be similarly classified as current smokers. In current study, 
the comparison was between never smokers and ever smokers.  
Future studies including more detailed analysis of smoking habits may be necessary to 
examine the relationship between smoking and sleep duration and quality. 
Additionally, a more detailed assessment of common sleep disorders such as 
obstructive sleep apnoea is required. Furthermore, it would be of interest to explore 
changes in sleep patterns in individuals undergoing smoking cessation programmes 
including a study of whether sleep duration has an impact on abstinence. In a recent 
randomised controlled trial, Okun and colleagues265 assessed whether sleep 
disturbance during smoking cessation is associated with relapse among 322 women. 
The authors found there was no significant association between subjective sleep 
disturbance symptoms such as drowsiness with smoking relapse. In general, sleep 
disturbances are relatively prevalent among smokers265 and future prospective studies 
are needed to examine whether such disturbances could predict the outcome of 
smoking cessation treatment.  
2.6.2.3 Physical activity 
In the present study, there was no significant association between physical activity 
levels and sleep duration. In line with this finding, Magee and colleagues210 did not 
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find any association between moderate physical activity and sleep duration in 49,405 
Australian adults aged 45 to 65 years. Similarly, Ryu and colleagues230 also did not 
observe any significant association between sleep duration and physical activity levels 
among 4,411 Korean adults (age ≥19 years). In contrast, Krueger and Friedman63 
reported that an increase in the physical activity index was associated with lower risk 
of sleeping 9 hours or more among 110,441 adults (age ≥18 years) in the US (OR 0.90, 
95% CI 0.87 – 0.93). 
It has previously been shown that both short and long-term exercise is associated with 
increased slow wave sleep and total length of nocturnal sleep as well as improvement 
in sleep latency among healthy individuals.216 Several studies have previously reported 
that increased physical activity may improve sleep among older adults. For example, 
Sherrill and colleagues215 studied 722 adult men and women  participants (mean age = 
57 years) and found that regular activity, at least once a week, was associated with 
lower risk for difficulties maintaining sleep (OR 0.71, 95% CI 0.50 – 0.99) and also 
for any other sleep problems (OR 0.62, 95% CI 0.44 – 0.87). In another study, Merill 
and colleagues216 assessed whether an intensive lifestyle modification programme 
(diet and physical activity) can reduce sleep problems among 2,624 individuals aged 
30 to 80 years, and found that from baseline to the end the of 4 week intervention, the 
number of people with insomnia significantly reduced (-64%).  
While a validated measure of general activity was used in the present study, more 
detailed assessment of physical activity including type, intensity, duration, and its 
relation to sleep timing maybe necessary to identify the relationship between physical 
activity and sleep. There are few studies describing the impact of physical activity on 
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sleep duration and there is a need for more randomised controlled trials.216 This is 
particularly important given the prevalence of sleep problems in older individuals. 
There are several hypotheses that explain how increased levels of physical activity 
could promote sleep including: thermoregulation and energy maintenance.266 The 
regulation of body temperature is mainly controlled by the anterior hypothalamus. It 
has been found that a decline in body temperature as a result of increased peripheral 
skin blood ﬂow plays an important role in sleep promotion in the evening.219 It has 
been suggested that the thermogenic effect of increased physical activity prior to bed 
time may promote the onset of sleep.267 It was reported that an exercise programme 
could potentially improve sleep impairment in vulnerable groups such as insomnia 
suffers and depressed individuals.268  
2.6.3 Health-related conditions and sleep 
2.6.3.1 Obesity 
The current study found that compared to sleep duration of 7-8 hours, long (≥9 hours) 
sleep duration was associated with 45% (95% CI 1.16 – 1.15) increased risk of obesity 
in the whole sample. In stratified analysis, males aged 65 years and older, who slept 
6-<7 hours and ≥9 hours had lower risk for being obese. Moreover, sleep duration of 
≥9 hours was strongly associated with 45% (95% CI 1.16 – 1.80) higher risk of obesity 
among females. As discussed earlier in Chapter 1, numerous cross-sectional3, 32, 48, 60, 
116-118, 120, 121, 124, 125, 127, 131-134  and longitudinal135-147, 149 studies, supported by 
systematic reviews113 and meta-analyses,114, 115 have previously investigated the 
possible link between sleep duration and obesity, but the findings of such studies have 
been mixed. The majority of current epidemiological studies suggest that short sleep 
duration131, 135-138 is an important risk factor for obesity, while others have found that 
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sleep and obesity may interact in U-shaped manner,3, 32, 121, 140-142 and some could not 
find any significant association between these two factors.126, 145, 147 The present study 
used waist circumference to measure central obesity, while the majority of current 
studies on association between obesity have used BMI, which could explain these 
discrepant findings. Only a few studies examined the association between waist 
circumference and sleep duration in adults. In the Better Health for Better Hong Kong 
campaign,120 involving 4,793 men and women with mean age of 42.4 years, central 
obesity was inversely associated with reduced sleeping hours in men (Regression 
coefficient (β) = -0.049, p = 0.014), in agreement with my data in men. In the Quebec 
family study, compared with adults reporting 7 to 8 hours of sleep, those with 5 to 6 
hours of sleep had higher waist circumference (OR 1.69, 95% CI 1.15 – 2.39).123 In 
contrast, sleep duration was not associated with abdominal obesity in sample of aged 
population (≥60 years) in Spain.140 The relationship between sleep duration and waist 
circumference is very important, as it has been found that central adiposity has a strong 
correlation with metabolic variables such as insulin resistance compared to general 
obesity.269 
In my study, short and long sleep duration was inversely associated with obesity in 
men. In women, the associations tended to be in the opposite direction, as long sleep 
duration was strongly associated with increased risk of obesity. The interpretation of 
these findings requires much caution, as gender differences have not been consistently 
reported in adults.  It was previously found that sleep may have greater impact on body 
composition in women compared to men.127 Sleep duration and sleep quality may be 
influenced by menopausal state.270 It is also believed that menopause may also be 
associated with weight gain.271 However, the underlying mechanisms for development 
of abdominal adiposity are complex and may include several other factors. Findings 
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from NHANES cohort143 demonstrated that each additional increase hour of total 
nocturnal sleep duration was negatively associated with change in BMI among men 
and women aged younger than 50 years (premenopausal state for women). In a sample 
of Japanese adults (30 to 60 years), a U-shaped association was found between sleep 
duration (<5 hours, β 0.01, 95% CI 0.02 – 0.14 and ≥9 hours β 0.01, 95% CI 0.07 – 
0.34) and BMI among men, but not among women. Results of a recent study by 
Theorell-Haglöw127 among 400 women, aged 20 to 70 years showed that sleep 
duration was inversely associated with waist circumference (β = -1.22, p = 0.016). 
Impact of gender on sleep needs further investigation, as the current studies are mainly 
focused on men. Future studies are needed to investigate the hormonal response to 
sleep duration in men and women.  
It is believed that chronic condition such as cardiovascular disease may disrupt sleep 
and induce unintended weight change.272 As chronic conditions are relatively prevalent 
among older people, it may influence sleep-obesity association. It is generally 
established that short sleep duration is associated with obesity among younger people; 
several studies reported that such associations may diminish or disappear with 
increased age.135, 143 Short sleep duration among older individuals could be due to 
underlying sleep disorders such as insomnia. Recently, Vgontzas and colleagues150 
reported that self-reported short sleep duration could be the result of the presence of 
emotional distress or presence of other underlying sleep problems rather than 
voluntary sleep restriction.  
I found that long sleep duration was associated with increased risk of obesity in the 
whole sample. Long sleep duration may reflect poor quality sleep that may result in 
prolongation of time in bed. Similarly, short sleep duration could be secondary to sleep 
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disturbance. Thus, any interpretation of the impact of sleep duration on health should 
also take sleep quality into account. Unfortunately, it was not possible to determine 
quality of sleep in the GBCS cohort. Future studies using objective measures of sleep 
are needed to investigate the association between sleep duration and obesity among 
older individuals. These studies also need to control for underlying sleep problems 
such as insomnia and obstructive sleep apnoea. 
2.6.3.2 Hypertension 
In the fully adjusted model, compared to sleep duration of 7-8 hours, sleep duration of 
6-<7 hours (OR 1.15, 95% CI 1.01 – 1.30) and 8-<9 hours (OR 1.14, 95% CI 1.01 – 
1.29) were associated with higher risk of hypertension in the whole sample. In 
stratified analysis by gender and age, in older (≥65 years) males, hypertension was 
associated with sleep duration of 6-<7 hours (OR 1.55, 95% CI 1.05 – 29) and in 
younger females (<65 years) was associated with sleep duration of 8-<9 hours (OR 
1.19, 95% CI 1.01 – 1.41). In line with this finding, previous studies also confirmed 
that there is a positive association between sleep duration and hypertension. Although 
there is a controversy between the findings of these studies, as some reporting that 
only short38 or both short and long sleep duration32 are associated with increased risk 
of hypertension. In contrast, a few studies36 did not find any significant association 
between sleep duration and increased risk of hypertension. There are also only a few 
studies33 highlighted the effect of gender and age on association between these two 
phenomena. 
I investigated the association between sleep duration and hypertension among older 
Chinese people, and majority of the current studies have looked at the same association 
in younger population. In contrast with my findings, results from the Rotterdam study36 
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involving 5,058 older age participants, and study by Lopez-Garcia and colleagues40 in 
3,686 participants aged 60 and older showed that there was no association between 
sleep duration and hypertension among older individuals. I found that both short and 
long sleep duration may increase the risk of hypertension in the whole sample. In line 
with these findings, results from the Sleep Heart Health Study,32 which involved 5,892 
participants aged between 40 to 100 years showed that both short (OR 1.66, 95% CI 
1.35 – 2.04) and long (OR 1.30, 95% CI 1.04 – 1.62) sleep duration were 
independently associated with increased risk of hypertension.  
The current studies also highlighted the effect of gender on the association between 
sleep duration and hypertension. Data on the impact of gender is lacking and future 
studies are needed to support these findings. Recently Fang and colleagues33 found 
that older women (≥65 years) who reported sleeping <6 hours a day had an increased 
risk of hypertension OR 1.44, 95% CI 1.16 – 1.80). Results from cross-sectional 
analysis by Cappuccio and colleagues40 showed sleep duration was significantly 
associated with increased risk for hypertension only among females (OR 1.72, 95% CI 
1.07 - 2.75). In another study, the association between sleep duration and hypertension 
was assessed both cross-sectionally and longitudinally among 10,308 British 
participants aged between 35 to 55 years old.34 The findings of the cross-sectional 
analysis indicated that there was no significant association between sleep and 
hypertension in men. However women who were short sleepers (≤5 hours sleep per 
night) had higher risk for incidence of hypertension compared to those who reported 
sleeping 7 hours per night (OR 1.72, 95% CI 1.07 – 2.74).34 In the longitudinal 
analysis, the significant association between short sleep duration and hypertension was 
attenuated following adjustment for cardiovascular (OR 1.42, 95% CI 0.94 – 2.16) and 
psychiatric co-morbidities (OR 1.31, 95% CI 0.65 – 2.63).34 The underlying 
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mechanisms for the observed gender-specific association between sleep duration and 
hypertension in these studies are unknown. The majority of female participants in this 
study were menopausal, and it can be interpreted that hormonal changes as a result of 
menopause may also have an impact on their sleep patterns.273   
The positive association between short sleep duration and hypertension may be 
attributed to sleep deprivation. It was previously found that sleep loss may have a 
negative impact on endocrine and metabolic function and also increase the activity of 
the sympathetic nervous system, and eventually result in hypertension.274 Results from 
experimental studies showed that even after one night’s sleep restriction (total sleeping 
time (3.6 to 4.5 hours), there were a significant increase in blood pressure in both 
normotensive275 and hypertensive43 individuals. Chronic sleep loss may lead to 
hypertension in the long run.276 The increased risk of hypertension was also observed 
among long sleepers (≥9 hours). Although, the biological mechanisms underlying the 
impact of long sleep duration and hypertension is less well understood. It is believed 
that there may other factors may have influence the link between long sleep duration 
and hypertension. For example, results from the Nurses’ Health Study52 showed that 
weekly physical activity levels among women who reported sleeping 9 hours or more 
were 15% lower compared to women who slept 7 to 8 hours, suggesting that physical 
inactivity may increase the risk of hypertension. Moreover, poor sleep quality or 
underlying sleep problems may contribute to long sleep duration.277  
In general, differences in geographical characteristics may have an influence on 
circadian rhythms among individuals.278 For example, number of hours with sunlight 
is longer in Mediterranean countries, affecting work and leisure time.38 Moreover, 
changes in sleep architecture due to ageing may be another explanation for observed 
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controversies among findings of studies investigating the association between sleep 
duration and hypertension. The studies that found a positive association between short 
sleep duration and hypertension were conducted in middle-aged participants,32, 34, 38 
and it can be argued that short sleep duration among these individuals may be mainly 
due to voluntary sleep restriction as a result of fixed schedules for getting up and going 
to work, whereas in older individuals who are mostly retired, short sleep may be due 
to underlying sleep disorders such as insomnia.22  
2.6.3.3 Diabetes 
There was no significant association between sleep duration and diabetes in the whole 
sample. However, in the stratified analysis, in female aged 65 years and older, 
compared to sleep duration of 7-8 hours, sleep duration of 6-<7 hours was associated 
with 55% (95% CI 1.07 – 2.24) increased risk for diabetes. Several other 
epidemiological studies45-52, 54-60 have previously examined a potential link between 
sleep duration and diabetes, but their findings are inconsistent. Some studies have 
observed a U-shaped48, 49, 56, 57, 279 association between sleep duration and diabetes, 
while some studies found either short45-47 or long52 sleep duration to be risk factors for 
prediction of diabetes. Additionally, several have reported no associations.51, 60  
In line with current findings, results from the Nurses’ Health study52 also showed that 
both short and long sleep duration were associated with type 2 diabetes; however after 
full adjustment for potential confounders, only long (≥9 hours per night) sleep duration 
was strong predictor for incidence of diabetes (HR 1.29, 95% CI 1.05 – 1.59). In 
another study, Tuomilehto and colleagues50 found that compared to 7 hours sleep 
duration, short (≤6 hours; OR 2.55, 95% CI 1.21 – 5.35), and long (≥8 hours; OR 1.76, 
95% CI 1.12 – 2.61) sleep duration were associated with higher risk for type 2 diabetes 
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among middle-aged women but not men. The findings from the current study showed 
that short sleep duration was associated with diabetes among women who were aged 
65 years and older.  
It is difficult to compare the results of my study with findings from other studies, as 
the majority of these studies have been conducted among middle-aged and younger 
participants. Epidemiological data on the association between sleep duration and 
diabetes among older Chinese adults is also lacking and the effect of gender on such 
associations has not been fully explored. Overall, current epidemiological studies on 
the association between sleep duration and diabetes have used subjective sleep 
measures (i.e. self-reported questionnaire), which may introduce some potential 
biases. Knutson and colleagues51 studied 670 men and women aged 18 to 30 years and 
they using objective measures of sleep (actigraphy) and they did not find any 
significant association between sleep duration and diabetes. Future studies using 
objective measures of sleep (i.e. actigraphy, polysomnography) are needed to assess 
the link between sleep duration and risk of diabetes in older people.  
There are several biological mechanisms that could explain the link between sleep 
duration and diabetes. Sleep deprivation may result in higher secretion of cortisol, a 
counter regulatory hormone, which could potentially promote insulin resistance.66 An 
increase in sympathetic tone also has been observed following sleep restriction, which 
would negatively influence pancreatic function, leading to glucose intolerance.66 It has 
also been hypothesised that sleep restriction may also lead to diabetes through its effect 
on weight gain and alteration in regulation hormones such as leptin.52  
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2.6.4 Clinical implications 
As stated earlier, sleeping shorter or longer than the average level (usually 7-8 hours 
per night) has been associated with greater risk for health and well-being.3 Previous 
studies carried out in Western countries have reported that factors including age, 
gender, income level, education level, smoking, alcohol consumption, physical 
activity, hypertension, obesity, diabetes are associated with sleep duration.63, 210 
Findings of the current study among older Chinese confirm some of these 
observations, but highlight the complexities of the relationships, and potential roles for 
gender and age in determining the associations between sleep and the various factors 
examined. 
Although the results did not demonstrate any significant association between lifestyle 
factors (smoking, alcohol consumption, and physical activity level) and sleep duration, 
current evidence suggest that changes in lifestyle routine such as increased physical 
activity levels may be beneficial for sleep improvement.215, 216 However, there is a need 
for well-designed future studies to assess the effectiveness of lifestyle modification on 
sleep among older individuals. Recently, in a randomised controlled study, Alessi and 
colleagues280 evaluated the effectiveness of a non-pharmacological interventions on 
the sleep patterns of older individuals in nursing homes. The intervention involved: a 
reduction of time spending in bed, increased sunlight exposure, increased physical 
activity, reduction in night-time noise, and structured nocturnal bedtime. Their 
findings demonstrated that the intervention resulted in significantly reduced daytime 
sleepiness and increased engagement in social activities. Data on the effect of other 
lifestyle modification such as smoking and alcohol consumption are lacking, although 
it was previously reported that smoking cessation could improve sleep.281 Lifestyle 
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interventions may perhaps have to be employed at an earlier age to have a beneficial 
effect. 
2.6.5 Strength and limitations 
The current study has some strengths and limitations. It benefits from a large sample 
of fairly well characterised individuals that provide higher statistical power to allow 
exploration of a range of factors that were potentially associated with short and long 
sleep durations while addressing a number of potential confounders. While in the 
current analysis, I have controlled for different confounders, it should be taken into 
account that there may be other confounders that were not measured. One of the main 
limitations of the present study was that the effect of obstructive sleep apnoea (OSA), 
as a potential confounder was not assessed nor other surrogate markers of OSA. Using 
validated and reliable questionnaires such as Berlin questionnaire,282 Epworth 
Sleepiness Scale (ESS)31 or even simple single question “Do you snore in your sleep?” 
would be useful to capture such data. Collection of such data would also enable 
categorisation of participants into either low or high risk of OSA based on reported 
snoring and for a higher ESS score. Comparing results of the stratified (high risk of 
OSA vs. low risk of OSA) analyses on the association between sleep duration obesity, 
hypertension, and diabetes would provide insight as to whether the associations remain 
and thus independent of OSA. Categorisation based on the combination of short sleep 
duration and OSA can be used to assess their joint effects. For instance, results of a 
very recent study283 in 838 community participants age 40-69 years in Korea showed 
that combination of OSA and short sleep (<5 hours) duration increased the risk of 
visceral obesity (OR 4.40, 95% CI 1.80, 10.77). 
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Moreover, the uniqueness of social and cultural characteristics of participants and also 
setting of the study would limit the generalisability and comparison of the results with 
many studies that have been carried out in Western populations.  
A major limitation of the study is its cross-sectional design that means the temporal 
sequence of the association between sleep duration and hypertension, obesity and 
diabetes is unclear and thus causality cannot be inferred. Additionally, there is a risk 
of reverse causality in cross-sectional studies. Findings of this study on the impact of 
gender on association between sleep duration, obesity, hypertension, and diabetes 
needs to be interpreted cautiously, as the role of chance needs to be considered while 
drawing conclusions. Using a multi-comparison correction could render some of the 
findings statistically insignificant. Future longitudinal studies are needed to further 
examine such associations among older individuals and also explore the impact of 
gender. There is a concern that the sample may not totally be representative of the 
older population in China as a result of the recruitment method. Nevertheless, the 
chance of selection bias is low because the membership was open to anyone and 
individuals have been chosen randomly for inclusion into the study. While some 
studies29 collect objective sleep data, it is not practical to utilise these labour and time-
consuming methods (actigraphy and polysomnography) to collect data from such a 
large sample. Because of data collection across a broad range of factors, it was not 
possible to collect detailed information regarding individual factors. This makes it 
difficult to study the relationship between sleep and these factors in detail and may 
miss subtle relationships that could, over time, have significant implications. The 
present study reports some interesting findings that need to be explored with more 
specific studies that include more detailed data collection. 
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2.6.6 Key points 
Both short and long sleep duration may have adverse health outcomes. Short sleep 
duration is relatively prevalent among this older Chinese population in the GBCS. I 
found that females, older age, being widowed, lower education level, and lower 
income level were strongly associated with short sleep duration, while hypertension 
was strongly associated with long sleep duration. There was an inverse association 
between short and long sleep duration and obesity among males aged 65 years and 
older. In females, long sleep duration was association with hypertension and obesity 
only among those who were younger (<65 years), and short sleep duration was 
associated with diabetes among those who were older (≥65 years). Further more 
detailed prospective study with objective measures of sleep (quantity and quality), 
including consideration of sleep disorders, is required to fully determine the various 
factors (also assessed objectively) associated with sleep and its impact on health. 
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3 THE COMPLEX ASSOCIATIONS AMONG SLEEP QUALITY, 
ANXIETY-DEPRESSION, AND QUALITY OF LIFE IN 
PATIENTS WITH EXTREME OBESITY  
 
3.1 Abstract 
Introduction: Sleep duration and quality have been associated with obesity. Sleep 
disturbance has been reported to be associated with stress and depression among non-
obese populations, but these relationships have not been previously examined in the 
extreme obese population. The objective of the present study was to examine the 
complex associations among sleep disturbance, quality of life, anxiety and depression 
in a patient sample with extreme obesity. 
Methods: Two hundred and seventy consecutively recruited patients with a mean 
body mass index (BMI) of 47.0 Kg/m2 were studied. The correlation coefficient, 
multiple linear regression, and structural equation model (SEM) analysis were utilised 
to evaluate the association between the Pittsburgh Sleep Quality Index (PSQI), 
Epworth Sleepiness Scale (ESS), Impact of Weight on Quality of Life-Lite (IWQOL-
Lite) and Hospital Anxiety and Depression Scale (HADS). 
Results: The mean (standard deviation; SD) PSQI score was 8.59 (5.11), and mean 
ESS score was 8.84 (5.79). After controlling for potential confounders, poor sleep 
quality and excessive daytime sleepiness were found to be significantly associated 
with all the components of IWQOL-Lite; physical function (β = -0.32, β = -0.27; 
p<0.01), self-esteem (β = -0.23, β = -0.30; p<0.05), sexual-life (β = -0.30, β = -0.35; 
p<0.05), public distress (β = -0.39, β = -0.39; p<0.01), and work (β = -0.26, β = -0.48; 
p<0.01). It was also found that the PSQI global score had a positive significant 
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association with anxiety (β = 0.29; p = 0.01) and depression (β = 0.31; p = 0.01) 
components of HADS. 
Conclusion: Poor sleep quality was strongly associated with mood disturbance and 
poor quality of life among extreme obese patients. Future interventions are needed to 
address sleep disturbance to prevent the further development of psychological co-
morbidity and potentially worsening of obesity among these individuals. 
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3.2 Introduction 
Obesity is a major public health problem. To prevent and manage severe obesity, there 
is a need for greater understanding of factors that could contribute to the development 
and perpetuation of obesity in this clinically challenging population. Recently, there 
has been great interest in the role of both sleep duration and quality in the onset and 
progression of obesity.114 The associations among sleep duration, sleep quality, and 
obesity are bidirectional. Once obesity occurs, sleep is likely to be disturbed, and 
weight loss has been observed to reduce sleep disturbance and obesity-associated 
sleep-disordered breathing.168  
Apart from the relationship with obesity, sleep duration and quality are related to other 
health outcomes including psychological problems.284 A number of studies have 
reported bidirectional relationships between sleep and depression with some 
suggesting that sleep quality may initiate and/or exacerbate mood disturbance, and that 
by improving sleep, it may be possible to improve mood.284 The majority of studies 
examining a link between sleep and depression, and quality of life, however, have 
focused on the non-obese population.285 In obese individuals, depression could hinder 
weight loss and its maintenance. Price and colleagues286 have reported that depressive 
symptoms could potentially predict weight regain among overweight individuals who 
are successful with initial weight loss.286 Currently, the potential role of sleep in health 
and wellbeing of individuals with severe obesity is underappreciated. An 
understanding of the interrelationships between sleep, mood and quality of life could 
inform a more tailored approach to the prevention and management of severe obesity. 
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3.2.1 Sleep as a potential risk factor for obesity 
Based on the limited data available, average total sleep duration appears to have 
decreased compared to previous decades. In the US, the results of the comparison of 
total nocturnal sleep duration in year 2009 vs. year 1969 demonstrated that there has 
been a reduction of sleep by 1 hour and forty minutes.3 The number of people who 
reported short sleep duration (≤6 hours of sleep per night) also increased in 2004 
compared to 1985 (Figure 3-1).287 It has been estimated that 43% of the younger 
population who aged 30 to 44 years consistently report that they sleep 7 hour or less 
per night.3 It appears that some features of modern society such as computers and the 
internet have a strong influence on shortening sleep duration over time.287 
Evidence describing the association between sleep and obesity has been fully 
discussed in Chapter 1. The results of the studies that evaluated the association 
between sleep and weigh gain are controversial. For instance, in the Wisconsin Sleep 
Cohort Study (WSCS), a U-shaped association was detected between sleep duration 
and BMI.121 In a similar study, Tamakoshi and colleagues116 found that only short 
sleep duration was significantly associated with obesity among 104,010 Japanese men 
and women. Magee and colleagues133 reported that the positive association between 
sleep and BMI was only observed in individuals who were younger than 65 years old. 
In contrast, a few studies146, 147 did not find an association between sleep and excessive 
weight gain. To date, longitudinal studies across different populations   (e.g. different 
sleep and age categories) in various countries consistently reported that short sleep 
duration is a strong predictor of obesity.136-139 In a recent meta-analysis, Cappuccio 
and colleagues114 systematically reviewed population-based studies and quantified the 
risk of short sleep duration (<10 hours per night for children and <5 hours per night 
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for adults) in onset of obesity. They found that a 1 hour reduction of total time of sleep 
per 24-hours could potentially predict a 0.35 kg/m2 increase in BMI in adults. 
 
 
Figure 3-1. Percentage of sleep deprived individuals (average of ≤6 hours of sleep per 
night), by gender and age, 1985 and 2004, United States.287 
Printed with the permission of Dr S Taheri. 
3.2.1.1 How does sleep relate to obesity? 
Some of the current potential mechanisms underlying association between sleep and 
obesity were fully discussed in Chapter 1.  
Sleep loss could potentially increase the activity of the sympathetic nervous system, 
which may affect food intake through disruption of the regulation of appetite hormones 
such as leptin and ghrelin.178 Sleep deprived individuals may also have a higher 
appetite for foods containing higher amount of fat, sugar and carbohydrate.190 
156 
 
Furhtermore, as a result of fatigue and daytime sleepiness they are more likely to be 
engaged in sedentary behaviours175 and consequently have reduced. Finally, disruption 
in circadian rhythm may also disrupt metabolism and affect appetite and food intake 
and increase the risk of obesity.178, 198-200 Each aspect may promote the opportunity for 
obesity development over time 
3.2.2 The intimate relationship between sleep and depression 
Depression results from an interaction between genetic, biological, and environmental 
factors.244 It has been previously found that lack of sleep was associated with mood 
disorders.203 It is unclear whether sleep is a predictor of depressive symptoms or sleep 
problems are the outcome of depression. It is believed that there is a bi-directional link 
between sleep difficulties and depressive psychopathology.244 Depressed individuals 
are more likely to complain about their sleep. On the other hand, sleep disturbances 
may be attributable to increased risk for the incidence and development of depression 
over time.244  
The results from experimental studies288, 289 demonstrated that sleep restriction may 
potentially increase depressive symptoms among healthy participants. For instance, 
Kahn-Greene and colleagues289 collected data using Personality Assessment Inventory 
(PAI) from 25 healthy adults and found that means and standard deviations for selected 
PAI subscales for cognitive (Baseline mean (SD): 44.7 (7.1) vs. Sleep deprived mean 
(SD): 48.3 (8.3) ) and affective (Baseline mean (SD): 45.3 (5.3) vs. Sleep deprived 
mean (SD): 48.8 (7.3) ) aspects of depressive symptoms significantly differed between 
baseline and following of 65 hours sleep deprivation among these individuals.289 No 
change was detected in the physiological component of depressive symptoms, but the 
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overall scores were found to be clinically higher once the sleep deprivation period 
terminated.   
Electroencephalograph (EEG) sleep studies have shown that a reduction of slow wave 
sleep (SWS) as a result of a reduction in the time gap between commencement of sleep 
and onset of first rapid eye movement (REM) episode has been observed in EEG 
records of depressed individuals.290 The sleep patterns of these individuals were also 
characterised by an increased amount of eye movement, prolonged REM sleep, and a 
delay of onset of first REM episode (Figure 3-2).291 It is postulated that a decrease in 
the length of REM periods plays an important role in the incidence of depression. 
However, the above hypothesis is yet to be confirmed as there are some potential 
factors such as age and gender that broadly influence sleep.292 It is of interest that 
treatment with antidepressants is associated with suppression of REM sleep. It has 
been found that the length of SWS also decreases as age increases. Data describing the 
effect of gender on sleep are limited. Compared to depressed women, reduced SWS 
were found in depressed men.292  
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Figure 3-2.  A comparison between sleep profiles of a medication-free depressed 
female with a healthy female control. Wake (W), Rapid Eye Movement (REM), S1-4 
(Sleep stages 1-4), Movement Time (MT), Body Movements (BM), Eye Movements 
(EM).291 
Printed with the permission from Professor Dieter Riemann. 
 
Epidemiological evidence suggests that sleep problems, such as insomnia, which is 
defined as difficulty initiating sleep and maintaining sleep, are associated with a higher 
risk of developing depression. Insomnia patients often face prolonged and 
disappointment at not being able to sleep, which can lead to hopelessness, a 
preliminary trigger for depression.293 A large number of longitudinal studies with 
either short or long follow-up periods have investigated the role of insomnia in the 
Depressed patient 
Healthy control 
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prediction of depression over time.293-298 The results from these studies have been 
controversial, in terms of reporting the odds ratio for measuring the association 
between insomnia and depression. For example, in 1989, Ford and Kamerow297 
reported that risk of developing major depression symptoms was much higher among 
individuals with insomnia compared to those without insomnia (Odds Ratio (OR) 
39.80, 95% CI 19.8 - 80.0) with a very large OR and wide confidence interval 
indicating a lack of precision,297 while another study by Neckelmann and colleagues296 
in 2007, reported no association (OR 1.10, 95% CI 0.80 - 1.60)296 The observed 
controversy across the studies might be due to the fact that each study defined insomnia 
differently, as the majority of studies that had been published after 2001, defined 
insomnia on the basis of difficulty initiating sleep, difficulty maintaining sleep and 
daytime consequences of insomnia, which indicated that the conceptualisation of 
insomnia had changed dramatically over the past 20 years. Additionally, the observed 
controversy might be explained by different in population characteristics, population 
size, and length of follow-up. It is almost impossible to differentiate whether the 
clinical symptoms of insomnia per se trigger depressive symptoms or the poor sleep 
quality as the result of insomnia is the predictor of depression.  
A recent meta-analysis of 21 longitudinal studies299 quantitatively investigated the 
impact of insomnia in the prediction of depression. The findings indicated that 
compared to people with no sleep difficulties, non-depressed people with insomnia 
have a two-fold increased risk (OR 2.10, 95% CI 1.86 - 2.38) of developing depression. 
One the major features of insomnia is excessive daytime sleepiness. It has been 
reported that fatigue and daytime sleepiness are highly correlated with both depression 
and anxiety.244 Excessive daytime sleepiness has a negative impact on daily 
functioning and work performance.299 
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3.2.2.1 How does sleep relate to depression? 
The exact underlying pathophysiology of sleep and promotion of depression is not 
known. It has been suggested that the prefrontal cortex (PFC) and the serotonergic 
system play an important role in regulation in sleep-wake cycle that might be 
associated with depression. 
3.2.2.1.1 Prefrontal cortex (PFC) 
It is hypothesised that co-occurrence of sleep interruption and depression take place in 
the PFC. Studies that previously evaluated metabolic regulation in the PFC indicated 
that metabolic activity levels may also have an impact in synchronisation of the 
sleep/wake cycle.300 Activation of the PFC is associated with wakefulness, while 
deactivation of the PFC could potentially induce sleep.301 Increased need to sleep 
during the daytime as a result of obtaining insufficient sleep at night has been found 
to be associated with a decrease in activity levels in the PFC, which support the 
hypothesis that impairment of the PFC affects mood regulation and can lead to 
development of depression.300 
3.2.2.1.2 Serotonergic system 
Another possible mechanism that may link sleep to affective disorders such as 
depression is an alteration in the functionality of serotonin, a neurotransmitter that 
decreases during nocturnal sleep and has been found to play an important role in 
depression.302, 303 In depressed individuals, the sensitivity of serotonin receptor 1A has 
been found to be dramatically decreased, therefore it was hypothesised that sleep 
restriction might also be associated with desensitisation of the serotonin receptor.303 
Roman and colleagues,303 examined whether there is a link between chronic sleep 
restriction and desensitisation of serotonin receptor 1A receptor system in rats. They 
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found that chronic sleep loss was significantly associated with desensitisation receptor 
1A, and receptor sensitivity was still not back to normal during sleep recovery.303 
Chronic sleep loss, which is highly prevalent among individuals with insomnia, may 
increase their susceptibility to develop depression over the longer term.299     
Additional evidence from animal304, 305 and human studies306, 307 postulated that the 
short allele of the serotonin transporter gene is associated with both insomnia and 
depression. It has been highlighted that the presence of short allele may have a negative 
impact on sleep and increase the risk for onset and progression of depression.89 While 
the result of such studies support the hypothesis for an existing relationship between 
sleep disturbance, serotonin and depression, these relationships were examined only 
in small samples.306  
3.2.3 Effects of antidepressant treatment on sleep 
Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat psychiatric 
disorders such as depression.308 It is well-known that the majority of depressed 
individuals suffer from sleep problems.299 Interestingly, insomnia appears to be an 
important symptom that most of patients with depression would seek medical 
treatment for, and it has been previously found that alleviation of sleep disturbance in 
depressed individuals was associated with higher adherence to psychological 
treatments.309 It was stated early on in this chapter that the sleep architecture of 
individuals with depression is more likely to be disrupted. Evidence indicates that anti-
depressants may have a therapeutic effect on the sleep profile of these individuals.308 
The majority of the current literature310 only assessed the acute effects of SSRIs on 
sleep and data on their chronic effects are lacking. Effects on REM sleep (reduction in 
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total amount of REM and delay of first entry into REM) have been reported by several 
controlled studies311, 312 on effects of SSRIs on sleep.  
3.2.4 Sleep as a risk factor for impaired quality of life 
Quality of life (QoL) and health-related quality of life (HRQoL) are defined as a 
personal perception of an individuals’ non-medical health and well-being.313 The 
concept of QoL cannot be driven from a single factor, whereas the interaction of 
several factors is required to reflect one’s satisfaction of different dimensions of life 
including; physical, social and mental well-being.314 It is also believed that perception 
of QoL may go beyond complete physical and mental health, although the exact 
definition is not known yet.315 The final estimation of QoL can only be declared by the 
individual him/herself, which has been found to be influenced by certain factors such 
as age, gender, social and socio-economic status.316  Sufficient sleep is necessary for 
physical and emotional wellbeing. Moreover, poor sleep may negatively affect one’s 
well-being and quality of life.317 Prolonged sleep deprivation has been found to be 
associated with lack of concentration, and social dysfunction.317 Daytime sleepiness 
as a result of chronic sleep problems has been found to have a negative impact on job 
satisfaction.318 Sleep disturbance, and particularly daytime sleepiness, can result in low 
energy levels, which could be a potential marker for impaired physical function of 
HRQoL. Sleep restriction triggers sympathetic nervous system activity and a rise in 
cortisol secretion i.e. a stress state.66 Sleep loss is also associated with impaired 
immune response and metabolic changes.319 These effects, in turn, could have an 
impact on physical and mental well-being, and hence quality of life. Sleep deprived 
individuals may experience a decline in cognitive function and mood instability which 
could potentially contribute to HRQoL impairment among these individuals.318  
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In a recent cohort study, Faubel and colleagues317 investigated the possible effect of 
sleep duration on quality of life in 3,834 young and middle-aged persons. Their results 
indicated that women who reported short (≤5 hours per night) or long sleep duration 
(≥10 hours per night) were more likely to report worse scores on the physical (≤5 hours 
sleep per night: Beta regression coefficient (β) −7.15, 95% CI −11.12 - −3.18, ≥10 
hours sleep per night: β −6.38, 95% CI −9.96 - −2.80) and mental (≤5 hours sleep per 
night: β −3.53, 95% CI −6.79 - −0.26, ≥10 hours sleep per night: β −0.98, 95% CI 
−3.92 - 1.97) component of short-form health survey-36 (SF-36) compared to those 
who reported sleeping 7 hours. They also reported that men with short sleep duration 
(≤5 hours per night) had lower scores on the physical dimension.  
Briones and colleagues320 assessed the link between sleepiness and general health 
status in a cross-sectional sample of 129 individuals aged between 25 to 65 years. Their 
result demonstrated that sleepiness is inversely correlated with different components 
of quality of life including; “general health perceptions” (r = -0.30, p<0.05), 
“energy/fatigue” (r = -0.41, p<0.05), and “role limitations due to emotional problems” 
(r = -0.30, p<0.05). The score of Multiple Sleep Latency Test (MSLT) was also 
inversely associated with "energy/fatigue" (r = -0.19; p<0.05). The authors controlled 
the analysis for some potential confounders such as chronic illness and BMI.320  
Medical and psychosocial stressors are prevalent among patients with insomnia. 
Vallieres and colleagues316 recently reported that death of loved ones, divorce, illness, 
and unemployment are common causes for short-term insomnia and that underlying 
stress could negatively affect an individual’s quality of life.   
Quality of life among individuals suffering sleep problems could significantly be 
affected by overall impairment in physical and mental well-being.318 Disrupted sleep 
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may lead to significant impairment in both social and work areas due to a decrease in 
work productivity, reduced cognition function, and increased morbidities.318  
3.2.5 Rationale for assessment of the interactions between sleep quality, 
depression, and quality of life among extreme obese individuals 
To my knowledge, no study has examined the interactions among sleep and 
psychological and quality life issues in extreme obese patients, an increasingly 
challenging clinical population. The current literature that evaluated the association 
between poor sleep and depression and also between poor sleep and quality of life 
mainly concentrated on associations in non-obese populations and across different age 
group with various health conditions including hemodialysis,321 cancer,322 heart 
diseases,323 Parkinson’s disease,324 and type 2 diabetes mellitus.325  
A growing body of epidemiological evidence indicates that both sleep quantity and 
quality are associated with increased risk of obesity among men and women.326 It is 
also known that sleep has an important role in development of depression. Therefore, 
it is necessary to have a greater understanding of obesity and its psychological co-
morbidities. Recognition and addressing sleep problems among obese individuals is 
necessary as sleep improvement interventions may thus improve mental health and 
prevent worsening of obesity per se among this population.  
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3.3 Aim and study questions  
To estimate the prevalence of mood disturbance, sleep disturbance and quality of life 
among extreme obese individuals. 
The study questions included: 
 Are there any associations between sleep disturbance and anxiety and 
depression levels among this population? 
 Is there any association between sleep disturbance and quality of life 
among this population? 
 How are sleep disturbance, depression, quality of life, and obesity-
related conditions associated in a single structural equation model 
(SEM)?
166 
 
3.4 Methods 
3.4.1 Study population 
A retrospective analysis of data collected as part of the evaluation of a regional 
specialist weight management service was carried out. The patients attended 
community-based clinics in the South Birmingham Primary Care Trust (PCT) 
catchment area. Clinics were held in large general practices in the area. Patients were 
referred to the service by their general practitioner using a standardised proforma. Two 
hundred and seventy adult patients (aged 17 to 80 years) consecutively enrolled into 
the service from January 2009 to October 2011 were included. The number of 
participants included was comparable to other studies of this patient population.321, 327, 
328 Criteria for enrolment were BMI ≥35 kg/m2 with a co-morbidity (e.g. diabetes 
mellitus) or BMI ≥40 kg/m2 without a co-morbidity, based on recommended criteria 
from the UK National Institute for Health and Clinical Excellence guidance (NICE 
CG43).329 There was also a requirement for patients to have previously attended other 
weight management services (commercial/community/primary care) without success. 
Self-reported questionnaires assessing sleep, anxiety-depression, and quality of life 
were collected at the first visit where detailed clinical information and anthropometric 
measures were collected from all patients. The study was done as part of service 
evaluation and examined anonymised data; therefore no formal ethical approval was 
needed.52 
3.4.2 Data collection 
Data collected included demographic information, height, weight, BMI, blood 
pressure, obesity co-morbidities, and questionnaire information (described below). 
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The service administrators collected demographic data while trained physicians with 
a specialist interest in weight management collected the clinical data. Questionnaires 
were mailed to patients prior to their first appointment and were collected at the first 
appointment. The validated questionnaires were selected by the specialist weight 
management service as part of their comprehensive patient assessment and in line with 
recent recommendations.330 All data was input into a secure NHS database with 
anonymised data used in the analyses. 
Sleep disturbance was assessed using the Pittsburgh Sleep Quality Index (PSQI)30 and 
daytime sleepiness using the Epworth Sleepiness Scale (ESS).31 Mood was assessed 
using the Hospital Anxiety and Depression Scale (HADS),331 and quality of life was 
assessed using Impact of Weight on Quality of Life-Lite (IWQOL-Lite).332 All 
questionnaires are shown in Appendices. 
3.4.2.1 Sleep disturbance 
Sleep quality and sleep disturbance were assessed using the PSQI, a validated self-
rated questionnaire that assesses sleep problems in seven aspects including sleep 
quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance use 
of sleep medications, and daytime dysfunction.30 A global score ranging from 0 to 21 
is generated from the sum of the component scores. Individuals with total PSQI scores 
of ≥5 are identified as having severe sleep problems.30 Daytime sleepiness was also 
assessed using ESS, a validated self-report questionnaire with the maximum score of 
24. It consists of eight questions with a 4-point scale, which asks participants to rank 
the chance of dozing off in different situations (e.g. sitting and reading; as a passenger 
in a car for an hour without a break). The higher the scores indicates the greater 
daytime sleepiness.31 
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3.4.2.2 Mood 
Mood (anxiety, depression) was assessed using HADS, a fourteen-item questionnaire 
that has been developed to screen non-psychiatric patients.331 It consists of two 
subscales; anxiety subscale (HADS-A) and depression subscale (HADS-D) each 
including seven items. Each item is measured on a 4-point Likert scale, each ranging 
from 0 to 3, resulting in a maximum score of 21. A score above seven on each subscale 
implies the presence of potential distress. The following cut-points were used to 
categorise the participants: 0–7 (non-case), 8–10 (borderline case), ≥11 (case).331 
3.4.2.3 Quality of life 
Quality of life was assessed using the weight specific IWQOL-Lite, a 31-item self-
rated questionnaire.332 It measures weight-related quality of life in five areas; physical 
function, self‐esteem, sexual life, public distress, work and a total score. Each 
component was measured on a five-point scale, ranging from 1 to 5 (from “never true” 
to “always true”). The total score ranges from 0 to 100, with a higher score indicating 
better health-related quality of life.332 
3.4.3 Statistical Analysis 
Data were analysed using the SPSS Version 18.0 (SPSS, Inc., Chicago, IL). Pearson 
correlation coefficients were used to assess the associations between questionnaire 
scores. Linear regression model was used for data analysis. For using regression 
model, I assumed that the responses are continuous, and they are normally distributed, 
the linearity assumption was visually assessed between independent variables (ESS 
scores and PSQI scores) and outcomes of interest (IWQOL-Lite scores and HADS 
scores), using scatter plot. In addition, using HADS and IWQOL-Lite scores as 
dependant variables in regression model, I also assumed that “distance” between 
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categories are equal. In previous studies that were assessing similar trend, the multiple 
regression was employed to assess such associations. For example, Havlikova and 
colleagues324 have previously examined the relationship between sleep disturbances 
(measured using the Epworth Sleepiness Scale (ESS), and the Pittsburgh Sleep Quality 
Index (PSQI)) and quality of life (measured using the Parkinson’s Disease Quality of 
Life Questionnaire (PDQ-39) and depression and anxiety (measured using, the 
Hospital Anxiety and Depression Scale (HADS)), among 93 Parkinson’s disease 
patients. Their findings showed that after adjustment for age, gender and disease 
duration, PSQI (β 0.30, p<0.001) and anxiety was significantly associated with quality 
of life scores (β 0.29, p<0.001) among these patients. In another study, Martin and 
colleagues333 used multiple regression to assess the association between sleep 
disturbance (measured using the Pittsburgh Sleep Quality Index (PSQI), and quality 
of life (measured using the Medical Outcomes Study 12-item Short Form Survey 
Mental Component Summary score), and depressive symptoms (measured using the 
five-item Geriatric Depression Scale) over 3 and 6 month follow-up of 121 older adults 
living in assisted living facilities (ALFs). Their findings showed that more self-
reported sleep disturbance at baseline was associated with worse health-related quality 
of life (β(SE) 0.01(0.004), p = 0.01) and worse depressive symptoms (β(SE) 0.06 
(0.02), p = 0.002).  
Associations between HADS-A and HADS-D and components of PSQI and ESS were 
assessed using multiple linear regression. Moreover the association between PSQI 
Global score and ESS total score with components of IWQOL-Lite (physical function, 
self-esteem, sexual life, public distress and work) were assessed using multiple linear 
regression. In the analyses, the score of dozing off in the situation “car in traffic” was 
omitted, because this question is commonly answered in the negative by patients 
170 
 
because of concerns about driving licences. The multiple linear regression was 
adjusted for age, gender, hypertension, diabetes, and obstructive sleep apnoea (OSA). 
Linear regression analysis, analysis of covariance and factors analysis are widely used 
to examine the association between predictor variables and outcome of interest, but 
they do not necessarily provide an explanation of how variables relate to one another. 
Structural Equation Modelling (SEM) is one of the methodological tools that are being 
recently used to overcome this problem.334 I used SEM to determine whether our 
hypothesised model is valid. The associations between poor sleep factors (PSQI and 
ESS) and obesity-related conditions (diabetes, hypertension and OSA) in predicting 
HADS-D and IWQOL-Lite total score based on the proposed theoretical model using 
statistical package SPSS/AMOS (student version 5). I removed one of the question of 
PSQI “During the past month, how much of a problem has it been for you to keep up 
enough enthusiasm to get things done?” due to the similarity with one of the HADS 
questions “I have lost interest in things, definitely, sometimes, not much, not at all”. 
Poor sleep factors latent was defined by two variables; ESS score and modified score 
of PSQI, and obesity-related Conditions was defined by three variables; hypertension, 
diabetes and OSA. The total score of IWQOL-Lite and HADS depression score were 
assessed by the both latent (endogenous factors). Maximum Likelihood (ML) 
estimation approach335 was applied for the models with an interaction terms, which 
included a latent variable. A bootstrap method was utilised to investigate the direct, 
indirect and total effects.336 The advantage of bootstrapping is that it can create 
accurate standard errors that are independent of any assumptions for a normal 
distribution of data, which is required for calculation of regression weight by 
AMOS/SEM. It can also provide the probability levels for direct, indirect and total 
effect.336 Five ﬁt indices were used to assess the adequacy of model fit; 1) The 
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comparative fit index (CFI) >0.90, 2) Goodness-of-fit statistic (GFI) >0.95, 3) 
Adjusted goodness-of-fit statistic (AGFI) >0.90, 4) standardised root mean square 
residual (SRMR) <0.08, 5) Root mean square error of approximation (RMSEA) <0.05 
and the upper bound of its 90% conﬁdence interval <1 values indicate a good fit.334 A 
two-tailed test were used throughout and a p-value of <0.05 was considered 
statistically signiﬁcant. 
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3.5 Results 
A total of 270 patients (202 female) were enrolled. The descriptive characteristics of 
the participants are presented in Table 3-1. The mean (standard deviation; SD) age was 
43.3 (12.6) years. The mean BMI was 46.9 (7.8) kg/m2. The mean PSQI global score 
was 8.6 (5.0) and 74.8% of patients were poor sleepers (PSQI total score ≥5). The 
mean ESS score was 8.8 (5.7). Approximately, 52% of all subjects were considered 
anxious (HADS-A, sub-score >7) and 43% were depressed (HADS-D, sub-score >7). 
The self-esteem component of IWQOL-Lite with the score of 26.0 (27.6 had the lowest 
score compared to the other components (Table 3-1).   
In the present study, Pearson’s correlation coefficients were used to assess the 
relationships between questionnaires scores, prior to conduct regression analysis. 
Pearson's correlation is a measure for the linear relationship between two continuous 
random variables. Pearson’s correlation test is applicable for parametric data, thus it 
was used to assess the correlation between data from questionnaires in the present 
study. The correlation coefficient, r, ranges from -1 to +1, the closer r is to ±1 suggests 
the stronger the correlations. (Interpretation of value of r: 1.0 (i.e. perfect correlation), 
0 to 1 (i.e. the two variables tend to increase or decrease together), 0.0 (i.e. the two 
variables do not vary together at all, -1 to 0 (i.e. one variable increases as the other 
decreases), -1.0 (i.e. perfect negative or inverse correlation)).  
There was a statistically significant moderate negative correlation between PSQI score 
and IWQOL-Lite score (a correlation coefficient, r = -0.26, p<0.01). There was a 
statistically significant strong positive correlation between PSQI score and HADS-A 
score (r = 0.30, p<0.01). There was also a statistically significant moderate positive 
correlation between PSQI score and HADS-D score (r = 0.25, p<0.01).  In addition, 
173 
 
there was a statistically strong negative correlation between ESS score and IWQOL-
Lite (r = -0.36, p<0.01). There was a statistically significant weak positive correlation 
between ESS score and HADS-A score (r = 0.22, p<0.01). There was a statically 
significant moderate positive correlation between ESS score and HADS-D score (r = 
0.24, p<0.01) (Table 3-2). The observed correlations between the variables of the 
present studies falls in the range of observed correlations from similar studies (Sandadi 
and colleagues,328Turkmen and colleagues,321 Norra and colleagues327), which 
indicates that observed correlations in this study is typical for this area of research.  
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Table 3-1. Descriptive characteristics of 270 study participants. 
Variable n (%)  Mean (SD) 
Age (years)   43.5 (12.4) 
Females/Males 202 (74.8)/ 68 (25.2)   
BMI (kg/m2)   46.9 (7.8) 
Marital status     
Married 86 (51.4)   
Living with a partner 24 (14.4)   
Single 38 (22.8)   
Divorced 13 (7.8)   
Widowed 6 (3.6)   
Occupational status    
Unemployed 42 (23.0)   
Employed 113 (61.7)   
Retired 15 (8.2)   
Student 13 (7.1)   
Smoker 79 (29.3)   
Alcohol consumption  125 (46.3)   
Hypertension  91 (33.7)   
OSA  67 (24.8)   
Diabetes  71 (26.3)   
IWQOL-Lite     
Physical function   42.7 (25.6) 
Self-esteem   26.0 (27.6) 
Sexual life   42.5 (36.4) 
Public distress   40.8 (29.1) 
Work   51.9 (30.8) 
Total score   42.0 (22.0) 
HADS Anxiety   10.4 (4.5) 
HADS Depression   9.1 (3.9) 
PSQI global score   8.5 (5.1) 
ESS total score   8.8 (5.7) 
Body mass index (BMI), obstructive sleep apnoea (OSA), Impact of Weight on Quality of Life (IWQOL-
Lite), Hospital Anxiety and Depression Scale (HADS), Pittsburgh Sleep Quality Index (PSQI), Epworth 
Sleepiness Scale (ESS).  
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      Table 3-2. Bivariate correlations between questionnaire scores. 
  
 Age BMI ESS IWQOL-
Lite 
HADS-A HADS-D 
BMI 0.02      
ESS 0.02 0.08     
IWQOL-
Lite 
0.04 -0.26** -0.36**    
HADS-A -0.18** -0.02 0.22** -0.51**   
HADS-D -0.11 0.01 0.24** -0.61** 0.65**  
PSQI -0.06 0.03 0.24** -0.26** 0.30** 0.25** 
 
 
        Body mass index (BMI), Impact of Weight on Quality of Life (IWQOL-Lite), Hospital Anxiety and Depression Scale  
         (HADS), Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS). 
                                                       
 
       **Correlation is significant at the 0.01 level (2-tailed) 
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A series of multiple linear regression analyses was performed in order to evaluate the 
associations among levels of anxiety and depression symptoms with components and 
total score of PSQI and ESS; they are summarised in Table 3-3 and Table 3-4. Our 
analyses demonstrated that HADS-A and HADS-D scores (outcome variables) were 
significantly associated with all the components of PSQI except sleep disturbance, use 
of sleeping medication and daytime dysfunction (p>0.05). The PSQI global score had 
a positive significant association with anxiety (β = 0.29, p = 0.01) and depression (β = 
0.31, p≤0.01) components of HADS (Table 3-3). 
Table 3-3. Association between the Hospital Anxiety and Depression Scale (HADS) 
anxiety and depression scores with components and global score of the Pittsburgh 
Sleep Quality Index (PSQI). 
a Adjusted for age, gender, hypertension, diabetes and Obstructive Sleep Apnoea (OSA). 
 
 
HADS-Anxiety 
(outcome) 
 
 HADS-Depression 
(outcome) 
 β (SE) P a β (SE) P a 
             (Predictors) 
 
Sleep quality 0.35 (0.44) 0.001  0.30 (0.46) 0.009 
Sleep latency 0.29 (0.46) 0.019  0.26 (0.46) 0.041 
Sleep duration 0.24 (0.41) 0.037  0.26 (0.40) 0.028 
Habitual sleep efficiency 0.32 (0.39) 0.006  0.43 (0.37) 0.000 
Sleep disturbance 0.11 (0.16) 0.335  0.04 (0.15) 0.707 
Use of sleeping medication 
 
0.09 (0.45) 0.452  0.04 (0.45) 0.705 
Daytime dysfunction 0.08 (0.50) 0.452  0.18 (0.49) 0.136 
Global PSQI score  0.29 (0.07) 0.010  0.31 (0.07) 0.009 
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The HADS-Anxiety was associated with all the components of ESS except the score 
of dozing off in the situation “car in traffic” (p>0.05). This question is commonly 
answered in the negative by patients because of concerns about driving licences. The 
HADS-D was associated with all the components of ESS except the score of dozing 
off in the situations of; “sitting and reading” and “car in traffic” (p>0.05). The 
excessive daytime sleepiness is highly associated with anxiety (β = 0.44, p<0.001) and 
depression (β = 0.41, p = 0.01) components of HADS (Table 3-4).  
Table 3-4. Association between the Hospital Anxiety and Depression Scale (HADS) 
anxiety and depression scores with components and total score of the Epworth 
Sleepiness Scale (ESS). 
a Adjusted for age, gender, hypertension, diabetes and Obstructive Sleep Apnoea (OSA). 
 HADS-Anxiety 
(outcome) 
 
 HADS-Depression 
(outcome) 
 β (SE) P a β (SE) P a  
 (Predictors) 
 
Sitting and reading 0.31 (0.41) 0.005  0.16 (0.41) 0.193 
Watching TV 0.36 (0.45) 0.002  0.34 (0.45) 0.006 
Inactive in public 0.36 (0.48) 0.001  0.28 (0.48) 0.019 
Car passenger 0.38 (0.36) 0.001  0.44 (0.35) 0.000 
Lying down 0.31 (0.44) 0.007  0.38 (0.42) 0.002 
Sitting talking 0.33 (0.75) 0.004  0.45 (0.69) 0.000 
Sitting quietly 0.32 (0.43) 0.005  0.29 (0.44) 0.016 
Car in traffic 0.22 (0.64) 0.060  0.14 (0.63) 0.256 
ESS total score 0.44 (0.08) 0.000  0.41 (0.07) 0.001 
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The association of IWQOL-Lite (outcome variable) with PSQI global score and ESS 
total score are presented in Table 3-5. After adjusting for age, gender, hypertension, 
diabetes and OSA, PSQI was significantly associated with physical function (β = -
0.32, p<0.01), self-esteem (β = -0.23, p = 0.03), sexual-life (β = -0.30, p = 0.01), public 
distress (β = - 0.39, p<0.01), work (β = -0.26, p = 0.02), and total score (β = -0.35, 
p<0.01). Similarly, ESS were also associated with physical function (β = -0.27, 
p<0.01), self-esteem (β = -0.30, p<0.01), sexual-life (β = -0.35, p<0.01), public 
distress (β = -0.39, p = 0.001), work (β = -0.48, p<0.001), and total score (β = -0.42, 
p<0.001). 
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Table 3-5. The association between subjective sleep disturbances (PSQI global score and excessive daytime sleepiness) with components of 
the IWQOL-Lite (Impact of Weight on Quality of Life). 
Variable β t R2 F P a 
Outcome: Physical function       
Predictor: Pittsburgh quality of life index  -0.32 -3.13 0.30 5.39 0.002 
Predictor: Epworth sleepiness scale  -0.27 -2.62 0.30 5.01 0.011 
Outcome: Self-esteem      
Predictor: Pittsburgh quality of life index  -0.23 -2.21 0.23 3.82 0.030 
Predictor: Epworth sleepiness scale  -0.30 -2.71 0.22 3.28 0.009 
Outcome: Sexual life      
Predictor: Pittsburgh quality of life index  -0.30 -2.49 0.13 1.67 0.015 
Predictor: Epworth sleepiness scale  -0.35 -2.91 0.17 2.08 0.005 
Outcome: Public distress      
Predictor: Pittsburgh quality of life index -0.39 -3.45 0.15 2.92 0.001 
Predictor: Epworth sleepiness scale -0.39 -3.50 0.17 2.31 0.001 
Outcome: Work      
Predictor: Pittsburgh quality of life index -0.26 -2.27 0.15 1.78 0.026 
Predictor: Epworth sleepiness scale -0.48 -4.56 0.31 4.94 0.000 
Outcome: Total score      
Predictor: Pittsburgh quality of life index -0.35 -3.16 0.17 2.72 0.002 
Predictor: Epworth sleepiness scale 
 
-0.42 -3.94 0.26 4.01 0.000 
a Adjusted for age, gender, hypertension, diabetes and Obstructive Sleep Apnoea (OSA).  
Note: t; t-statistic is the regression coefficient of the independent variable divided by its standard error.  A t-stat larger than +2 or less than -2 indicates that independent variable has a significant impact on dependant 
variable (having greater confidence in the coefficient as a predictor).  R2; a statistical measure of how close the data are to the fitted regression line with values range from 0.0 to 1.0. Higher values indicate that the 
model fits the data better. F; a value that determines if the variance between two populations are significantly different and this value determines the p-value. If the null hypothesis is true, it is expected F to have a 
value close to 1.0 most of the time. A large F ratio means that the variation among group means is meaningful and not happened by chance.
180 
 
I tested an SEM (Figure 3-3), representing the hypothesised model in which the Poor 
Sleep Factors latent was defined by two variables; ESS and PSQI, and the Obesity-
Related Conditions latent was defined by three variables; hypertension, diabetes and 
OSA; was set to predict the total IWQOL-Lite score and HADS-Depression score 
(endogenous variables). The result postulated that our hypothesised model has a good 
fit to the data. The CFI was 0.988, the GFI was 0.953, the AGFI was 0.881, the SRMR 
was 0.056, and the RMSEA was 0.034, with a 90% confidence interval of 0.000–0.135 
indicating a good fit of the model. Obesity-Related Conditions was negatively 
associated with HADS-D (β = -0.16; p<0.05), Poor Sleep Factors was positively 
associated with HADS-D (β = 0.82; p<0.001) and was negatively associated with 
IWQOL-Lite (β = -0.79; p<0.001). A summary of standard errors, direct effects, 
indirect effects and total effects based on 1000 bootstrap sample is presented in 
Table 3-6. The strongest standardized total (direct and indirect) effect was of Poor 
Sleep Factors on HADS-D and was 0.82.  
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Figure 3-3. Measurement (standardised estimates) of hypothesised structure equation 
model (SEM). Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale 
(ESS), Obstructive Sleep Apnoea (OSA), Impact of Weight on Quality of Life-Lite 
(IWQOL-Lite), Hospital Anxiety and Depression Scale-Depression (HADS-D), 
Comparative Fit Index (CFI), Goodness-of-fit statistic (GFI), Adjusted Goodness-of-
Fit statistic (AGFI), Standardised Root Mean Square Residual (SRMR), Root Mean 
Square Error of Approximation (RMSEA). 
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RMSEA = 0.034 (LO 90/0.000; HI 90/0.135) 
 
 
 
e1  
ESS        
(Total Score) 
 
PSQI 
(Modified Score) 
Diabetes Hypertension 
182 
 
Table 3-6. Standardised effect sizes based on 1000 bootstrap samples 
Predictor Response Standard  
error 
 
Direct 
effect 
Indirect 
effect 
Total 
effect 
Obesity-related 
conditions 
 
Poor sleep 
factors 
2.812 0.330  0.330 
Obesity-related 
conditions 
 
HADS-D 2.880 -0.434 0.272 -0.162* 
Obesity-related 
conditions 
 
IWQOL-Lite 14.377 0.266 -0.263 0.003 
Poor sleep 
factors 
 
HADS-D 0.255 0.824    0.824** 
Poor sleep 
factors 
IWQOL-Lite 1.346 -0.797   -0.797** 
Hospital Anxiety and Depression Scale-Depression (HADS-D), Impact of Weight on Quality of Life-Lite (IWQOL-
Lite). 
  * p  <0.05 
**p <0.001 
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3.6 Discussion 
The present study found that poor sleep quality (measured using PSQI) mean (SD) 8.5 
(5.1), anxiety symptoms (measured using HADS-Anxiety) 10.4 (4.5), depression 
symptoms (measured using HADS-Depression) 9.1 (3.9), and reduced quality of life 
(measured using IWQOL-Lite) 42.0 (22.0) were highly prevalent among patients with 
extreme obesity. More than two thirds of patients with extreme obesity reported poor 
sleep quality and the average self-reported sleep duration was 6.2 (1.5) hours. I also 
found that sleep quality correlated significantly with anxiety (β (SE) (0.29 (0.07), p = 
0.01) and depression (β (SE) (0.31 (0.07), p = 0.009), with the observed associations 
were stronger for depression than for anxiety. Sleep quality were also significantly 
correlated with quality of life (β -0.35, p = 0.002). Moreover, daytime sleepiness 
correlated significantly with anxiety (β (SE) (0.44 (0.08), p<0.001) and depression (β 
(SE) (0.41 (0.07), p = 0.001) and also with quality of life (β -0.42, p<0.001). The 
associations above were controlled for age, gender, hypertension, diabetes, and OSA, 
indicating these associations are independent of these potential confounders, 
particularly OSA.337  
3.6.1 Sleep patterns in extreme obese population  
The results of the present study demonstrate that extremely obese individuals have a 
short average sleep duration (mean sleep = 6.2 hours) and reported poor sleep quality 
(mean PSQI= 8.6). This is in agreement with recent observation by Toor and 
colleagues338 who evaluated the sleep duration of 45 bariatric patients with extreme 
obesity (mean body mass index = 49 kg/m2) compared to 45 non-obese controls. The 
study also reported that obese individuals slept less (6 hours per night) compared to 
control group reported sleeping 7 hours per night. Obese individuals also had a higher 
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PSQI score (8.5) than their non-obese controls (4.5). It was reported that bariatric 
surgery dramatically improved both sleep duration and quality. Similarly, in a large 
epidemiological study339 involving 2,803 adult participants from China, obese 
individuals (n = 617) had a higher PSQI global score (7.02 ± 2.95) compared to 
overweight (n = 1,127, 6.61 ± 2.96) and normal weight (n = 1,059, 6.30 ± 2.56). 
Moreover, other factors in addition to obesity including duration of sleep, and female 
gender were found to be significantly associated with poor sleep quality even after 
controlling for potential confounders such as cardiometabolic risk factors.339 
Interestingly, obese individuals with poor sleep may be less likely to be successful in 
weight loss programmes. In a randomised controlled study, Thomson and 
colleagues340 assessed whether female participants (mean age 45.5 years, mean BMI 
33.9 kg/m2) with a better PSQI global score or sleep duration of >7 hours per night 
would achieve greater weight loss compared to those with a lower PSQI score or sleep 
duration of ≤7 hours per night over the 6 month study duration. Findings indicated that 
a better PSQI score was associated with 33% higher chance for weight-loss success 
(weight loss success: achieving >5% weight loss compared to baseline) (Relative risk 
(RR) 0.67, 95% CI, 0.52 - 0.86).  
Extreme obese individuals in this study had a short sleep duration and poor sleep 
quality as assessed by the PSQI. Cumulative evidence from epidemiological and 
experimental studies suggests that both short sleep duration and poor sleep quality are 
associated with a higher risk for obesity as well as several other adverse health 
outcomes such as hypertension, diabetes, and cardiovascular complications among 
individuals with different age, ethnicity, and socioeconomic background.113, 114 The 
consequences of poor sleep have not been previously studied among individuals with 
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extreme obesity. There is a need for future studies to assess the impact of short or poor 
sleep among extreme obese population.   
Based on findings of present study and also the highlighted evidence, it is known that 
individuals with obesity are more likely to suffer from poor sleep. It can be argued that 
obesity per se may be the main cause for sleep disruption. Obese individuals normally 
suffer from several obesity-related conditions such as difficulty breathing, urinary 
incontinence, body temperature dysregulation, and pain, which may contribute to poor 
sleep quality. Additionally, it was hypothesised that mental health problems may be a 
potential mediator on the causal pathway between poor sleep and obesity. Recently, 
Bidulescu and colleagues158 analysed data from 1,515 residents of metropolitan 
Atlanta, aged 30-65 years with mean BMI of 29.4 kg/m2 in the Cardiovascular Health 
Epidemiology Study (CHES), and found that poor sleep quality was associated with 
increased risk for obesity (OR 1.08, 95% CI 1.03 – 1.12), but after adjustment for stress 
the association was diminished, suggesting that perceived stress mediated the 
associations between reduced sleep quality and obesity.  
3.6.2 Symptoms of depression in extreme obese population 
The extreme obese individuals in the study also reported a high level of anxiety (mean 
HADS-Anxiety score 10.4) and depression (mean HADS-Depression score 9.1). 
Similar studies also in line with this finding consistently suggest that depressive 
symptoms are prevalent among obese individuals.341 Epidemiological evidence 
suggests that there is a positive association between obesity and depressive symptoms. 
For example, Simon and colleagues342 collected data using telephone interviews from 
4,641 women aged 40 to 65 years old. They found that those with a BMI of 35 kg/m2 
or more were 4 times more likely to report depressive symptoms compared to those 
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with a BMI of less than 25 kg/m2 (OR 4.95, 95% CI 3.47 – 7.05), and such associations 
were remained significant even after multivariate adjustment for factors including: 
age, race, marital status, education level, smoking status, and using of anti-depressant 
medications. In another study, Zhao and colleagues343 analysed data from a cross-
sectional, nationally representative sample of 2,439 U.S. adults (1,325 men and 1,114 
women) who were aged 20 years and above and found that individuals with abdominal 
obesity, defined as waist circumference of >102 cm for men and >88 cm for women 
were more likely to have major (OR 2.18, 95% CI 1.35 – 3.59) or moderate (OR 2.56, 
95% CI 1.34 – 4.90) depressive symptoms compared to those without abdominal 
obesity. Similarly, Dunbar and colleagues344 analysed data from a representative 
sample of 1,690 Australian, aged 25 to 84 years. They reported that waist 
circumference was significantly associated with higher risk of higher HADS score 
among these individuals (OR 2.86, 95% CI 2.66 – 3.06). 
Based on results from current study and studies discussed earlier, depression is 
prevalent among individuals with obesity. The current study is unique in investigating 
the extreme obese population. Depression among extreme obese individuals may 
worsen obesity per se. Increased food intake and appetite are believed to be associated 
with depression.341 It is also believed that depression is associated with increased 
weight gain through excessive alcohol consumption.341On the other hand, depressed 
obese individuals are less likely to have a desire to take part in weight loss 
programmes. However, evidence indicates that weight loss may potentially reduce 
depressive symptoms.286 It is important that depressive symptoms among obese 
individuals should be addressed and treated to prevent further deleterious 
consequences of depression among these individuals.  
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The underlying mechanism for the association between obesity and depression is yet 
to be understood. Obesity is associated with stigma and obese individuals, particularly 
women are less likely feel like appearing in public places and they may also suffer 
from lower self-esteem that has been linked to depression.345 Obesity, can be 
accompanied by pain as result of multiple co-morbidities, which can cause limitations 
in physical movement, which can ultimately lead to depression though reduced 
involvement in pleasurable activities.346 
3.6.3 Impaired quality of life among extreme obese population  
The results of the current study showed that extreme obese individuals reported lower 
score in all five components of the IWQOL-Lite (physical function = 42.7, self-esteem 
= 26.0, sexual life = 40.8, work = 51.9). Current evidence also indicates that impaired 
quality of life is prevalent among obese individuals. In line with my finding, Fontaine 
and colleagues347 evaluated HRQoL measured by the Study Short Form-36 Health 
Survey (SF-36) among 312 adult individuals seeking outpatient obesity treatment and 
they found that individuals with extreme obesity (mean body mass index = 48.7 kg/m2) 
were more likely to report impairment on all eight quality-of-life domains and in 
particular on the physical and social components. Recently, McDonough and 
colleagues348analysed data from 4,989 adult men and women and found that compared 
to normal weight individuals (n = 1,230), overweight (n = 2,154, OR 1.22, 95% CI 
1.10 - 1.41) and obese (n = 1,605, OR 1.81, 95% CI 1.56 - 2.10) individuals were more 
likely to report lower health-related quality of life (HRQoL) scores. Results from 
similar studies showed that in general obese individuals tend to report discrete 
reductions in all aspects of the HRQoL, with a dose-response relationship between 
188 
 
BMI and impaired HRQoL. Finally the majority of obese individuals reported higher 
impairment in physical function as a result of pain.349  
Studies that evaluated HRQoL among the obese population utilised generic measures 
such as SF-36, or more obesity-specific measures such as IWQOL-Lite. Each measure 
provides data on different domains of quality of life, therefore it is very difficult to 
compare such results and draw a confirmative conclusion on how obesity may affect 
HRQoL. IWQOL-Lite is a new instrument that has been designed to assess the effect 
of weight on a number of life components.350 However, validation studies for IWQOL-
Lite are largely lacking. Overall, assessment of HRQoL may provide a better 
understanding of the psychosocial impact of excess body weight not only for clinicians 
and obesity researchers, but also for obese individuals. As weight gain occurs 
gradually over time, the majority of obese individuals may not be aware of the adverse 
consequences of their weight on important quality of life dimensions such as social 
functioning. Based on my results, extreme obese individuals obtained the lowest score 
on the self-esteem domain (26.0), and such assessment may help people with obesity 
to identify their significant milestones and help them focus more on their effort toward 
achieving their goals for weight control. Assessment of HRQoL of individuals with 
obesity can also help designing future treatment interventions to address unique 
individual needs.  
It is not known how obesity may affect HRQoL. It is believed that there is a high level 
of stigmatisation and discrimination attached to obesity, which could potentially affect 
all aspects of an obese individual’s life.341 In a longitudinal study by Gortmaker and 
colleagues351 10,000 individuals aged 16 to 24 years at baseline, were followed for 7 
years and the consequences of weight gain on socioeconomic life of these people was 
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assessed. Overweight individuals were less likely to have a higher education (0.3 year 
less; 95% CI 0.1 - 0.6) and lower income levels ($6,710 less per year; 95% CI $3,942 
- $9,478) and also were less likely to get married (20% less likely; 95% CI 13% - 
27%).351 In another study352 with 57 severely obese, 91% of the obese individuals 
reported that they perceived discrimination at work and also in public places, and 
within their families. Furthermore, 84% declared they avoided public appearances.352 
Evidence also indicates that weight loss, via bariatric surgery may induce dramatic 
improvements on all aspects of HRQoL.349 Extreme obese individuals that underwent 
weight loss surgery obtained better scores on mobility, sexual activity, self-esteem, 
and social interaction.349 Moreover, a longer follow-up of the patients (over 1-year 
period) showed that such improvements on HRQoL are durable.349  
3.6.4 Associations among sleep quality, depression and quality of life among 
extreme obese individuals 
The result of the present study showed that poor sleep quality and excessive daytime 
sleepiness were strongly associated with mood disturbance and poorer quality of life. 
Such associations remained significant even after controlling for age, gender, 
hypertension, diabetes, and obstructive sleep apnoea (OSA). To my knowledge, this is 
the first study that investigated such associations among the extreme obese population, 
with other studies evaluated association between poor sleep and depressive symptoms 
and quality of life among non-obese participants with various morbidities. For 
example, recently, Turkmen and colleagues321 studied 63 haemodialysis older (aged 
65 to 89 years) non-obese patients (32 women; mean BMI 23.9 kg/m2) and found that 
poor sleepers were more likely to report depressive symptoms and impaired HRQoL 
compared to good sleepers. Poor sleep quality found to negatively correlated with 
physical (r = -0.50, p<0.001) and mental (r = -0.53, p<0.001) components of HRQoL 
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and positively (r = 0.60, p<0.001) correlated with depression. In another study, Norra 
and colleagues323 reported that poor sleep quality was significantly associated with 
depressive symptoms (R2 = 0.40) among 204 patients with heart disease (mean age= 
41.6 years). Similarly, Sandadi and colleagues328 studied 86 women with a mean age 
of 58.1 years that had been diagnosed with ovarian cancer, and they found that the 
PSQI score was significantly and inversely correlated with all aspects of QoL (physical 
component r = -0.59, p<0.001, functional component r = -0.69, p<0.001, social 
component r = -0.21, p<0.001, emotional component: r = -0.37, p<0.001, fatigue 
component; r = -0.65 p<0.001) and were positively correlated with depression (r = 
0.53, p<0.001).  
I investigated whether PSQI and ESS scores are predictors of higher HADS-A,   
HADS-D scores, and IWQOL-Lite via the utilisation of linear regression models. 
Since the data were cross-sectional, causal pathways among these variables cannot be 
inferred. I used SEM analysis to test whether poor sleep factors negatively influence 
mood or vice versa. Interestingly, the model that was presented earlier supported our 
prior findings. I hypothesised that sleep can be influenced by obesity-related 
conditions, and both poor sleep factors and obesity-related conditions may influence 
quality of life and mood of the participants. In an on-going randomised controlled 
study, Cizza and colleagues353 testing the hypothesis on whether increasing total sleep 
duration in sleep-deprived obese participants would have an impact on their body 
weight. The study randomised 150 obese patients, aged 35 years and older who 
reported sleeping less than 6 hours per night to the extension sleep intervention and 
control groups. Data on the endocrine and immune function of these individuals in 
both groups will be collected and compared. The results of this study and potential 
future studies may draw a new horizon on tacking obesity.  
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The mechanism underlying the association between sleep disturbance and reduced 
quality of life is not known. The sleep disturbances and particularly daytime sleepiness 
can result in low energy levels, which could be a potential marker for impaired 
physical function of HRQoL. Additionally, the association between sleep and 
depression is complex and the bi-directional association between sleep and depression 
makes it difficult to infer any causal pathways between them.354 It is believed that 
obese individuals with sleep problems may be frustrated with battling for a better 
night’s sleep and develop depression over time.  
3.6.5 Clinical implications 
Results of the present study are statistically significant showing strong associations 
between the questionnaire score. The effects are very small and are unlikely to be 
clinically significant. The findings, however, cannot estimate the impact of 
improvements in sleep on quality of life and depression and anxiety. Future 
longitudinal/intervention studies with objective measures of sleep are needed to 
measure the change in scores of questionnaires measuring health-related quality of life 
and anxiety/depression, in order to establish clinically meaningful change scores of 
such questionnaires among people with extreme obesity. 
The study’s findings have clinical implications. The results of the present study 
highlighted that extremely obese individuals had a short average sleep duration (mean 
sleep = 6.2 hours) and reported poor sleep quality (mean PSQI = 8.6). As it was 
discussed earlier in this chapter, poor sleep quality has other adverse outcomes such 
as failure to achieve weight loss among obese patients, thus sleep problems should be 
detected and addressed among these individuals. The impact of sleep disorders on 
various aspects of individuals’ lives should not be underestimated. It is very important 
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to design mechanisms to screen for sleep problems among obese individuals. 
Routinely screening for sleep disorders by being aware of clinical symptoms can help 
clinicians more accurately diagnose such disorders. Because time is an important 
factor in clinical practice, barriers might exist in implementing such routine screening 
programmes. Nonetheless, starting to screen for sleep problems, can be as simple as 
asking the patient if they snore, if they feel tired during the day, if they have difficulties 
initiating sleep/maintaining asleep, or if they have noticed any changes in their mood. 
Healthcare providers can also administer sleep scales tools such as Epworth Sleepiness 
Scale (ESS), Pittsburgh Sleep Quality Index (PSQI), and Berlin questionnaire. If the 
patient’s responses to a screening tool indicate a sleep problem, it would be appropriate 
to refer them to sleep specialist for further evaluation. The sleep specialists can aid in 
diagnosing and managing sleep disorders. Future intervention studies are needed to 
explore the effects sleep disorders treatment on depressive symptoms and quality of 
life among people with extreme obesity. 
The prevalence of sleep problems such as excessive daytime sleepiness and short sleep 
duration is relatively high among these obese subjects.168 Although short sleep 
duration has been recognised as an important risk factor for obesity, data on the effect 
of sleep treatment and on obesity are unavailable. The treatment of sleep could 
potentially prevent worsening obesity and could also prevent the initiation and 
progression of psychological conditions such as depression among these individuals. 
In a randomised controlled trial, Reid and colleagues355 investigated the effectiveness 
of aerobic exercise and sleep hygiene education programme on sleep, mood, and 
quality of life adults aged 55 years and older. Their results showed that compared to 
control group, the physical activity group had a significant reductions on PSQI global 
scores (p<0.001) and several sub-scores; sleep latency (p = 0.04), sleep duration (p = 
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0.04), daytime dysfunction (p = 0.02), and sleep efficiency (p = 0.03). Moreover, 
individuals in the physical group also had improvements in depressive symptoms (p = 
0.04), daytime sleepiness (p = 0.02) compared to controls.355  
3.6.6 Strengths and limitations 
To date, no studies have previously investigated the associations between poor sleep 
factors and depression and anxiety symptoms of extreme obese population. The study 
has the merit of detailed statistical analysis. I used SEM analysis to test whether poor 
sleep factors negatively influence mood or vice versa. It is of interest that the model 
that was presented earlier supported the prior findings. The result demonstrated that 
poor sleep factors are strongly associated with higher levels of depression and also 
inversely associated with quality of life. The hypothesised model had a strong evidence 
(p-value>0.05) indicating that the hypothesised model fitted the data. Other 
hypotheses for the model were also tested such as if the mood and quality of life would 
predict sleep disturbances, but the p-value for the model fit was not good. Similar 
studies found that there is a strong bi-directional association between sleep disturbance 
with mood and also sleep disturbance with quality of life. Future longitudinal studies 
using objective measurements are needed to investigate the causal pathway in depth 
and also investigate the underlying mechanisms. 
The main limitation of the study is its cross-sectional design, so a direct causal 
relationship between sleep disturbances and anxiety and depressive symptoms cannot 
be inferred. The other limit is using self-report questionnaires. However, PSQI is a 
reliable and validated instrument, although it cannot be used as an accurate diagnostic 
tool.  
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3.6.7 Key points 
The participants reported shorter sleep duration and low sleep quality scores. I found 
that depression and anxiety scores were high among extreme obese individuals. The 
participants reported lower scores across all components of the IWQOL-Lite (quality 
of life), and especially the self-esteem component. The PSQI global and ESS scores 
were associated with anxiety and depression symptoms. The PSQI global and ESS 
scores were associated with poor quality of life. The SEM model supported the 
direction of the associations that were previously inferred from the linear regression 
models. Routine screening for sleep disorders in obese populations could be beneficial, 
as the early detection of such problems could prevent the potential development and 
perpetuation of psychological disorders among these individuals that may impact on 
their efforts to address their obesity. 
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4 EFFECTIVENESS OF LIFESTYLE INTERVENTIONS ON 
OBSTRUCTIVE SLEEP APNOEA (OSA): SYSTEMATIC 
REVIEW AND META-ANALYSIS 
 
4.1 Abstract 
Introduction: Obstructive sleep apnoea (OSA) is a common sleep disorder associated 
with several adverse health outcomes. Given the close association between OSA and 
obesity, lifestyle and dietary interventions are commonly recommended to patients. 
However, the evidence for their impact on OSA has not been systematically examined. 
The main objective of this study was to conduct a systematic review and meta-analysis 
to assess the impact of weight loss through diet and physical activity on measures of 
OSA: apnoea–hypopnoea index (AHI) and oxygen desaturation index (ODI).  
Methods: A systematic search was performed to identify publications using 
MEDLINE (1948-2011 week 40), EMBASE (from 1988-2011 week 40), and 
CINAHL (from 1982-2011 week 40). An inverse variance method was used to weight 
studies and the random effects model was used to analyse data.  
Results: Seven randomised controlled trials (519 participants) showed that weight 
reduction programmes were associated with a decrease in AHI (-6.04 events/hour 
[95% confidence interval -11.18 to -0.90]) with substantial heterogeneity between 
studies (I2 = 86%). Nine uncontrolled before-after studies (250 participants) showed a 
significant decrease in AHI (-12.26 events/hour [95% confidence interval -18.51, -
6.02]). Four uncontrolled before-after studies (97 participants) with ODI as outcome 
also showed a significant decrease in ODI (-18.91 episodes/hour [95% confidence 
interval -23.40 to -14.43]).  
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Conclusion: Published evidence suggests that weight loss through lifestyle and dietary 
interventions results in improvements in OSA parameters, but is insufficient to 
normalise them. The changes in OSA parameters could, however, may be clinically 
relevant in some patients by reducing OSA severity. These promising preliminary 
results need confirmation through larger randomised studies including more intensive 
weight loss approaches. 
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4.2 Introduction 
4.2.1 Epidemiology of obstructive sleep apnoea   
4.2.1.1 Description of condition 
Obstructive sleep apnoea (OSA) is a common sleep disorder, which is characterised 
by complete or partial collapse of upper airway. OSA is associated with episodic 
hypoxia, arousal, and sleep fragmentation.105 OSA commonly presents with excessive 
daytime sleepiness. Other reported symptoms include nocturia, gastro-oesophageakl 
reflux disease, early morning headaches, sexual dysfunction, and reduced quality of 
life.356 According to the American Academy of Sleep Medicine (AASM) guideline, a 
complete collapse of the airway is defined as an apnoea and partial airway collapse is 
defined as an hypopnoea (Table 4-1).357  
Table 4-1. Definition of apnoea and hypopnoea according to the American Academy 
of Sleep Medicine (AASM) guideline.357 
Term Definition 
Apnoea (Figure 4-1)  Drop in airflow by  >90% of pre-event baseline 
 Duration >10 seconds 
Hypopnoea (Figure 4-2)  Drop in airflow by >30% from pre-event 
baseline 
 Duration >10 seconds 
 3% oxygen desaturation or associated with an 
arousal 
Overnight polysomnography (PSG) is the gold standard diagnostic tool for OSA,105 
and provides the apnoea-hypopnoea index (AHI) which is a common measure that is 
widely used to assess presence and severity of OSA. AHI is calculated using the 
following equation: 
AHI=  Total number of apnoea events + Total number of hypopnoea events
Total number of minutes of acutual sleep time
  * 60 
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Figure 4-1. Apnoeas: drops in airflow by >90% of pre-event baseline lasting >10 
seconds. Note that apnoeas in this recording are accompanied by oxygen desaturation 
(SaO2%). There is thoracic and abdominal effort, but no airflow. The presence of 
effort distinguishes an obstructive apnoea from a central apnoea where there is no 
airflow and no effort. 
 
 
 
 
Figure 4-2. Hypopnoeas: drops in airflow by >30% of pre-event baseline, lasting >10 
seconds and associated with oxygen desaturation or arousal. There is thoracic and 
abdominal effort, but airflow is reduced. The first event highlighted is associated with 
an arousal. 
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OSA is defined as AHI ≥5 events/hour of sleep. Based on different thresholds of AHI, 
OSA is categorised into three groups: mild OSA (AHI 5-14 (events/hour)), moderate 
OSA (AHI 15-30 (events/hour)) and severe OSA (AHI ≥30 (events/hour)).357 Similar 
to AHI, there are other indices (Table 4-2) that are also used in the clinical setting such 
as respiratory disturbance index (RDI) and oxygen desaturation index (ODI).105 
Table 4-2. Different indices to measure severity of OSA. 
Term Definition 
Apnoea-Hypopnoea Index (AHI)  The total number of complete 
obstructions of upper airways (apnoea) 
and partial obstructions (hypopnoea) per 
hour of sleep 
Respiratory Disturbance Index (RDI) The combined number of apnoeic and 
hypopnoeic episodes per hour of sleep 
Oxygen Desaturation Index (ODI) A drop in blood’s oxygen level by 4 per 
cent per hour of sleep 
 
4.2.1.2 Prevalence of OSA 
Cumulative evidence from Western countries indicates that the prevalence of sleep 
apnoea for adults is 3 to 7% among males and 2 to 5% among females.105, 358-360 In 
1993, in the US, Young and colleagues360 assessed the frequency of episodes of apnoea 
and hypopnoea per hour of sleep among 602 men and women 30 to 60 years old via 
overnight PSG. Their results demonstrated that the apnoea-hypopnoea score of 5 or 
greater was present in 4% of men and 2% of women. It was also postulated that obesity 
was significantly associated with OSA and severe cases of the disease was 
substantially more prevalent among habitual snorers. Similar large population-based 
studies have been conducted in United States,360, 361 Spain,362 India,363 China,364, 365 
Korea,366 and, Australia.367 (Table 4-3)   
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Determining the precise prevalence of OSA is controversial, as diversity in sampling 
methods, differences in diagnostic test employed, and variability in defining the 
disease may lead to differences in the prevalence of OSA. It is estimated that the 
prevalence of OSA may vary across different population subsets and it may be higher 
among overweight/obese, African-American, older people (≥65 years old), and also 
among individuals with craniofacial abnormalities.360, 361  
Table 4-3. Summary of studies investigated the prevalence of obstructive sleep 
apnoea. 
Authors and year Country  Sample size Diagnostic 
measure 
Prevalence 
Male Female 
 
Young et al,360 1993 
 
United 
States 
 
602 
 
PSG 
 
4% 
 
2% 
Bixler et al,361 2001 1,741 PSG 3.9% 1.2% 
 
Marin et al,362 1997 
 
 
Spain 
 
1,360 
 
NHO 
 
2.2% 
 
0.7% 
 
Udwadia et al,363 2004 
 
India 
 
250 
 
PSG 
 
7.5% 
 
4.5% 
 
 
Ip et al,365 2001 
 
 
China 
 
 
258 
 
 
PSG 
PSG 
 
 
4.1% 
 
 
- 
Ip et al,364 2004 - 2.1% 
Kim et al,366 2004 Korea 457 PSG 4.5% 2.2% 
 
Bearpark et al,367 1995 
 
Australia 
 
485 
 
MESAM 
IVa 
 
3.1% 
 
- 
Polysomnography (PSG), nocturnal home oximetry (NHO) 
a MESAM: device that measures oxygen saturation, heart rate, snoring, and body position 
 
4.2.1.3 Pathophysiology of OSA  
The pathophysiology of OSA is complex. In normal condition during both sleep and 
wakefulness, the net acting forces tend to keep the upper airways patent. However it 
is not the case in apnoeic individuals.360 It is believed that anatomic factors may 
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increase the susceptibility of airways to collapse during inspiration or insufficient 
neuromuscular compensation predispose upper airway to be obstrcuted.368 It has been 
hypothesised that factors such as age, gender, and ethnicity may affect the contribution 
of anatomic versus neuromuscular factors in occurrence of OSA. However 
epidemiological data are extensively lacking to support such hypothesis. In contrast to 
OSA, central sleep apnoea may lead to a decrease in neural output of respiratory 
motoneurons in the absence of airways obstruction.368 In general, there may be an 
overlap in the pathophysiology of these two conditions. However, the anatomic factors 
play an important role in pathogenesis of OSA. The functionality of oropharyngeal 
and abductor muscles may be diminished as a result of decreased neural output and it 
may either lead to central apnoea if upper airways are anatomically less prone to 
collapse or may lead to OSA if upper airways are anatomically more prone to 
collapse.369 Despite the important role of anatomic abnormalities in the pathogenesis 
of OSA, it has been suggested recently that sleep apnoea may be a manifestation of 
metabolic abnormalities.370 There is a close link between OSA and factors associated 
with metabolic syndrome such as obesity, male gender, post-menopausal state, 
hypertension and diabetes.370 As OSA is featured by various factors including: weight 
gain, snoring, respiratory cessation, somnolence, further weight gain and severe 
breathing abnormalities, all suggesting that it is a systematic condition and cannot 
solely be the result of a local abnormality in respiratory system.161 There is an on-
going debate whether OSA should be considered an anatomic disorder or a 
manifestation of metabolic syndrome.  
The evidence from Wisconsin Sleep Cohort Study (WSCS) indicates that body weight 
alteration can predict the severity OSA. For instance, 10% weight gain compared to 
baseline was associated with an increased risk for progression of moderate to severe 
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OSA up to 6-fold (95% CI, 2.2 – 17.0). On the other hand, a 10% weight reduction 
was associated with a 26% reduction in AHI (95% CI, 18% -34%).161 Similarly, 
findings over a 5-year period from the Sleep Heart Health Study371 demonstrated that 
10 kg weight gain was a strong predictor of a higher RDI (15 events per hour ≥) in 
men (OR 5.21, 95% CI 2.35 – 11.53), but such a trend was not clinically significant 
among women. The influence of body weight on the development of OSA was also 
observed in the Cleveland Family Study,372 which postulated that age (per 10-year 
increase, OR 1.79; 95% CI, 1.41 – 2.27), gender  (men vs. women OR 4.12, 95% CI 
2.29 – 7.43) and body mass index (per 1 unit increase OR 1.14, 95% CI 1.10 – 1.19) 
have a very important role in the incidence and progression of sleep apnoea over time.  
The longitudinal change in body weight and its impact on AHI suggests that 
overweight/obese individuals are at greater risk of developing the disease. With the 
enormous rise in prevalence of obesity across different countries, it is not surprising to 
observe an increase in the prevalence of OSA, which could potentially impose an 
additional burden on healthcare resources.  
4.2.1.4 Risk factors of OSA 
Understanding risk factors for OSA could be beneficial in terms of detecting the 
individuals who are at increased risk for developing the condition and directing 
sufficient diagnostic attention to them to prevent the development of further adverse 
consequences of the condition. Some of main the risk factors for OSA including, age, 
gender, ethnicity, overweight/obesity, genetics, craniofacial anatomy, smoking and 
alcohol consumption are discussed below.  
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4.2.1.4.1 Age 
According to several epidemiological studies,361, 373 the prevalence of moderate OSA 
(AHI ≥ 15 events/hour) varies widely between 7 to 44% in aged population, and 
differences in the prevalence diminish significantly after the menopause. Interestingly, 
the increase in the prevalence of OSA plateaus around age 65 years. However, the 
underlying mechanisms are unclear; there are several hypotheses to explain the 
phenomenon. It is believed that the effect of BMI on AHI is less strong among older 
individuals compared to middle-aged individuals.361, 374Other explanation includes 
lack of a bedtime partner to report sings such as snoring and apnoeas.   
In general, the occurrence and implication of OSA in older adults compared to younger 
and middle-aged adults is under debate. It has been previously reported that OSA was 
weakly correlated with common risk factors such as excessive weight and common 
symptoms such as snoring among older individuals.374 The impact of OSA is also 
different between younger and older individuals. OSA is associated with increased 
impairment in cognitive function in older adults, whereas it is associated with 
increased cardiovascular complications in younger individuals.360 
There are some underlying factors that explain the link between ageing and OSA. 
Advancing age has been found to be an independent risk factor for functional 
impairment of pharyngeal dilator muscles, which lose their ability to maintain 
patentcy.374 Older individuals are more susceptible to OSA as ageing is associated with 
changes in the anatomical structure of upper airways.374 Young and colleagues360 
investigated the predictors of SDB in a representative sample of 5,615 adults aged 40 
to 98 years. They reported that there is ageing is positively associated with OSA, and 
65 years of age was found to be a plateau for these associations. 
204 
 
4.2.1.4.2 Gender 
A great number of epidemiological studies have previously suggested that the 
prevalence of OSA is approximately 1.5 to 3 times higher in men than in women.105 
Although the exact mechanism of gender impact on OSA is not clear, there are several 
hypotheses that may potentially explain the male preponderance. The characteristics 
of OSA symptoms have been reported to differ between men and women.247 Women 
are less likely to report snoring as a symptom and are more likely to report other 
symptoms such as headache and other sleep problems and in some cases depression, 
which can increase the risk of receiving treatment for depression rather than OSA. 
Undiagnosed OSA among women may impact mortality, as results from a study by 
Young and Finn152 showed that the proportion of deaths in women with AHI of ≥ 5 
events/hour was higher compared to men (n = 354, 27% (3/11) vs. 2% (1/49), women 
vs. men respectively). There are other explanations such as the difference in the 
anatomical structure of upper airways in men and women.375 Although women have 
smaller upper airways and might be expected to be at higher risk of developing OSA, 
interestingly men have longer airways which are more susceptible for collapse.375 The 
results of imaging studies suggest that the distribution of fat is different in men and 
women, as there is more fat tissue around the pharyngeal area in men, whereas in 
women, the fat is distributed at lower part of the body.375 
4.2.1.4.3 Ethnicity 
Since the consequences of untreated OSA and its related adverse health complications 
such as cardiovascular diseases were appreciated, several studies have been conducted 
in America, Europe, Asia, and Australia to characterise the disease burden in those 
regions (Table 4-3).  Evidence indicates that the prevalence of OSA in China364, 365 and 
Korea366 may be comparable with that in the US,360, 361 Spain362 and Australia,367  but 
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the prevalence of the disease is higher in India363 compared to those regions. In a recent 
population-based study, Leong and colleagues376 compared the prevalence of OSA 
between South Asians and white Europeans with a total of 308 participants (mean (SD) 
age: 46 (12) years, and mean (SD) BMI: 49 (8) kg/m2). The findings showed that South 
Asians had an increased prevalence of OSA compared to white Europeans (85% vs. 
66%, p = 0.017). The severity of the OSA is higher in South Asians.358 Leong and 
colleagues376 reported that in their sample, South Asians were more likely to suffer 
from severe OSA (AHI ≥30 events/hour) (42.5% vs. 21.6%, p = 0.015) compared to 
white Europeans. This study, however, was carried out in individuals with extreme 
obesity and may not be applicable to other groups. 
There is a limited data on prevalence of OSA among Hispanics.  It was previously 
found that the prevalence of the disease in African-American middle-aged adults is 
comparable to other ethnic groups.377 However, younger African-American adults 
(<25 years old) had a higher prevalence of the disease compared to African-American 
middle aged adults or Chinese or Caucasians.377  
There are differences in the prevalence and severity of OSA among different ethnic 
group. The mechanism mediating the observed associations require further 
investigation, but may include body fat distribution, craniofacial anatomical 
differences and variations in the control of breathing. 
4.2.1.4.4 Overweight/obesity 
The prevalence of obesity is increasing worldwide. Epidemiological studies 
consistently suggest excessive body weight is prevalent in approximately 60% of 
people that have been diagnosed with OSA.105 Evidence indicates that an increase in 
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measures of body habitus (BMI, neck circumference, or waist-to-hip ratio) could 
potentially result in an increase in the prevalence of OSA (Table 4-4).  
Table 4-4. Prevalence of OSA by BMI in several population-based studies.378 
Authors and 
year 
Country Sample  AHI 
(events/hour) 
BMI  
(kg/m2) 
Prevalence 
of OSA 
(%) 
 
Bixler et al, 
1998, 2001361, 
374 
United 
States  
1,000 F, 741 
M,  
20 – 100 years 
≥15, Laboratory 
PSG  
F,  <32.3 
      ≥32.3 
1.1 
7.2 
M, <32.3 
      ≥32.3 
 
2.0 
13.8 
Young et al, 379 
2002 
United 
States 
5,616 M,F 
40 – 98 years 
≥15,  
Home PSG 
Quartiles:   
      16-24 10 
       24-48 13 
       28-32 17 
       32-59 
 
32 
Ip et al,364, 
3652001, 2004 
Hong 
Kong 
106 F, 153 M,  
30 – 60 years 
≥5,  
Laboratory PSG 
F,   <23 
       ≥23 
0.9 
14.5 
M,  <23 
        ≥23 
0.9 
8.8 
Apnoea Hypopnoea Index (AHI), Body Mass Index (BMI), Obstructive Sleep Apnoea (OSA), Male (M), 
Female (F). 
Used with the permission from Dr Young. 
 
Excessive body weight is highly contributory to the increase the prevalence of OSA, 
as each unit increase in BMI could potentially increase the risk of development of OSA 
by 14% (95% CI 1.10 – 1.19). However, the impact of BMI on OSA is less significant 
among older individuals (>60 years).372 
As stated earlier, changes in body weight could increase or decrease OSA. Body 
weight gain by %10 among individuals with no OSA or mild OSA (<15 events/hour) 
was associated with a 32% (95% CI 20% – 45%) higher risk of developing or 
worsening of OSA (AHI ≥15 events/hour). Additionally, a 10% weight loss was 
associated with a 26% (95% CI 18% - 34%) decrease in severity of OSA.161Simarly, 
results from the Sleep Heart Health Study,371 involving 5-year evaluation of weight 
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changes among 2,968 men and women aged 40 to 95 years showed that effects of 
weight gain on an increase in AHI is much stronger than the effects of weight loss on 
a decrease in AHI. For example, in men, a 10 kg weight gain was associated with an 
odds ratio of 5.21 (95% CI 2.35 – 11.53) for progression of AHI of >15events/hour, 
while the odds ratio of 10 kg weight loss for a decrease in AHI by 15 event/hour was 
2.85 (95% CI 1.28 – 6.31).371 Due to the lack of observational and randomised 
controlled studies on the effect of weight loss (via either surgery or lifestyle 
modification) on treatment of OSA, it is difficult to draw concrete conclusions as to 
whether a reduction in weight can be known as a curative method for treatment of 
OSA. 
Despite the cumulative evidence suggesting that obesity is an important risk factor for 
OSA, it is largely unknown that whether it is central or peripheral distributions of fat 
that are associated with a greater risk of having OSA. It can be argued that such a 
challenge to findings answer to the above question may be due to limitations of current 
measures of obesity as described in Chapter 1. Waist and neck circumferences were 
found to be significantly associated with AHI.360 It can be explained that changes in 
waist and neck circumferences are highly correlated with changes in total body weight, 
and weight loss would also reflect reductions in waist and neck circumference. 
Breathing may be influenced by excessive body weight through several mechanisms: 
1) alterations of upper airway structure by increased fat deposition around the neck 
area, 2) decreased neural compensatory mechanisms to signal greater respiratory effort 
and increased susceptibility of airways to be blocked, 3) instability of respiratory 
control system, and 4) instability of caudal tracheal traction that ordinarily assists in 
airway patency as a result of reduced functional residual capacity (the volume of air in 
the lungs after normal expiration).163 It appears that weight gain may increase the risk 
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of developing of OSA, and also worsen the condition among those who have already 
been affected. 
Public health strategies with a focus on long-term weight loss are favoured to tackle 
the epidemics of both obesity and OSA.  
4.2.1.4.5   Genetics 
The role of genetics on the development of OSA was first suggested by Strohl and 
colleagues when they observed the clustering of OSA within the same family.380 Since 
then, numerous epidemiological studies have suggested that individuals with a family 
history of OSA are at higher risk of developing the disease.163 An increase in number 
of relatives with OSA may be associated with higher risk of OSA in an individual.381 
It has been highlighted that familial connections in weight and craniofacial 
morphology may also increase the risk for development of OSA.163 Findings from 
Cleveland Family Study163 showed that independent of obesity, 35% of variance in the 
AHI could be explained by genetic factors. The susceptibility of OSA as a result of 
genetic factors may differ between ethnic groups.382 It has been argued that confounder 
variables and in particular obesity may mediate the association causality between 
genetic factors and OSA, therefore future studies are needed to confirm the 
independent familial predisposition.  
4.2.1.4.6 Craniofacial anatomy 
Evidence indicates that there is a difference in skeletal and soft-tissue structural 
differences among OSA and non-OSA patients.383 Craniofacial abnormalities 
including mandibular deficiency, enlarged soft plate, decreased posterior air space and 
tonsillar hypertrophy may narrow the upper airway dimension and yield apnoea and 
hypopnoea events.383 The results of a systematic review demonstrated that mandibular 
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length was associated with increased risk of OSA and a slight difference in mandibular 
size may result in development of the condition, even in the absence of distinct 
craniofacial deformity.384 Interestingly, craniofacial morphology may differ among 
different ethnic groups. Evidence indicates that the association between AHI and 
measurements of the soft palate was stronger in African Americans compared to 
Caucasions.385 Similar studies386, 387 have been conducted among Chinese and Asian 
individuals and their results revealed that independent of obesity measures (e.g. BMI 
and neck circumference) Chinese OSA patients had more mandibular retrognathia 
(retracted mandible) compared to their matched white controls. Moreover, Asians have 
a shorter cranial base, which may increase their vulnerability to develop the disorder. 
Craniofacial anatomy is an important risk factor for OSA, particularly in lean 
individuals. Evaluation for OSA in presence of apparent anatomical abnormalities may 
lead to early detection of the disorder and prevention of further health consequences. 
4.2.1.4.7 Smoking and Alcohol consumption 
It has been hypothesised that smoking may affect OSA through sleep instability and 
airway inflammation.388 Numerous cross-sectional studies have previously reported 
that there is a positive link between cigarette smoking and OSA.389, 390 Current smokers 
are three times more likely to have OSA compared never smokers (95% CI, 1.4 - 
6.4).391 Interestingly, the prevalence of the disease did not significantly differ between 
former smokers and never smokers, which suggesting that smoking cessation, could 
potentially reduce the risk of OSA. 391 In a longitudinal study, Lindeberg and 
colleagues389 found that smoking was a strong predictor for snoring among young 
adults (aged <60 years old) (OR 1.4, 95% CI 1.1 - 1.9). Unexpectedly, analysis of data 
from the Sleep Heart Health Study demonstrated that there is a negative link between 
current smoking and OSA following adjustment for age and BMI.390 The authors 
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suggested that the observed inverse association may be due the fact that individuals 
with severe OSA are more likely to quit smoking. However, there was no significant 
association between former smoking status and OSA. Data on the biological 
plausibility of smoking and OSA are lacking, therefore future studies are needed to 
address this.  
Nasal and pharyngeal resistance are found to be associated with alcohol ingestion 
during wakefulness: therefore it can be hypothesised that alcohol may disrupt 
respiratory patterns during sleep during sleep.392 To date, the majority of 
experimental393-395 and epidemiological studies394, 396 found a positive association 
between alcohol consumption and OSA. Alcohol may result in pharyngeal 
collapsibility, prolonged apnoeas, more frequent hypopnoeas and increased frequency 
of hypoxaemia.394 Moreover, alcohol is a muscle relaxant that may affect the muscular 
mechanisms of airway patency. In general, studies have evaluated the acute effects of 
alcohol on sleep and little is known about its longer-term effects. In the WSCS, 
Peppard and colleagues397 evaluated the long-term effect of alcohol consumption on 
sleep and they reported that excessive alcohol intake was strong predictor for mild to 
severe OSA (OR 1.25, 95% CI 1.07-1.46). Future studies are needed to confirm these 
findings.     
4.2.1.5 Consequences of untreated OSA 
Despite the fact that OSA was first recognised almost 35 years ago, data on the 
prevalence of OSA were markedly lacking until a decade ago. It is estimated the 
prevalence of undiagnosed OSA would differ between 0.3 to 5%.105 Under- 
recognition of the disorder in both public and clinical settings may lead to multiple 
adverse health outcomes. Some of the main consequences of untreated OSA such as 
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cardiovascular morbidity and mortality, diabetes and sleepiness are discussed as 
below.  
4.2.1.5.1 Cardiovascular morbidity and mortality 
It was previously found that apnoea and hypopnoea events may result acute rise in 
mean arterial pressure by 30 mmHg or even higher during sleep.398 Results from 
epidemiological evidence suggests that OSA may increase the risk for hypertension 
independent of obesity and other potential confounders, as I have reported earlier.399  
Population-based cross-sectional data using both objective measures of OSA and self-
reported snoring report positive associations between OSA and with cardiovascular 
disease (CVD). In the Sleep Heart Health Study involving 6,424 participants, Shahar 
and colleagues400 found that the risk for CVD was  (OR 1.42, 95% CI 1.13 - 1.78) 
higher among those in the upper quartile of AHI (≥11 events/hour) compared to those 
in the lowest quartile (<1.3 events/hour) following multivariate adjustment for 
potential confounders.  Results from case-control evidence have demonstrated that 
OSA may increase the risk of myocardial infarction (MI) by up to 4-fold among men 
and women.401 It appears that the link between stroke and OSA is stronger than the 
link between CVD and OSA.402 However, alterations in cardiac output and medication 
following MI may affect the severity of OSA.403 Longitudinal studies that have 
assessed the possible link between OSA and CVD have also confirmed the 
observations from cross-sectional studies.402 Using data from Nurses’ Health Study, 
Hu and colleagues402 reported that self-reported snoring was a strong predictor for 
incidence of CVD among 72,000 women across 8-year follow-up period (OR 1.33, 
95% CI 1.06 – 1.67).  
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It has been previously hypothesised that OSA may lead to cardiovascular morbidity 
and mortality through several mechanisms including atherosclerosis as a result of 
hypoxaemia and sympathetic hyperactivity, increased blood pressure, rise in 
fibrinogen, and increased risk for heart failure.398 Evidence indicates that treatment of 
OSA may also help to reduce blood pressure.404 Results of a recent systematic review 
and meta-analysis including 28 studies which represented of 1,948 participants showed 
that CPAP did result in a significant decrease in diurnal systolic (-2.58 mmHg, 95% 
CI -3.57 to -1.59 mmHg) and diastolic (-2.01 mmHg, 95% CI -2.84 to -1.18 mm Hg) 
blood pressure compared to controls.  
Epidemiological evidence have suggested that OSA may potentially increase CVD 
mortality.405 Lindberg and colleagues405 have assessed the potential link  between 
snoring and excessive daytime sleepiness and mortality over a 10-year follow-up. They 
could not find any significant association between snoring and mortality across the 
whole sample, but in a subgroup of men aged 60 years and younger, those who reported 
snoring with excessive daytime sleepiness were twice likely to die over the course of 
the study, compared to those who were symptoms free (OR 2.2, 95% CI 1.3 – 3.8). In 
similar studies involving less than 200 older participants, Bliwise and colleagues406 
and Mant and colleagues407 did not detect any statistically significant relationships 
between age-adjusted cardiovascular mortality and OSA. It is possible that compared 
to younger individuals, less noxious feature of OSA would be present in older 
individuals or older individuals are more resistant to adverse consequences of OSA. In 
general, individuals with untreated OSA may be at higher risk for early death. Future 
studies with objective measures of OSA are needed to quantify the magnitude risk of 
OSA on cardiovascular morbidity and mortality.  
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4.2.1.5.2 Diabetes 
Type 2 diabetes could be another consequence or another chronic condition associated 
with untreated OSA. West and colleagues408 reported that the prevalence of OSA was 
higher in diabetes population (23% vs. 6%, p<0.001, diabetics vs. non-diabetics 
respectively). Numerous cross-sectional and a few longitudinal studies have 
previously investigated the link between OSA and type 2 diabetes. In some studies, 
the presence of OSA was assessed by PSG and in some others it was assessed using 
self-reported snoring. Cross-sectional studies that used PSG to assess OSA 
consistently reported that OSA was associated with an increased risk of diabetes. 
Using data from 2,656 participants in the Sleep Heart Health Study, Punjabi and 
colleagues409 found that higher AHI and ODI were associated with an increased risk 
of glucose intolerance and insulin resistance measured by an oral glucose tolerance 
test. This association was independent of body mass index and other potential 
confounders (OR 1.46, 95% CI 1.09 - 1.97). Results from the Cleveland Family study 
showed that individuals with OSA that had spent 2% time in saturation level of <90% 
had an increased risk for impaired glucose tolerance (OR 2.33, 95% CI 1.38 - 3.94).410 
The results from the only longitudinal study that assessed OSA using overnight 
polysomnography did not find an independent association between OSA and the 
incidence of diabetes following 4-year follow-up period.411 Findings from studies that 
explored the potential link between snoring and the parameters of glucose tolerance 
also suggested that there is a positive association between these phenomena.  
Data on causal role of OSA in the progression of type 2 diabetes is lacking and it is 
hypothesised that OSA can lead to abnormalities in glucose metabolism through 
various mechanisms including: increased activity of sympathetic nervous system, 
hypoxaemia, endothelial dysfunction, sleep fragmentation, alteration in cytokines, and 
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dysregulation of the hypothalamic-pituitary axis.412 For examples, increased 
sympathetic nervous system and release of hormones counter-regulatory to insulin, 
could affect glucose homeostasis.412 Also, hypoxaemia, has been associated with 
abnormalities in insulin secretion from pancreatic beta cells.412  
4.2.1.5.3 Daytime sleepiness 
Excessive daytime sleepiness is a key feature of OSA, giving the full obstructive sleep 
apnoea “syndrome”. The possible link between OSA and sleepiness is poorly 
understood, but current evidence has confirmed the causal role of OSA and non-
apnoeic snoring in occurrence of sleepiness.413 Repeated arousals from apnoeas and 
hypopnoea result in sleep fragmentation during the night, which could lead to daytime 
sleepiness the next day. Results from the Sleep Heart Health Study414 demonstrated 
that there is a positive association between the total score of the Epworth Sleepiness 
Scale (ESS) and RDI, independent of age, gender, race, BMI, and insufficient sleep 
time (ESS, mean (SD) RDI<5 events/hour 7.2 (4.3) vs. 9.3 (4.9) RDI≥30 events/hour). 
Stradling and colleagues413 found that habitual snoring independent of the severity of 
OSA could potentially increase the risk of daytime sleepiness by 5-fold (95% CI 2.7 - 
12.5). Findings from several other epidemiological studies,360, 414 have confirmed that 
snoring even in absence of evident apnoea and hypopnoea events can increase the risk 
for daytime sleepiness, although the underlying mechanisms are not fully understood 
as there might be some potential confounders such as voluntary sleep restriction, 
although one study reported that the positive association between snoring and daytime 
sleepiness is independent of voluntary sleep restriction.415  
Numerous studies suggest that motor vehicle accidents are prevalent among OSA 
patients and that these individuals also suffer from poor performance while driving on 
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the road.171 Using data from Wisconsin Sleep Cohort Study, Young and colleagues171 
found that only among males, those with AHI ≥5 events/hour or habitual snorers were 
more likely to have at least 1 road accident in a 5-year period compared to those with 
AHI <5 events/hour or non-habitual snorers. It is believed that sleepiness may explain 
the link between OSA and increased risk for work and road accidents. However, recent 
findings showed that the association between OSA and motor vehicle accidents is 
independent of sleepiness.416 A Swedish cohort study,389 involving 2,724 male 
participants, found that OSA patients or heavy snorers had higher risk for occupational 
accidents in a 10-year period (OR 2.2, 95% CI 1.3 - 3.8). The economic burden of 
OSA is substantial.417 It is known that OSA is associated with OSA-related accidents 
cost approximately $15.9 billion annually and medical treatment can markedly reduce 
this cost by up to $11.1 billion.417 
4.2.1.6 Treatment  
Continuous positive airway pressure (CPAP) is the gold standard treatment for 
OSA.105 CPAP usually delivers a pneumatic splint to the airway during expiration. 
More complex patients may require bi-level treatment with pressure delivered during 
both inspiration and expiration. CPAP reduces AHI and may also reduce OSA 
associated morbidities, in particular cardiovascular events mortality. In a long-term 
follow-up study, Doherty and colleagues418 evaluated the impact of CPAP therapy on 
cardiovascular outcomes of 168 OSA patients, who had received CPAP treatment for 
5 years prior to the study. After 7.5 years follow-up, those patients who were intolerant 
of CPAP (n = 61) had higher AHI compared to those continuing the therapy (48.3 
events/hour vs. 36.7 events/hour, respectively; p = 0.02). Death from cardiovascular 
disease was significantly higher among those who were CPAP intolerant compared to 
CPAP adherent group (14.8% vs. 1.9%, respectively; p = 0.009).  
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Overall, almost a quarter of patients have difficulties tolerating CPAP therapy.419 
Studies have demonstrated that CPAP treatment cannot always alleviate OSA 
symptoms such as daytime sleepiness.419 Given that best CPAP usage is between 4-5 
hours per night, it is likely that OSA patients on CPAP still continue to have 
hypoxaemia and sleep disruption for the remainder of the night. Compared to CPAP, 
oral appliances and surgery are less effective and maybe successful in only a small 
proportion of patients.420 Oral appliances (OA) are another treatment method for OSA 
and they may reduce the collapsibility of upper airways by enlarging the airways and 
keeping them patent.421 Although OAs are not as effective as CPAP, they are usually 
recommended in patients who did not respond to other treatment methods such as 
CPAP or lifestyle interventions.421 Surgery is also used for the treatment of OSA. 
Surgical procedures are reversed for extreme cases and may result in complications 
and side-effects such as bleeding and infection.422 Pharmacotherapy has been 
employed effectively to improve daytime sleepiness in OSA, but is unlikely to improve 
the cardiovascular problems that accompany it. Given the issues with current treatment 
methods, and the important association between OSA and obesity, lifestyle change 
with weight reduction is a common clinical recommendation by several guidelines.423  
Regardless of benefits of weight loss on reducing AHI,161 it is has been hypothesised 
that OSA per se may increase the risk for obesity with several potential mechanisms.424 
Sleep fragmentation as a result of OSA is highly correlated with excessive daytime 
sleepiness which may preclude OSA patients from carrying out physical activity that 
may translate to greater obesity.424 West and colleagues, however, found that even 
after CPAP therapy and elimination of sleepiness, the physical activity levels of OSA 
patients did not increase.425 Another mechanism through which OSA could predispose 
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to obesity is loss of sleep and poor sleep quality, which have been associated with 
increased body weight. Other mechanisms are discussed below (see discussion). 
It is generally recommended that obese OSA patients reduce weight through diet and 
exercise programmes or a mixture of both. It has been previously found that weight 
loss via a very low calorie diet (VLCD) can markedly reduce AHI. Increase in physical 
activity levels can also reduce AHI severity.424 The most common form of exercise 
employed in research studies on obese OSA patients is aerobic exercise.424 
4.2.2 Lifestyle interventions for OSA: mechanisms 
It is well known that obesity is a major risk factor for sleep apnoea. Epidemiological 
evidence indicates that OSA is highly prevalent among the obese population, and the 
majority of OSA patients are obese.  
Results from a recent published meta-analysis426 of 12 studies representing 342 
patients suggested that bariatric surgery could potentially reduce the severity of OSA 
in a sample of individuals with extreme obesity. The random-effects pooled baseline 
apnoea hypopnoea index of 54.7 events/hour (95% CI, 49.0 - 60.3) was reduced by 
38.2 events/hour (95% CI, 31.9 - 44.4) to a final value of 15.8 events/hour (95% CI, 
12.6 - 19.0). Evidence from lifestyle interventions such as diet and increased physical 
activity levels showed a reduction in AHI. 424, 427 Moreover, it has been found that 
weight loss could reduce upper airway collapsibility and increase several measures of 
lung function including vital capacity, functional residual capacity, forced expiratory 
volume and total lung volume (see appendix regarding lung volume).428 There are 
some unaddressed issues regarding the effect of weight loss on OSA. For instance, the 
amount of weight loss that requires producing significant improvement in OSA and 
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associated symptoms (e.g. daytime sleepiness) is yet to be confirmed. Data on weight 
loss sustainability and longer-term effects of lifestyle intervention on OSA are lacking. 
Compared to other treatment options and at first consideration, lifestyle weight loss 
interventions are likely to be cheaper and more feasible, but their effectiveness has not 
been assessed systematically. These interventions can be used mutually with CPAP. A 
decrease in severity of OSA through lifestyle modification intervention may improve 
CPAP adherence through a potential reduction of applied expiratory pressures required 
to maintain airway patency.    
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4.2.3 Aims  
Although several treatment options are available for OSA patients, not all patients 
adhere to or respond well to options such as CPAP and oral devices. On the other hand, 
surgical options are associated with a higher risk of adverse outcomes.422 Lifestyle 
modification strategies such as weight loss through diet and exercise or their 
combination may be an attractive alternative treatment option. These approaches are 
also generally recommended to patients, but are not systematically addressed.  
Given the recommendation of lifestyle interventions for the treatment of OSA, a 
systematic review and meta-analysis was conducted to examine the available evidence 
for this. I sought to assess the effectiveness of lifestyle interventions on reducing the 
severity of OSA. In particular, I was interested in determining the mean changes in 
AHI and oxygen desaturation index of 4% (ODI) following termination of lifestyle 
interventions. Additionally, I also assessed the impact of these interventions on 
common symptoms of OSA such as daytime sleepiness. 
4.2.4 Hypothesis  
The systematic review aimed to assess the effectiveness of lifestyle interventions on 
the severity of OSA. In particular, it was hypothesised that the mean change in AHI 
and oxygen desaturation index of 4% (ODI) would significantly vary from baseline to 
post lifestyle intervention.  
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4.3 Methods 
4.3.1 Data sources and searches  
Study protocol was registered with International Prospective Register Of Systematic 
Reviews (PROSPERO) (Registration Number: CRD42011001511).429   
A systematic search was performed to identify relevant publications using Medline 
(from 1948), Embase (from 1988), CINAHL (from 1983), Opengrey, OAIster, Zetoc, 
BioMed Central, NLM Gateway, Cochrane Library, ISRCTN, and 
www.clinicaltrials.gov (from database inception to April 2011). Reference lists and 
unpublished studies were also checked. In order to formulate the search strategies, the 
record of exact search terms and their results were kept to refine the final search 
strategy. The search terms were (“obstructive sleep apnea” or “obstructive sleep 
apnoea” or “sleep disordered breathing”) and (“lifestyle” or “exercise” or “weight 
loss” or “weight” or “diet” or “physical activity”) 
4.3.2 Study selection  
To be eligible for inclusion, research papers had to report data on adult patients (≥18 
years old; male and female) with confirmed diagnosed OSA (AHI ≥5 events/hour or 
ODI4 ≥5 episodes/hour) and investigated lifestyle modification interventions (defined 
as a comprehensive program of diet and/or exercise therapy430 without treatment with 
CPAP at the start of the intervention). Surgical and pharmacological interventions 
were excluded. Randomised and non-randomised studies that compared a lifestyle 
modification intervention with no intervention, usual care or placebo were eligible for 
inclusion. Uncontrolled before-and-after studies were also included to provide 
supportive evidence given the small number of comparative studies identified. 
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Based on the above inclusion criteria, titles and abstracts were screened independently 
by two members of the research team (AJ, SC) with access to full-text where necessary 
to select studies to include in the review. Disagreements on inclusion decisions were 
resolved by discussion.  
4.3.3 Data extraction and quality assessment 
A standardised form was used to extract data on the descriptive findings including; 
patients’ demographic and clinical characteristics, length of weight loss intervention, 
length of follow-up, and change in body mass index (BMI), change in AHI, and change 
in ODI4 pre- and post- intervention and been checked for accuracy by AJ and SC. 
Additional information from each study was also obtained on the first author’s last 
name, year of publication, country where the study was done, study name, and sample 
size. Authors were contacted to provide requested data.   
The methodological quality of the included randomised controlled studies was 
assessed using Cochrane risk of bias tools. These studies were assessed for random 
sequence generation, allocation concealment, blinding (as the blinding of the 
participants is not possible for such interventions, blinding of statistician), incomplete 
outcome data, selective outcome reporting and any other biases (Table 4-5). The 
methodological quality of uncontrolled before-and-after studies was assessed using 
relevant items from the Cochrane Effective Practice and Organisation of Care 
Group (EPOC) risk of bias tool for interrupted time series studies and items used by 
Chambers and colleagues431 for assessing case series (Table 4-6). 
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4.3.4 Data synthesis and analysis 
Outcomes (AHI, ODI4, BMI, ESS) were combined using the random effects model of 
DerSimonian and Laird,432 and expressed as weighted mean differences. Randomised 
controlled trials (RCTs) and uncontrolled before-and-after studies were analysed 
separately. For randomised controlled studies, data included in the analysis were the 
change from baseline to post- intervention between intervention and control groups.  
For uncontrolled studies, the data analysed were the changes post intervention 
compared to baseline for a single group. In the latter analysis because ODI4 was the 
outcome, data from the intervention arm of one RCT433 was regarded as an 
‘uncontrolled before-after studies’ and was also included. The meta-analysis was 
performed using RevMan 5.1 (Update Software, 2011). In order to weight the studies, 
an inverse variance method was used.434 Meta-regression was carried out using 
restricted maximum likelihood estimators (REML) to examine the coefficient of 
variability between reduction of weight and change in AHI and also between baseline 
AHI and change in AHI. I assessed the presence of potential publication bias using 
Dear and Begg’s test435 and results were obtained from using the “selectMeta” package 
in R.436 Statistical heterogeneity was assessed using the chi-square statistic and the 
I2 statistic, with I2 greater than 50% indicating at least moderate heterogeneity. A p-
value less than 0.05 was considered to be statistical significance. 
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4.4 Results 
4.4.1 Study characteristics  
A total of 3,837 references were retrieved by the search. The flow of the studies is 
shown in Figure 4-3. A review of the titles allowed for the exclusion of 3,791 
publications. I reviewed the full-text of 46 studies that were potentially suitable for 
inclusion in the meta-analysis. After excluding duplicate studies and those that did not 
meet the inclusion criteria, 21 studies representing 893 patients were identified for 
inclusion. Seven randomised controlled trials424, 427, 437-441 with a total of 519 
participants and fourteen uncontrolled before-and-after studies428, 433, 442-453 with a total 
number of 374 participants were included. All studies assessed the effect of weight 
loss through lifestyle modification interventions such as diet, exercise or using both 
methods on patients with OSA. The length of the intervention varied from 4 weeks to 
24 months. Descriptive data for the included studies are presented in Table 4-7 and 
Table 4-8. 
Most studies were performed in Finland and the Unites States. The rest of the studies 
were from Sweden, Spain, Australia, Canada and Brazil. The sample size varied from 
8 to 264 individuals with an average age of the participants being 49 years. Despite 
attempts to contact authors to provide additional unpublished data, I could not find 
information describing changes in BMI for one randomised controlled study.438 With 
the agreement of all the co-authors, the observational study by Johansson and 
colleagues445 was recognised as an independent study from their previous randomised 
controlled study and was eligible for inclusion.427  
224 
 
A very low calorie diet (VLCD) (intake <800 kcal.d-1) intervention was used by 
thirteen studies.427, 433, 438, 439, 441, 443-445, 447-449, 451, 454 Four studies used combined 
interventions 437, 442, 446, 452  including VLCD with either exercise or cognitive 
behavioural therapy. An exercise intervention was used by four studies.424, 440, 450, 453 
Five studies reported ODI4 as the outcome measure 433, 443, 446-448; six studies reported 
both AHI and ODI4,424, 427, 428, 437, 445, 449and ten studies only reported AHI as the 
outcome.438, 439, 441, 442, 444, 445, 450-453 
The baseline BMI average varied from 29.0 to 54.6 kg/m2. For the sleep outcome, AHI 
varied from 10 to 66.5 events/hour and for ODI4 varied from 30 to 51 events/hour. 
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Table 4-5. Quality assessment of randomised controlled trials. 
 Sequence 
Generation 
Allocation 
concealment 
Blinding 
 
Incomplete outcome 
data 
 
Selective outcome 
reporting 
Free from other bias 
Kajaste et al 2004433 Low Risk Unclear Unclear Low Risk High Risk Unclear 
Habdank et al 2006438 Unclear Unclear Unclear High Risk High Risk Unclear 
Kemppainen et al 2008439 High Risk Unclear Unclear Low Risk Low Risk High Risk 
Johansson et al 2009427 Low Risk Low Risk Low Risk Low Risk Low Risk Low Risk 
Sleep AHEAD 2009455 Low Risk Low Risk Low Risk Low Risk Low Risk Unclear 
Tuomilehto et al 2009441 Low Risk Low risk Unclear Unclear Low Risk Unclear 
Kline et al 2011424 Low Risk Low Risk Low Risk Low Risk Low Risk Unclear 
Sengul et al 2011440 Low Risk Unclear Unclear Low Risk Low Risk High Risk 
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Table 4-6. Quality assessment of uncontrolled before-after studies. 
 Suratt et al428 
1987 
Pasquali 
et al451 
1990 
Kajaste 
et al446 
1994 
Hakala 
et al443 
1995 
Lojander 
et al448 
1998 
Sampol 
et al452 
1998 
Kansanen 
et al447 
1998 
Norman 
et al450 
2000 
Ueno 
et al453 
2009 
Barnes 
et al442 
2009 
Hernandez 
et al444 
2009 
Nerfeldt 
et al449 
2010 
Johansson 
et al445 
2011 
1. Were selection/eligibility 
criteria adequately 
reported?  
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
2. Was the selected 
population representative of 
that seen in normal 
practice? 
Unclear Unclear Yes Yes Yes Unclear Yes Yes Yes Yes Yes Yes Yes 
3. Were patients recruited 
prospectively? 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
4. Were patients recruited 
consecutively? 
Unclear Unclear Yes No No No No No Yes Yes Yes Yes Yes 
5. Did the study report 
relevant prognostic factors? 
Yes Yes Yes Yes Yes Unclear Yes Yes No Yes Yes Yes Yes 
6. Was the intervention 
independent of other 
changes?  
Unclear Unclear Yes Yes Unclear Unclear Yes Unclear Yes Yes Yes Yes Yes 
7. Was the intervention 
unlikely to affect data 
collection? 
Unclear Unclear Yes Yes Unclear Unclear Yes Unclear Yes Yes Yes Yes Yes 
8. Were objective outcomes 
used or were outcomes 
assessed blindly?  
Yes Yes Unclear Yes Yes Unclear Yes Yes Yes Yes Yes Unclear Unclear 
9. Were incomplete 
outcome data (missing data 
or loss to follow-up) 
adequately addressed? 
Yes Unclear Unclear Unclear Unclear Yes Yes Yes Unclear Yes Yes Yes Yes 
10. Was the study free from 
selective outcome 
reporting? 
Unclear Unclear Unclear Yes Yes Unclear Unclear Yes Yes Yes Yes Yes Yes 
11. Was the study free from 
other risks of bias? 
Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear Unclear Yes Unclear  Yes Yes 
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Figure 4-3. The flow diagram describes the flow of information through the various 
stages of the systematic review.
References could clearly be excluded on basis 
of title/abstract (n=3,791) 
Potentially relevant references identified from 
database search and additional sources (n=3,837) 
Potentially relevant studies identified (n=46) 
Articles excluded after review of full text 
(n=25): 
Not in English (n=3) 
No original data or reviews (n=5) 
Duplicate publication (n=2) 
No associations of interest (n=13) 
Other intervention (n=2) 
 
Primary articles fulfilling inclusion for systematic 
review (n=21): 
Randomised controlled trials (n=7) 
Uncontrolled before-after-studies (n=14) 
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Table 4-7. Key characteristics of included trials. 
Trial Location Design Size Length of   
intervention 
Length of  
follow-up 
Intervention Key findings 
Suratt et al 
1987428 
USA Prospective 
observational 
8 4 weeks NR* Diet A great reduction in number of apnoeas and hypopnoea was observed 
among eight OSA patients. BMI was found to be highly correlated 
with AHI 
 
Pasquali et al 
1990451 
Italy Prospective 
observational 
23 6 months NR Diet Weight loss was associated with a significantly reduction in AHI. 
Weight loss was an important predictor of change in total number of 
apnoeas and  hypopnoea events  
 
Kajaste et al 
1994446 
Finland Prospective 
observational 
32 6 months 12 months, 
24 months 
Cognitive-
behavioural 
(encouraging 
low calorie 
diet) 
 
At 12-month follow-up there was a significant improvement in ODI4. 
At 2-year follow-up both BMI and ODI4 were lower compared to 
baseline which demonstrated that the participants were enthusiastic to 
sustain to the changes   
  
Hakala et al 
1995443 
Finland Prospective 
observational 
13 6 weeks NR Diet Rapid weight loss was observed following the utilisation of VLCD 
programme. There was a strong correlation between BMI and ODI4. 
Seven out of thirteen OSA patients achieved normal ODI4 after six 
weeks dietary weight loss intervention 
 
 
Lojander et al 
1998448 
Finland Prospective 
observational 
24 6 weeks 1 year Diet A nurse-managed dietary weight loss programme is relatively safe 
and cheap method to normalise sleep among OSA patients. No link 
was found between weight loss and ODI4 improvement 
 
Sampol et al 
1998452 
Spain Prospective 
observational 
67 NR 2 years Diet+ 
Exercise 
Mixed programme of dietary and physical activity weight loss 
interventions were associated with a significant reduction in AHI. 
OSA patients were also benefited the intervention in long term   
 
 
Kansanen et al 
1998447 
Finland Prospective 
observational 
18 3 months NR Diet Lifestyle weight loss through dietary intervention can be considered 
as an effective method to normalise sleep in obese OSA patients. 
Weight loss had a positive impact on  blood pressure and baroreflex 
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Table 4-7 cont’d       
Trial Location Design Size Length of   
intervention 
Length of   
follow-up 
 
Intervention Key findings 
Norman et al 
2000450 
 
USA Prospective 
observational 
11 6 months NR Exercise Regular exercise training had a positive impact on the AHI 
 
Kajaste et al 
2004433 
Finland Randomised 
controlled trial 
31 6 weeks 6 months, 
12 months, 
24 months 
 
Diet At 6-month follow-up, the mean reduction of weight loss was 19 kg 
and at 2-year follow-up was 13 kg which demonstrated that the 
participants were enthusiastic to sustain to the changes  
 
Habdank et al 
2006438 
Canada Randomised  
controlled trial 
 
18 6 months NR Diet Compared to usual care, the dietary intervention did not result in 
greater weight loss or improved AHI 
 
Kemppainen et al 
2008439 
Finland Randomised  
controlled  
trial 
52 3 months NR Diet  The intervention program achieved a significant reduction in BMI 
and AHI. There were no significant changes in rhinometric 
measurement 
Ueno et al 
2009453 
Brazil Prospective 
observational 
25 4 months NR Exercise No change was observed in anthropometric measurements, although 
exercise programme could potentially lessen the severity of OSA and 
improve  neurovascular function, quality of life and functional 
capacity 
 
Barnes et al 
2009442 
Australia  Prospective 
observational 
12 16 weeks 12 months Diet + 
Exercise 
A combined programme of dietary and physical activity programme 
was associated with significant improvement sleep apnoea, as well as  
cardiometabolic outcomes 
 
Johansson et al 
2009427 
Sweden Randomised  
controlled  
trial 
 
63 9 weeks NR Diet Weight loss via VLCD resulted a significant reduction in AHI among 
obese men  
Hernandez et al 
2009444 
USA Prospective 
Observational 
14 6 months NR Diet A significant reduction was observed in AHI between pre and post 
weight loss intervention. Patients with severe OSA at baseline had 
benefited the most from the intervention 
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Table 4-7 cont’d       
Trial Location Design Size Length of   
intervention 
Length of   
follow-up 
 
Intervention Key findings 
Sleep AHEAD 
2009437 
USA Randomised  
Controlled 
 Trial 
264 1 year NR Diet + 
Exercise 
It has been found that baseline AHI was a strong predictor of AHI 
reduction following a dietary weight loss intervention. It was also 
observed that OSA patients that could achieve weight reduction of 10 
kg had better improvement in AHI 
 
Tuomilehto et al 
2009441 
Finland Randomised  
controlled  
trial 
 
59 10 weeks 3 months, 
12 months 
Diet  The lifestyle weight loss intervention was associated with significant 
improvement in AHI. A dose-response trend was found between 
weight and AHI 
Nerfeldt et al 
2010449 
Sweden Prospective  
Observational 
33 8 weeks  2 years Diet The dietary weight loss programme resulted significant improvement 
in reducing AHI as well as weight, ODI,  and subjective symptoms 
 
Kline et al 
2011424 
USA Randomised  
controlled trial  
43 12 weeks NR Exercise AHI was significantly reduced following an aerobic exercise 
intervention. In contrast no reduction in weight and BMI was 
observed may also indicate that the association between weight loss  
and AHI improvement may goes beyond weight loss 
 
Sengul et al 
2011440 
Turkey Randomised  
controlled  
trial  
20 12 weeks NR Exercise The anthropometric characteristics of patients with mild to moderate 
OSA did not change after completion of exercise intervention, while 
significant improvement was ascertained in AHI, quality of sleep, 
quality of life 
 
Johansson et al  
2011445 
Sweden Prospective  
Observational 
63 9 weeks 1 year Diet Weight loss maintenance was achieved flowing 1-year follow-up. 
OSA patients with severe AHI had attained greater reduction in AHI 
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Table 4-8. Key characteristics of study participants. 
 
Trial 
 
Sex 
Age 
(years) 
Weight 
at baseline 
(kg) 
Weight after 
intervention 
(kg) 
BMI 
at baseline 
(kg/m2) 
BMI after 
intervention 
( kg/m2) 
AHI 
at baseline 
(events/hour) 
AHI after 
intervention 
(events/hour) 
ODI4 
at baseline 
(episodes/hour) 
ODI4 after 
intervention 
(episodes/hour) 
Suratt et al 1987428 M/F 48 153.0 134.7 54.6 45.9 25.3 22.7 33.0 20.1 
Pasquali et al 1990451 M/F 46 105.1 86.7 37.5 30.9 66.5 33.0 NR NR 
Kajaste et al 1994446 M/F 48 NR NR 38.5 35.0 NR NR 38.6 23.9 
Hakala et al 1995443 NR NR 111.0 95.0 35.0 31.8 NR NR 31.0 10.0 
Lojander et al 1998448 M 49 110.0 97.0 36.0 31.0 NR NR 30.0 13.0 
Sampol et al 1998452 M/F 53 NR NR 31.5 25.9 52.3 44.2 NR NR 
Kansanen et al 1998447 M/F 52 114.0 105.0 38.1 35.1 NR NR 31.0 19.0 
Norman et al 2000450 M/F 48 110.9 104.7 31.2 29.6 21.7 11.8 NR NR 
Kajaste et al 2004433 M/F 50 140.0 121.0 43.8 37.8 NR NR 51.0 23.0 
Habdank et al 2006438 M/F 50 NR NR  NR NR 26.3 
 
34.3 
 
NR NR 
Kemppainen et al 
2008439 
M/F 50 NR NR 33.0 
 
27.6 
 
11.0 
 
7.8 
 
NR NR 
Ueno et al 2009453 M/F 58 NRa NR 26.5 27.2 34.1 21.2 NR NR 
Barnes et al 2009442 M/F 42 95.6 82.9 36.1 30.1 24.6 18.3 NR NR 
Johansson et al 2009427 M 48 113.4 94.3 34.4 
 
28.7 
 
37.0 
 
12.0 
 
26.0 
 
7.0 
 
Hernandez et al 2009444 M/F 43 134.6 117.7 48.0 42.8 10.6 5.7 NR NR 
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*NR= Not Reported 
 
 
 
Table 4-8 cont’d 
 
Trial 
 
Sex 
Age 
(years) 
Weight 
at baseline 
(kg) 
Weight after 
intervention 
(kg) 
BMI 
at baseline 
(kg/m2) 
BMI after 
intervention 
( kg/m2) 
AHI 
at baseline 
(events/hour) 
AHI after 
intervention 
(events/hour) 
ODI4 
at baseline 
(episodes/hour) 
ODI4 after 
intervention 
(episodes/hour) 
Sleep AHEAD 2009437 M/F 61 102.9 90.5 36.8 
 
33.0 
 
22.9 
 
17.5 
 
18.6 
 
13.1 
 
Tuomilehto et al 2009441 M/F 50 101.2 90.5 33.4 
 
29.9 
 
10.0 
 
6.0 
 
NR NR 
Nerfeldt et al 2010449 M/F 52 122.0 110.0 40.0 35.0 43.0 28.0 42.0 23.0 
Kline et al 2011424 M/F 46 105.6 104.9 35.3 35.0 32.2 24.6 24.5 21.5 
Sengul et al 2011440 M 54 86.4 NR 29.7 29.2 15.1 11.0 NR NR 
Johansson et al  2011445 M 30-65 113.1 95.4 34.8 29.3 36.0 15.0 25.0 9.0 
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4.4.2 Effect of lifestyle intervention on obstructive sleep apnoea (OSA) 
Figure 4-4 shows the forest plot of differences in AHI changes between intervention 
and control groups after intervention in 7 randomised controlled studies (n = 532). The 
pooled mean reduction in AHI was -6.04 events/hour (-11.18 to -0.90). Heterogeneity 
between studies was high (Q = 42.26, df = 6, p <0.00001, I2=86%). Figure 4-5 shows 
forest plot of AHI changes after intervention from 9 before-and-after studies (n = 482). 
The pooled mean reduction in AHI was -12.26 events/hour (-18.51 to -6.02). 
Substantial heterogeneity was observed between studies (Q = 64.92, df = 8, p<0.00001, 
I2 = 88%). All five uncontrolled studies with ODI4 outcome reported significant 
reduction in amount of oxygen desaturation after the intervention. Figure 4-6 shows 
forest plot of ODI4 changes after intervention in 5 uncontrolled studies (n = 236). The 
pooled mean reduction in ODI4 was -18.91 episodes/hour (-23.40 to -14.43). There 
was little heterogeneity between studies (Q = 4.23, df = 4, p = 0.38, I2 = 5%).  
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Figure 4-4. Forest plot of differences in AHI (events/hour) changes between 
intervention and control groups after intervention in randomised controlled studies. 95 
CI indicates 95% confidence interval. 
 
 
 
 
 
 
Study or Subgroup
1.1.1 Diet
Habdank 2006
Kemppainen 2008
Johansson 2009
Tuomilehto 2009
Subtotal (95% CI)
Heterogeneity: Tau² = 84.46; Chi² = 36.57, df = 3 (P < 0.00001); I² = 92%
Test for overall effect: Z = 0.86 (P = 0.39)
1.1.2 Exercise
Kline 2011
Sengul 2011
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.22, df = 1 (P = 0.64); I² = 0%
Test for overall effect: Z = 2.84 (P = 0.005)
1.1.3 Diet+Exercise
Sleep AHEAD 2009
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 4.49 (P < 0.00001)
Total (95% CI)
Heterogeneity: Tau² = 36.55; Chi² = 42.26, df = 6 (P < 0.00001); I² = 86%
Test for overall effect: Z = 2.30 (P = 0.02)
Test for subgroup differences: Chi² = 3.89, df = 2 (P = 0.14), I² = 48.6%
Weight
4.8%
16.8%
13.8%
17.5%
52.9%
17.2%
13.3%
30.6%
16.5%
16.5%
100.0%
IV, Random, 95% CI
20.30 [0.14, 40.46]
0.10 [-4.02, 4.22]
-23.00 [-30.15, -15.85]
-3.60 [-6.81, -0.39]
-4.42 [-14.44, 5.61]
-4.30 [-7.85, -0.75]
-6.30 [-13.90, 1.30]
-4.66 [-7.87, -1.44]
-10.00 [-14.36, -5.64]
-10.00 [-14.36, -5.64]
-6.04 [-11.18, -0.90]
Year
2006
2008
2009
2009
2011
2011
2009
Mean Difference Mean Difference
IV, Random, 95% CI
-50 -25 0 25 50
Favours intervention Favours control
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Figure 4-5. Forest plot of AHI (events/hour) changes after intervention in uncontrolled 
before-after studies 95 CI indicates 95% confidence intervals. 
 
 
 
 
 
 
 
Study or Subgroup
1.2.1 Diet
Suratt 1987
Pasquali 1990
Hernandez 2009
Nerfeldt 2010
Johansson 2011
Subtotal (95% CI)
Heterogeneity: Tau² = 120.48; Chi² = 63.48, df = 4 (P < 0.00001); I² = 94%
Test for overall effect: Z = 2.78 (P = 0.005)
1.2.2 Exercise
Norman 2000
Ueno 2009
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.16, df = 1 (P = 0.69); I² = 0%
Test for overall effect: Z = 3.45 (P = 0.0006)
1.2.3 Diet+Exercise
Sampol 1998
Barnes 2009
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.08, df = 1 (P = 0.78); I² = 0%
Test for overall effect: Z = 2.30 (P = 0.02)
Total (95% CI)
Heterogeneity: Tau² = 68.41; Chi² = 64.92, df = 8 (P < 0.00001); I² = 88%
Test for overall effect: Z = 3.85 (P = 0.0001)
Test for subgroup differences: Chi² = 1.58, df = 2 (P = 0.45), I² = 0%
Weight
8.3%
8.4%
14.7%
10.5%
13.8%
55.7%
12.7%
8.8%
21.5%
11.8%
11.0%
22.8%
100.0%
IV, Random, 95% CI
-2.60 [-16.97, 11.77]
-33.50 [-47.75, -19.25]
-4.90 [-6.43, -3.37]
-15.00 [-25.44, -4.56]
-21.00 [-25.32, -16.68]
-15.00 [-25.56, -4.44]
-9.90 [-16.57, -3.23]
-12.90 [-26.26, 0.46]
-10.50 [-16.46, -4.53]
-8.10 [-16.37, 0.17]
-6.30 [-15.86, 3.26]
-7.33 [-13.59, -1.07]
-12.26 [-18.51, -6.02]
Year
1987
1990
2009
2010
2011
2000
2009
1998
2009
Mean Difference Mean Difference
IV, Random, 95% CI
-50 -25 0 25 50
Intervention better No intervention better
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Figure 4-6. Forest plot of ODI4 (episodes/hour) changes after intervention in 
uncontrolled before-and-after studies. 95 CI indicates 95% confidence intervals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study or Subgroup
Kajaste 1994
Hakala 1995
Lojander 1998
Kansanen 1998
Kajaste 2004
Total (95% CI)
Heterogeneity: Tau² = 1.51; Chi² = 4.23, df = 4 (P = 0.38); I² = 5%
Test for overall effect: Z = 8.26 (P < 0.00001)
Weight
15.0%
38.6%
21.7%
12.6%
12.2%
100.0%
IV, Random, 95% CI
-14.70 [-26.05, -3.35]
-21.00 [-27.81, -14.19]
-17.00 [-26.33, -7.67]
-12.00 [-24.43, 0.43]
-28.00 [-40.62, -15.38]
-18.91 [-23.40, -14.43]
Year
1994
1995
1998
1998
2004
Mean Difference Mean Difference
IV, Random, 95% CI
-50 -25 0 25 50
Intervention better No intervention better
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4.4.3 Effect of lifestyle intervention on body mass index (BMI) 
Figure 4-7 shows forest plot of differences in BMI changes between intervention and 
control groups after the intervention in randomised controlled studies. They reported 
a reduction in BMI after the interventions, but this was not statically significant. The 
pooled mean reduction in BMI was -2.32 kg/m2 (-5.06 to 0.42) but heterogeneity 
between studies was very high (Q = 128.16, df = 5, p<0.0001, I2 =96%). Figure 4-8 
shows the forest plot of BMI changes after intervention in uncontrolled before-and-
after studies. They also reported a significant reduction in BMI. The pooled mean 
reduction in BMI was -4.94 kg/m2 (-5.66 to -4.21). No heterogeneity was observed 
within each type of lifestyle interventions (e.g. diet, exercise and both combined), but 
a significant reduction in BMI appeared to have been observed only in diet or 
combined interventions but not in exercise interventions (test for differences between 
subgroups, p = 0.003). From the data, diet and exercise together appear to be most 
effective, but there are too few studies (1 RCT and 2 before-and-after studies). 
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Figure 4-7. Forest plot of differences in BMI (kg/m2) changes between intervention 
and control groups after intervention in randomised controlled studies. 95 CI indicate 
95% confidence intervals. 
 
 
 
 
 
 
 
Study or Subgroup
1.4.1 Diet
Kemppainen 2008
Tuomilehto 2009
Johnsson 2009
Subtotal (95% CI)
Heterogeneity: Tau² = 12.16; Chi² = 99.79, df = 2 (P < 0.00001); I² = 98%
Test for overall effect: Z = 1.80 (P = 0.07)
1.4.2 Exercise
Kline 2011
Sengul 2011
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.00, df = 1 (P = 0.97); I² = 0%
Test for overall effect: Z = 0.75 (P = 0.46)
1.4.3 Diet+Exercise
Sleep AHEAD 2009
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 4.65 (P < 0.00001)
Total (95% CI)
Heterogeneity: Tau² = 10.35; Chi² = 128.16, df = 5 (P < 0.00001); I² = 96%
Test for overall effect: Z = 1.66 (P = 0.10)
Test for subgroup differences: Chi² = 7.97, df = 2 (P = 0.02), I² = 74.9%
Weight
17.5%
18.4%
18.8%
54.7%
13.7%
13.6%
27.3%
18.0%
18.0%
100.0%
IV, Random, 95% CI
-3.90 [-5.64, -2.16]
-0.70 [-1.75, 0.35]
-6.40 [-6.84, -5.96]
-3.68 [-7.69, 0.32]
1.00 [-2.88, 4.88]
1.10 [-2.81, 5.01]
1.05 [-1.71, 3.81]
-3.30 [-4.69, -1.91]
-3.30 [-4.69, -1.91]
-2.32 [-5.06, 0.42]
Year
2008
2009
2009
2011
2011
2009
Mean Difference Mean Difference
IV, Random, 95% CI
-50 -25 0 25 50
Favours experimental Favours control
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Figure 4-8. Forest plot of BMI (kg/m2) changes after intervention in uncontrolled 
before-and-after studies. 95 CI indicates 95% confidence intervals. 
 
 
 
 
Study or Subgroup
1.5.1 Diet
Suratt 1987
Pasquali 1990
Kajaste 1994
Hakala 1995
Lojander 1998
Kansanen 1998
Kajaste 2004
Hernandez 2009
Nerfeldt 2010
Johansson 2011
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 3.00, df = 9 (P = 0.96); I² = 0%
Test for overall effect: Z = 14.81 (P < 0.00001)
1.5.2 Exercise
Norman 2000
Ueno 2009
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.69, df = 1 (P = 0.41); I² = 0%
Test for overall effect: Z = 0.36 (P = 0.72)
1.5.3 Diet+Exercise
Sampol 1998
Barnes 2009
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.05, df = 1 (P = 0.83); I² = 0%
Test for overall effect: Z = 8.65 (P < 0.00001)
Total (95% CI)
Heterogeneity: Tau² = 0.30; Chi² = 15.66, df = 13 (P = 0.27); I² = 17%
Test for overall effect: Z = 13.31 (P < 0.00001)
Test for subgroup differences: Chi² = 11.92, df = 2 (P = 0.003), I² = 83.2%
Weight
0.1%
2.5%
11.2%
0.9%
13.1%
3.2%
5.3%
0.8%
10.4%
24.4%
71.9%
3.5%
3.2%
6.7%
17.3%
4.2%
21.5%
100.0%
IV, Random, 95% CI
-8.70 [-35.41, 18.01]
-6.60 [-11.10, -2.10]
-4.60 [-6.49, -2.71]
-3.20 [-10.89, 4.49]
-5.00 [-6.70, -3.30]
-3.00 [-6.92, 0.92]
-6.00 [-8.97, -3.03]
-5.20 [-13.13, 2.73]
-5.00 [-6.99, -3.01]
-5.50 [-6.51, -4.49]
-5.20 [-5.88, -4.51]
-1.60 [-5.36, 2.16]
0.70 [-3.20, 4.60]
-0.49 [-3.20, 2.22]
-5.60 [-6.98, -4.22]
-6.00 [-9.40, -2.60]
-5.66 [-6.94, -4.37]
-4.94 [-5.66, -4.21]
Year
1987
1990
1994
1995
1998
1998
2004
2009
2010
2011
2000
2009
1998
2009
Mean Difference Mean Difference
IV, Random, 95% CI
-50 -25 0 25 50
Intervention better No intervention better
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4.4.4 Effect of lifestyle intervention on daytime sleepiness 
Data on the effect of weight loss interventions on common OSA symptoms was 
markedly lacking across studies. For the meta-analysis, we presented the results from 
RCTs427, 440, 441 first and then presented the results from before-after studies442, 445, 449 
as a subgroup. 
Figure 4-9 shows the forest plot of differences in Epworth Sleepiness Scale (ESS) 
across RCTs and before-after studies. The pooled mean reduction of ESS from RCTs 
was -1.04 (-2.31 to 0.23) and no heterogeneity was found between studies (Q = 
2.14, df = 2, p = 0.11, I2 =0%). The pooled mean reduction of ESS from before-after 
studies was -2.87 (-4.30, -1.44) low level heterogeneity was found between studies (Q 
=3.16, df = 2, p = 0.21, I2 =37%). 
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Figure 4-9. Forest plot of Epworth Sleepiness Scale (ESS) changes after intervention 
across the studies. 95 CI indicates 95% confidence intervals. 
 
 
 
 
 
 
 
Study or Subgroup
1.7.1 RCTs
Tuomilehto 2009
Johansson 2009
Sengul 2011
Subtotal (95% CI)
Heterogeneity: Tau² = 0.10; Chi² = 2.14, df = 2 (P = 0.34); I² = 6%
Test for overall effect: Z = 1.61 (P = 0.11)
1.7.2 Before-after studies
Barnes 2009
Nerfeldt 2010
Johansson 2011
Subtotal (95% CI)
Heterogeneity: Tau² = 0.59; Chi² = 3.16, df = 2 (P = 0.21); I² = 37%
Test for overall effect: Z = 3.94 (P < 0.0001)
Total (95% CI)
Heterogeneity: Tau² = 1.05; Chi² = 10.00, df = 5 (P = 0.08); I² = 50%
Test for overall effect: Z = 3.24 (P = 0.001)
Test for subgroup differences: Chi² = 3.54, df = 1 (P = 0.06), I² = 71.7%
Weight
23.1%
17.6%
5.4%
46.1%
8.1%
21.2%
24.6%
53.9%
100.0%
IV, Random, 95% CI
-0.80 [-2.33, 0.73]
-2.00 [-4.09, 0.09]
1.70 [-3.15, 6.55]
-1.04 [-2.31, 0.23]
-2.70 [-6.47, 1.07]
-4.00 [-5.71, -2.29]
-2.00 [-3.40, -0.60]
-2.87 [-4.30, -1.44]
-2.01 [-3.22, -0.79]
Year
2009
2009
2011
2009
2010
2011
Mean Difference Mean Difference
IV, Random, 95% CI
-50 -25 0 25 50
Intrvention better No intervention better
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4.4.5 Sensitivity analysis and investigation of heterogeneity 
We re-ran the meta-analysis excluding studies judged to be of lower quality. The 
overall findings remained unchanged in the sensitivity analysis.  
Substantial heterogeneity was observed between studies in the meta-analyses of AHI 
and BMI. I explored the source of heterogeneity by performing subgroup analyses and 
stratified the studies according to the baseline level of AHI (>25, 15-25, <15 
events/hour), change in BMI (0-3, 3-5, ≥5 kg/m2), and duration of intervention (≤12, 
>12 weeks) (Table 4-9).  The results indicate that the greatest source of heterogeneity 
was from studies with higher AHI at the baseline, and also those with greater change 
in the BMI. Meta-regression of the studies suggested a positive correlation between 
baseline AHI and change in AHI (r = -0.41, p = 0.001) (Figure 4-10) and between 
weight loss and change in AHI (r = 0.56, p = 0.186) although the latter did not reach 
statistical significance partly due to the small number of studies (Figure 4-11).     
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Table 4-9. Investigation of heterogeneity and findings from subgroup analysis. 
Subgroup category No. of 
studies 
Pooled mean change in 
AHI, 95% CI 
Heterogeneity 
(I2) 
Randomised Controlled Studies    
Baseline AHI    
AHI≥ 25 (events/hour) 3 -4.91 (-21.97, 12.15) 93% 
AHI 15-25 (events/hour) 2 -9.08 (-12.87, -5.30) 0% 
AHI<15 (events/hour) 2 -1.99 (-5.58, 1.61) 48% 
Test for subgroup differences: (p = 0.03)    
Change in BMI    
0-3 kg/m2 2 -7.12 (-9.14, -5.10) 12% 
3-5 kg/m2 2 -4.11 (-5.89, -2.33) 0% 
≥5 kg/m2 2 -13.74 (-35.10, 7.61)  95% 
Test for subgroup differences: (p = 0.07)    
Duration of intervention    
≤12 weeks 4 -8.78 (-15.65, -1.87) 88% 
>12 weeks 3 -0.67 (-11.18, 9.83) 88% 
Test for subgroup differences: (p = 0.52)    
Uncontrolled before-after studies    
Baseline AHI    
AHI≥ 25 (events/hour) 6 -15.60 (-22.95, -8.24) 71% 
AHI 15-25 (events/hour) 2 -8.72 (-14.19, -3.25) 0% 
AHI<15 (events/hour) 1 -4.90 (-6.43, -3.37) N/Aa 
Test for subgroup differences: (p = 0.01)    
Change in BMI    
0-3 kg/m2 2 -10.50 (-16.46, -4.53) 0% 
3-5 kg/m2 1 -15.00 (-25.44, -4.56) N/Aa 
≥5 kg/m2 6 -12.30 (-20.92, -3.68) 92% 
Test for subgroup differences: (p = 0.76)    
Duration of intervention    
≤ 12 weeks 3 -14.79 (-24.41, -5.17) 69% 
>12 weeks 5 -12.66 (-19.85, -5.47) 76% 
Test for subgroup differences: (p = 0.52)    
*N/A= Not Applicable  
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Figure 4-10. Regression analysis of pooled data on correlation of baseline AHI and 
change in AHI (the shading area represent the 95% confidence interval). 
 
 
Figure 4-11. Regression analysis of pooled data on reduction of weight and change in 
AHI (the shading area represent the 95% confidence interval). 
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4.4.6 Analysis of publication bias 
I assessed the presence of potential publication bias using Dear and Begg’s test.435 
There was no evidence of publication bias across 21 studies (Figure 4-12). I computed 
a simulation-based p-value to assess the null hypothesis of no selection bias across 
studies and the overall computed p-value was 0.76, which strongly support the 
previous indication. The estimated weight function which is a proportional to the 
probability that a study is published introduced by Dear and Begg,435 showed random 
configuration (no observable trend), which visually confirmed the lack of bias across 
the studies. Using Dear and Begg435 the estimated weight function for the current study 
was as follows: 0.330, 0.088, 0.359, 0.999, 0.179, 0.385, 0.174, 0.194, 0.153, 0.999, 
and 0.195. The weight was constructed based on the two sided p-value. For the (n) 
independent studies then the number of point in the weight function was equal to 1 + 
integer (n/2). 
 
 
Figure 4-12. Estimated of publication bias based on the Dear and Begg’s test.435 
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4.5 Discussion 
CPAP is commonly employed for the treatment for OSA and its sequelae. However, 
the adherence to CPAP is usually below the optimal level.172 The non-adherence level 
(≤4 hours of use per night) ranges from 29% to 83% among OSA patients.456 For the 
majority of patients with OSA, lifestyle change and weight loss are recommended by 
guidelines,174 but supportive evidence for this recommendation remains unexamined 
through systematic review and meta-analysis. This study provides a systematic review 
of the literature and quantitative assessments of the effect of the non-surgical and non-
pharmaceutical weight loss interventions on OSA. Based on the 21 studies (both RCTs 
and uncontrolled before-after studies) included representing 893 patients with OSA, a 
reduction in AHI was detected after completion of the intervention. The effect of the 
interventions seemed larger in uncontrolled before-after studies than in controlled 
studies. A significant portion of this can be explained through methodological 
differences between study designs. In before and after studies, both participants and 
investigators are aware that they are receiving active treatment, which will influence 
outcomes. It is well accepted that the most vigorous approach for detecting a cause-
effect association between treatment and outcome is using a randomised controlled 
trial approach. In clinical trial design, investigators seek to fully control the exposure 
in terms of its type, amount, and duration, and most importantly who receives it 
through the randomisation procedure. A control group is the main feature of all 
randomised controlled trials. The main purpose of the control group is to measure 
cumulative effects of all other factors (spontaneous improvements, non-specific 
responses, and specific treatment effects) other than active treatment itself that can 
influence outcome over time. In absence of control arms in uncontrolled before-after 
studies, participants may change their behaviour as a result of simply being observed 
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by a healthcare worker rather than because of any manipulation of independent 
variables (e.g. the Hawthorne effect). However, even in clinical trials the Hawthorne 
effect may blunt the difference between the placebo and the active treatment, but 
cannot explain the absence of a significant difference. Concealed random allocation is 
another important feature of randomised controlled trials that eliminates (or at least 
greatly reduces) confounding from known and unknown prognostic factors, thus the 
groups become equivalent in terms of their prognosis at baseline). Through the process 
of concealment, unpredictability is assured, which crucial in preventing selection bias.  
Blinding is another feature of randomised controlled trials that ensures that views of 
clinicians and statisticians cannot bias the outcomes, so that outcomes are measured 
with the same degree of accuracy and completeness in every participant. Blinding 
prevents measurement bias as opposed to concealed random allocation which prevent 
selection bias and confounding bias.  Finally, in randomised controlled trials, patients 
are analysed within the group that they were initially allocated regardless of whether 
they experienced the intended intervention (intention to treat analysis). 
This allows the findings to be more applicable to the clinical setting. I explored the 
source of heterogeneity by performing sub-group analysis; I categorised the studies 
into three groups based on their baseline AHI, duration of intervention, and change in 
BMI. 
4.5.1 Obesity is an important risk factor for OSA 
It is known that obesity is an important risk factor for OSA.161 The increasing 
prevalence of OSA, driven by increasing levels of obesity necessitates an approach to 
treatment that not only addresses the symptoms of OSA, but also the obesity that 
contributes to some extent to OSA development and severity.  
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Obesity is associated with a higher risk of OSA, but conversely OSA is found to be 
associated with an increased risk for obesity.167 The mechanism for these associations 
are complex with many factors contributing to the relationship between obesity and 
OSA. These include anatomical narrowing of the upper airway and physiological 
alterations in airway control. Additionally, obesity impacts on ventilation through 
increased abdominal pressure secondary to visceral adiposity accompanied by 
impaired diaphragmatic and ribcage movement. Other mechanisms are described 
above. On the other hand, OSA may promote obesity.167 Sleep fragmentation as a 
result of OSA makes individuals sleepy during the day, which could ultimately lead to 
inactivity. 457 Evidence indicates that OSA could also negatively influence glucose 
metabolism.458 For example, growth hormone (GH), a hormone that regulates 
metabolism is secreted during slow-wave sleep. It is believed that the negative effect 
of OSA on slow-wave sleep, and hence GH, may be a potential explanation on how 
OSA causes diabetes.458 The negative impact of sleep disturbance on appetite and 
energy metabolism could be another explanation on how OSA could promote 
obesity.459 It can be hypothesised that OSA could alter the secretion and 
responsiveness of appetite hormones such as leptin and ghrelin, but one study has 
suggested that this may not be the case.460   
4.5.2 Effect of lifestyle interventions on OSA 
The meta-analysis of the seven randomised controlled trials detected a reduction in 
AHI after completion of the intervention. The meta-analysis of fourteen uncontrolled 
before-and-after studies also showed a reduction in AHI and ODI4. Substantial 
heterogeneity was observed across studies that reported AHI as an outcome. Subgroup 
analysis showed that heterogeneity resulted from the studies with severe OSA at 
baseline with meta-regression indicating a linear relationship between baseline AHI 
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and reduction in AHI, while the latter suggests a greater intervention effect in patients 
with more severe OSA, the possible influence of regression to the mean, can be ruled 
out,461 which is a statistical feature that can be caused by enrolment of participants in 
trials based on a single baseline measurement.  Regression to the mean is a main issue 
within uncontrolled before-after studies. However, in RCTs, the effect should be equal 
between groups and therefore its influence is expected to be cancelled out in ‘between-
group difference’ data.   
Overall, few studies demonstrated the normalisation of AHI with the interventions 
employed. For the seven randomised controlled studies that have reported AHI as their 
outcome, only two studies427, 437 attained a reduction in AHI of more than 10 
events/hour and in nine uncontrolled studies that also reported AHI as their outcome, 
only three studies445, 449, 451  reported a reduction in AHI of more than 10 events/hour. 
The significant reduction in ODI4 was achieved by all five uncontrolled studies. It 
seems that the interventions may have greater impact on reduction of ODI4 compared 
to AHI. Apart from OSA, obesity has effects on ventilation, which may explain the 
greater effect observed with ODI4. The results indicated that interventions that 
employed physical activity alone were not successful in reducing AHI compared to 
dietary approaches. A combination of diet and physical activity, however, resulted in 
significant reductions in AHI. While physical activity alone may not be as effective 
for weight loss as dietary interventions, it has a role in weight loss maintenance.424 
The exact mechanism underlying the effect of lifestyle intervention on OSA is yet to 
be confirmed, because, at least in the meta-analysis of RCTs, there was no significant 
difference in BMI. The results from the studies with physical activity weight loss 
showed no significant change in body weight and BMI, yet a positive effect on AHI. 
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Interestingly, a recent published meta-analysis426 on the effect of weight loss via 
bariatric surgery reported that the mean AHI still remained at moderate levels even 
after surgical weight loss. It might indicate that improvement in OSA might go beyond 
the weight loss.462 There are several hypotheses regarding the impact of increased 
physical activity and reduced AHI.268, 370, 462 It has been previously suggested that 
thermogenic enhancement, and energy alterations effectively contribute to changes in 
sleep-awake cycle.463 It has been found that exercise training normalises 
chemoreceptor sensitivity in athletes which can improve breathing.464 It is also 
hypothesised that a further possible cause of decrease in AHI is increased strength of 
tongue muscles as a result of inspiratory and expiratory pressure following increased 
physical activity.465  
4.5.3 Effect of lifestyle interventions on BMI 
The pooled estimate of six randomised controlled trial (one trial438 did not report the 
data on change of BMI) showed a decrease in BMI, but this was not statically 
significant. The meta-analysis of fourteen uncontrolled before-after studies showed a 
significant reduction in BMI. I observed relatively mild heterogeneity across studies, 
therefore sub-group analysis was performed and the results showed that the main 
source of the heterogeneity comes from greater changes in BMI ≥5 kg/m2.   
Three RCTs427, 437, 441 that investigated the impact of weight loss on severity of OSA 
have reported that a mean range of weight loss by 10-16% can reduce AHI by 20% to 
50%. Three uncontrolled before-after studies442, 449, 451 on weight loss also reported that 
the average weight reduction by 13% and 30% is associated with a decrease in AHI by 
10% to 50%. A prospective analysis from the Wisconsin Sleep Cohort161 demonstrated 
that a 10% weight loss was associated with a 26% reduction in AHI. However it seems 
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less likely that the 10% reduction of weight from baseline could be applicable to all 
the individuals as there could be other factors that contribute to the reduction of AHI. 
Johansson and colleagues427 suggested that the baseline AHI is a strong predictor for 
reduction in AHI using a dietary weight loss intervention. They indicated that patients 
with severe OSA at baseline are more likely to benefit from the intervention.427 Foster 
and colleagues437 in the Sleep AHEAD study also reported that the initial AHI and 
weight loss contributes to the change in AHI. They reported that a 1-kilogram decrease 
in total body weight was associated with a reduction in AHI of 0.6 events/hour.437 An 
uncontrolled before-after study by Hernandez and colleagues444 also postulated that 
patients with severe OSA had a greater reduction in AHI. The amount of weight loss 
that an individual with OSA needs to achieve a significant reduction in AHI is 
unique.451 The confounding part is otorhinolaryngological anatomy differences 
between individuals.466, 467 The adipose tissue distribution is different for different 
individuals, which makes it difficult follow a single recommendation for weight loss 
in order to achieve OSA improvement.468 
A major obstacle with lifestyle weight loss interventions the sustainability of reduced 
weight and adherence to the new lifestyle.  Data describing a longer follow-up period 
is extensively lacking. Tuomilehto and colleagues441 indicated that after a one year 
follow-up, the average weight loss of their participants was 11 kg.  Kajaste and 
colleagues433 also indicated that at 6-month follow-up, the mean reduction of weight 
loss was 19 kg and at 2-year follow-up was 13 kg which demonstrated that the 
participants were enthusiastic to sustain to the changes.  The result of the 2-year dietary 
weight loss intervention by Nerfeldt and colleagues449 indicated that sustained 
improvement in OSA severity was acquired following long-term weight loss 
maintenance. Similar improvements were obtained following a 1-year weight loss 
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program by Johansson and colleagues.427 The Sleep AHEAD study469 examined 
whether the initial improvement in OSA using intensive lifestyle intervention would 
be maintained after a 4-year follow-up duration. The results demonstrated that amount 
of weight loss over time was a strong predictor of change in AHI. Despite a 50% 
weight regain, however, improvement in AHI persisted at four years.  
Using anti-obesity medication could potentially be considered as a promising approach 
to achieve weight loss maintenance in long term.470-472 Thus, more long-term studies 
are required to examine the effectiveness of such treatment in sleep apnoea 
improvement.  
4.5.4 Effect of lifestyle interventions on daytime sleepiness 
Daytime sleepiness is a well-recognised symptom of OSA. Daytime sleepiness is 
associated with an increased risk of road and occupational accidents. Data on the 
impact of lifestyle weight loss intervention on daytime sleepiness are broadly lacking 
and surprisingly only few studies, three randomised controlled trials427, 440, 441 and three 
before-after studies442, 445, 449, examined the impact of lifestyle intervention on 
excessive daytime sleepiness or other symptoms of OSA. All of these studies had 
measured the daytime sleepiness via the Epworth Sleepiness Scale (ESS) which is a 
validated self-administrated questionnaire that evaluates the likelihood of dozing off 
in 8 different situations.31 The higher total scores indicate higher levels of sleepiness.31 
The results indicate that lifestyle weight loss intervention could improve the ESS 
score. It should be taken into account that although the OSA patients subjectively 
reported better ESS, it does not indicate that objective measures of sleepiness are 
necessarily consistent with these results.473 Future studies are needed to measure 
sleepiness via objective measures such as the Multiple Sleep Latency Test (MSLT) or 
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the Multiple Wakefulness Test (MWT). Obese individuals are more likely to feel 
sleepy and this can be independent of OSA.168 Even following the completion of the 
lifestyle intervention, the majority of the patients were still in the obesity category 
range (BMI ≥30 kg/m2). The adverse consequences of untreated excessive daytime 
sleepiness should be recognised. Evidence indicates that a reduction in weight via 
bariatric surgery did not eliminate the OSA symptoms and in particular daytime 
sleepiness.173 Weight loss may not be considered as an effective therapy method for 
OSA, however even minimal weight loss has been found to be associated with a 
reduction in metabolic parameters.474 For example, in a recent 4-arm RCT,475 439 
obese middle aged women were assigned to dietary weight loss, exercise, both diet 
and exercise intervention or control group. The success of the interventions was 
defined as 10% weight loss from baseline. Following completion of 12 months 
interventions, a significant improvement was detected in insulin resistance measured 
by the Homeostasic Model of Assessment-Insulin Resistance (HOMA-IR) in the diet  
(-24%, p<0.001) and both diet and exercise (-26%, p<0.001) groups compared with 
the control group. Moreover, individuals with impaired fasting glucose (5.6-6.9 
mmol/L) in the diet (OR 2.5, 95% CI 0.8 - 8.4), exercise (OR 2.76, 95% CI 0.8 - 10.0), 
both diet and exercise (OR 3.1, 95% CI 1.0 - 9.9) were more likely to regress to normal 
fasting glucose compared with controls.475 
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4.5.5 Clinical implications 
Compared to bariatric surgery, lifestyle weight loss interventions such as diet and 
physical activity with lower cost and lower adverse outcomes are a potential treatment 
option for OSA improvement. These interventions, however, based on the current 
evidence examined, are unlikely to normalise breathing during sleep. Nevertheless, a 
sufficient change in AHI is likely to reduce the severity of OSA, which could, in turn, 
reduce its cardiovascular consequences.476 The meta-regression carried out, although 
not statistically significant, most likely due to lack of statistical power, shows that the 
greatest weight loss is associated with greatest improvement in AHI. It appears that at 
least a 5% and preferably at 10% weight loss is required to be beneficial to making the 
greatest impact on OSA parameters and cardiovascular health.427 Importantly, those 
with greatest AHI at baseline, who are at greatest risk for the cardiovascular 
consequences of OSA, are most likely to benefit from the lifestyle interventions 
employed.  
The most dramatic weight loss has been observed with bariatric surgery and 
interventions employing VLCD (intake <800 kcal.d-1).173, 477, 478 A systematic review 
of randomised weight loss trials with a minimum follow-up of a year suggested that 
VLCD achieved up to 10% weight reduction from baseline after a year, compared with 
pharmacologic treatment (8% weight reduction).479 The long-term outcomes of 
bariatric surgery and VLCD interventions are unclear with both being associated with 
varying degrees of weight regain and potentially the resurgence of OSA.480 The 
findings from studies employing VLCDs, however, demonstrate that this approach 
may be useful clinically for reducing measures of OSA.  
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Based on my findings, lifestyle weight loss interventions cannot be accepted as a 
curative treatment for OSA. As stated earlier, OSA is associated with an increased risk 
of metabolic disturbances481 and even a slight change in weight may help to reduce 
these metabolic abnormalities. It is well-known that weight reduction as a treatment 
for normalisation of sleep among OSA patients is certainly more difficult than weight 
loss maintenance among these individuals. Lifestyle weight loss interventions can be 
used in the early stage of the disease. A recent published study by Hood and 
colleagues482 postulated that weight loss via lifestyle intervention could potentially 
increase CPAP adherence. 
4.5.6 Strengths and limitations 
I conducted a comprehensive systematic review and meta-analysis to evaluate the 
effectiveness of lifestyle weight loss intervention for OSA patients. One of the 
strengths of the study is a published protocol which indicates that the research strategy 
and inclusion criteria have been checked by peer review. 429 As a result of the small 
number of randomised controlled trials identified, uncontrolled before-and-after 
studies were also included in this review to provide supportive evidence. Two 
independent reviewers searched the relevant studies and also checked data extraction 
and data analysis procedures. A recent published systematic review and meta-
analysis483 including 9 studies representing 557 OSA patients, evaluated the efficacy 
of dietary weight loss interventions. The results demonstrated that the severity of OSA 
was noticeably improved by such interventions. The study combined the results of both 
RCTs and uncontrolled before-after studies. Uncontrolled before-and-after studies, 
however, have limitations. These include small sample size, lack of control group, and 
systematic errors. Additionally, I evaluated the impact of physical activity 
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interventions on OSA. I statistically assessed the effect of potential selection bias 
across the studies and computed the overall p-value and the results showed that the 
study is free from publication bias. The overall quality of the included studies was 
assessed via Cochrane risk of bias tools and Cochrane Effective Practice and 
Organisation of Care Group (EPOC) risk of bias tool. The study also benefited from 
compliance of PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-
Analyses). A potential source of heterogeneity was explored. Appropriate subgroup 
analysis was planned to investigate the source of heterogeneity when required. 
A potential limitation of the study is that the overall quality of included randomised 
studies was fairly poor. The absence of control groups and low sample size of before-
after studies makes it difficult to draw any concrete conclusions from these studies. 
The mean age of the participant across the studies is 45 years and above, so the results 
cannot be generalised to younger individuals.  
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4.6 Key points 
The results of the study revealed that lifestyle weight loss interventions could 
potentially improve OSA. It should be taken into account that such interventions are 
insufficient to normalise breathing during sleep, but may be used to increase the 
efficacy and adherence of other treatments such as CPAP. Future robust randomised 
controlled trials with longer follow-up periods are needed to confirm the results. The 
improvement in OSA by utilisation of such interventions may go beyond weight loss, 
and future studies are needed to control for potential mediators such as upper airway 
size, nasal resistance, and lung volume. To date, several treatment options have 
reported residual sleepiness despite the reduction of AHI up to the normal level (<5 
events/hour). The adverse outcome of excessive daytime sleepiness needs to be more 
appreciated in future studies. 
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5 CONCLUSIONS AND FUTURE WORK 
5.1 Predictors of total sleep duration in older Chinese adults- The 
Guangzhou Biobank Cohort Study (GBCS) 
The findings indicated that being female, older, widowed, having lower education 
level, and having lower income levels, were strongly associated with short sleep 
duration, while hypertension was strongly associated with long sleep duration. 
Additionally, the results of the logistic regression model controlling for age, gender, 
marital status, education level, income level, smoking, alcohol consumption, physical 
activity, obesity, hypertension and diabetes showed that long sleep duration was 
significantly associated with obesity and both short and long sleep duration were 
associated with hypertension in the whole sample. No significant association was 
found between sleep duration and diabetes in the whole sample. The results of the 
stratified analysis by gender and age showed that there was an inverse association 
between short and long sleep duration and obesity among males aged 65 years and 
older. In females, aged below 65 years, only long sleep duration was positively 
associated with obesity. Short sleep duration was associated with hypertension among 
older males, while in younger females, long sleep duration was associated with 
increased risk of hypertension. Moreover, in older females, only short sleep duration 
was positively associated with increased risk of diabetes. 
Effect of sleep duration on body weight among younger populations is well known; 
however, the presence of such an association among older populations is less studied 
and requires further investigation. Alteration in sleep patterns in older populations may 
not have a similar effect on metabolism as in younger individuals, due to the high 
prevalence of other chronic conditions such as hypertension, diabetes, and arthritis, 
which may influence their sleep. The present study also suggested that the association 
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between sleep duration, obesity, hypertension and diabetes may differ between men 
and women. Present knowledge of the mechanisms for such associations is insufficient 
to explain sex differences. Thus, findings of the study on this particular issue should 
be confirmed in future studies. A better understanding of the lifestyle factors that 
correlate with sleep duration will provide perspectives for future studies to establish 
appropriate therapies and health interventions to improve sleep behaviours in order to 
enhance health and functioning among older populations. 
5.1.1 Future work  
The present study was one of the few studies that have examined factors associated 
with sleep duration among a representative sample of older individuals and also 
examined the association between sleep duration and obesity, hypertension, and 
diabetes among men and women. Identifying determinants of sleep duration is 
important because such factors can be addressed in future health promotion 
interventions aiming to increase sleep duration among potentially sleep-deprived 
individuals. Sleep problems could be potentially improved by targeting modifiable 
lifestyle factors such as diet, smoking, drinking, and physical activity, which may also 
help prevent the initiation and progression of chronic diseases. The association 
between sleep duration and health complications should be further examined in older 
individuals, as sleep patterns change dramatically across the life span.  The potential 
gender differences in the relationship between sleep duration and obesity, hypertension 
and diabetes require further investigation, since evidence from previous literature is 
relatively controversial. Future studies should be conducted to investigate the 
hormonal difference in response to sleep duration in men and women.  
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The present study and also the majority of population-based studies and surveys have 
employed self-report measures of sleep duration, which could not necessarily indicates 
actual sleep time and may reflect the total time in bed. Nevertheless, time in bed, the 
usual surrogate for sleep in large population studies, has been shown to have 
implications for health. With increasing availability and reduced costs of actigraphy, 
it will be possible to include an objective measure of sleep in population studies. Future 
studies should aim to sufficiently characterise “short sleepers” and “long sleepers”, 
and ascertain that from what extent deviation from certain actual sleep time or the total 
time sleeping in bed should be referred to as short sleep or long sleep. Future studies 
should also control for a greater range of potential cofounding factors.    
5.2 The complex associations among sleep quality, anxiety-depression, 
and quality of life in patients with extreme obesity 
The above published study was the first study to investigate the associations among 
poor sleep quality, and mood and quality of life, in individuals with extreme obesity. 
The study benefited from a large clinical sample size and detailed statistical analysis. 
Overall, the participants reported short sleep duration and poor sleep quality. Anxiety 
and depressive symptoms were relatively high among these individuals. Moreover, 
participants reported low scores on all components of quality of life, and in particular 
self-esteem.  The findings from linear regression analysis showed that poor sleep 
quality and excessive daytime sleepiness were positively associated with anxiety and 
depression symptoms and these were also associated with impaired quality of life. 
Structural equation modelling (SEM) supported the earlier findings from regression 
models. Short sleep duration and poor sleep quality are relatively prevalent among 
obese individuals. It is well known that insufficient sleep per se may contribute to 
incident and progression of obesity. Addressing sleep problems among obese 
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individuals could potentially prevent worsening obesity and progression of further 
psychological conditions among these individuals.  
5.2.1 Future work 
Previous studies among samples of non-obese individuals showed that there is a close 
relationship between sleep loss and depression that may also have deleterious impact 
on individuals’ quality of life. Previous studies have consistently reported a high 
prevalence of psychiatric disorders among those with insomnia and vice versa. Prior 
work has also shown that for individuals who suffer from both conditions, treating 
insomnia may eliminate depressive symptoms. It is known that poor sleep quality is 
prevalent among individuals with extreme obesity, and poor sleep may increase the 
risk of development of further adverse physical and mental health outcomes and also 
worsen obesity per se. It can be hypothesised that treatment of sleep problems among 
individuals with extreme obesity could potentially prevent worsening obesity, and 
could also prevent initiation and progression of psychological conditions such as 
depression among these individuals. Future randomised controlled trials are needed to 
investigate the effectiveness of sleep improvement interventions on body weight, 
mood, and quality of life.  
Future experimental studies are needed to examine the underling mechanisms between 
sleep loss and mental health. Additional investigation needs to be conducted to fully 
explore the potential role neurobiological consequences of sleep loss on initiation and 
development of depression. Further functional imaging techniques are needed to fully 
assess the patterns of activity in specific brain regions that are both implicated in sleep 
and in depression. 
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5.3 The effectiveness of lifestyle interventions on obstructive sleep apnoea 
(OSA): systematic review and meta-analysis 
Given the increase in prevalence of obesity, OSA is likely to become an even greater 
health challenge. My published study provided a systematic review of the literature 
and quantitative assessments of the effect of the non-surgical and non-pharmaceutical 
interventions on OSA. Twenty-one studies, representative of 893 patients with OSA, 
were found to be eligible for inclusion. The meta-analysis of seven randomised 
controlled trials involving 519 participants, detected a reduction in AHI after 
completion of the intervention. Additionally, the meta-analysis of fourteen 
uncontrolled before-and-after studies involving 374 participants showed a reduction 
in AHI and ODI4. The results also indicated that interventions that employed physical 
activity alone were not successful in reducing AHI compared to dietary approaches. A 
combination of diet and physical activity, however, resulted in significant reductions 
in AHI. Compared to bariatric surgery, lifestyle weight loss interventions such as diet 
and physical activity, which likely to be of lower cost with lower adverse outcomes, 
are a viable treatment option for OSA. These interventions, however, based on the 
current evidence examined, are unlikely to normalise breathing during sleep. 
Therefore, lifestyle weight loss interventions cannot be accepted as a curative 
treatment for sleep apnoea. However, lifestyle interventions have additional health 
benefits that could improve the quality of life in patients with OSA.  
5.3.1 Future work  
Excessive daytime sleepiness is a well-recognised symptom of OSA that may increase 
the risk for several adverse health conditions. Data on the impact of lifestyle weight 
loss on daytime sleepiness intervention are broadly lacking. Future studies are needed 
to measure sleepiness via objective measures such as the Multiple Sleep Latency Test 
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(MSLT). None of the studies examined investigated the impact of lifestyle 
interventions in OSA patients on quality of life. Also, no health economic evaluation 
has been carried out to examine whether these interventions are cost-effective. Future 
randomised controlled trials need to incorporate these essential components. 
A major obstacle with lifestyle weight loss interventions is sustainability of the 
reduced weight and adherence to the new lifestyle.  Data describing a longer follow-
up period are extensively lacking. Additionally, the exact mechanism underlying the 
effect of weight loss on OSA is less well understood. There is a now need for larger 
randomised controlled trials aiming for at least a 10% weight loss and longer term 
follow-up to examine the effectiveness of such treatment scheme in improvements of 
sleep apnoea. In the meantime, given that there are cardio-metabolic benefits of weight 
loss, there is a need for a more proactive role in treating obesity amongst the OSA 
patient population. 
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5.4 Final conclusions  
Sleep is one of the fundamental aspects of healthy living and increasing evidence 
suggests that it should be a pillar of a healthy lifestyle in addition to diet and physical 
activity. Insufficient sleep may have a deleterious impact on both physiological and 
psychological well-being. It should also be taken into account that impact of sleep on 
health could potentially be attenuated across the life span and is likely to be influenced 
by ethnicity and environmental factors. Untreated sleep disorders such as chronic sleep 
loss, excessive daytime sleepiness and OSA may result in road and occupational 
accidents and increase economic burden and health care utilisation. Overall, this thesis 
highlighted the potential link between different dimensions of sleep (sleep duration, 
sleep quality and obstructive sleep apnoea) and obesity. Moreover, it also suggested 
that the association between sleep duration and obesity may differ between older men 
and women. The evaluation of the sleep patterns among individuals with extreme 
obesity showed that these individuals have a short average sleep duration and reported 
poor sleep quality. The poor sleep factors were also shown to be associated with 
impaired mood and quality of life among these individuals. This may influence weight 
gain and influence weight loss outcomes, which needs to be confirmed through further 
study. 
OSA often accompanies obesity. A slight reduction in severity of OSA may be 
achieved as a result of weight loss, using lifestyle interventions among obese 
individuals. Modification in lifestyle habits, including sleep behaviours, diet, and 
exercise maybe a key to maintaining a healthy weight. Although sleep problems 
contributes to obesity, the reverse association is also true, obesity may cause sleep 
problems. The nature and the direction of this association requires further study, using 
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measures from several domains, including sleep (objective and subjective), stress 
(physiologic, emotional, and social), and mental and physical health. In general, the 
obesity epidemic requires a multidimensional approach, promoting a healthy lifestyle, 
which includes attention to sleep quality and duration. 
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C) Standard (static) lung volumes as measured with a spirometer (Chapter 4) 
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D) MEDLINE search strategy used to identify studies for systematic review  
(Chapter 4) 
 
1. exp Sleep Apnea Syndromes/ 
2. (sleep$ adj3 (apnea$ or apnoea$)).mp. 
3. (hypopnea$ or hypopnoea$).mp. 
4. OSA.mp. 
5. SHS.mp. 
6. OSAHS.mp. 
7. or/1-6 
8. lifestyle.mp. 
9. exercise.mp. 
10. weight loss.mp. 
11. weight.mp. 
12. physical activity.mp. 
13. or/8-12 
14. 7 and 13 
Filter to identify RCTs 
1. exp “clinical trial [publication type]”/ 
2. (randomised or randomised).ab,ti. 
3. placebo.ab,ti. 
4. dt.fs. 
5. randomly.ab,ti. 
6. trial.ab,ti. 
7. groups.ab,ti. 
8. or/1-7 
9. Animals/ 
10. Humans/ 
11. 9 not (9 and 10) 
12. 8 not 11 
 
The MEDLINE strategy and RCT filter are adapted to identify trials in other 
electronic databases 
 
